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1. Introduction  
1.1 Mitochondria in cellular Ca2+ signalling and cell death. 
A basic notion of cell biology is that calcium, in its ionic form (Ca2+), is a ubiquitous 
second messenger of eukaryotic cells, participating in numerous signal transduction pathways. 
Cellular Ca2+ signals are crucial in the control of most physiological processes, cell injury and 
programmed cell death. Mitochondria, in addition to their function as cellular power plants, 
have been recognized to play a central role in Ca2+ homeostasis and cellular Ca2+ signalling 
(Duszynski et al., 2006).  
It has been known for several decades that sequestration of vast amounts of Ca2+ in 
the mitochondria occurs under various pathophysiological conditions and contributes to the 
demise of the cells (Krieger and Duchen, 2002). In these paradigms, the loss of the balance 
between plasma membrane Ca2+ influx and Ca2+ export leads to a sustained elevation in 
cytosolic Ca2+ from 100 nM to ≥ 1 μM, inducing a progressive increase in mitochondrial Ca2+ 
uptake. Mitochondria dampen changes in cytosolic Ca2+ loads and sustain cellular Ca2+ 
homeostasis that is required for normal function of cells. However, mitochondria take up a 
limited amount of calcium up to a certain threshold. Accumulation of Ca2+ over-load leads to 
increased permeability of the inner mitochondrial membrane due to formation of an 
unselective pore at the contact site between outer and inner membranes (Smaili et al., 2000; 
Sullivan et al., 2005). This permeability transition pore (PTP) forms the major Ca2+ efflux 
pathway from mitochondria. Since mitochondria both accumulate and release Ca2+, these 
organelles play various roles within cells (Giacomello et al., 2007).  
Opening of the PTP by Ca2+ is effectively modulated by several factors, including 
reactive oxygen species (ROS), pH, mitochondrial membrane potential (Δψm), the level of 
which is affected by a variety of metabolic intermediates, signalling molecules and drugs 
(Bernardi, 1999). Although Ca2+-dependent mitochondrial membrane permeabilization has 
been implicated in a broad range of cell death and tissue injury, the exact mechanism of the 
PTP opening remains elusive (Hajnoczky et al., 2006). Therefore study and search for new 
proteins and molecules involved in control of Ca2+-induced PTP opening will provide 
additional insight into pathways that are critical for cell survival and cell death. 
1.1.1 Permeability transition pore (PTP) 
The mitochondrial permeability transition is defined as the sudden nonselective 
increase in the permeability of the inner mitochondrial membrane (IMM) to solutes of 
molecular mass less than ~1500 Da, and results in loss of mitochondrial membrane potential, 
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mitochondrial swelling, and rupture of the outer mitochondrial membrane (OMM). More than 
30 years ago, it was first reported that the mitochondrial permeability transition is a 
consequence of Ca2+-induced increased permeability of the IMM that is characterized by 
simultaneous stimulation of ATPase, uncoupling of oxidative phosphorylation, and loss of 
respiratory control (Hunter et al., 1976).  
Later it was suggested that the mitochondrial permeability transition is not a 
consequence of non-specific mitochondrial membrane damage; it is, instead, the result of the 
opening of an authentic pore or megachannel. The last 25 years of study dealing with the 
mitochondrial permeability transition have been characterized by an intensive search for the 
identity of the components of the mitochondrial permeability transition megachannel. 
The permeability transition pore (PTP) is a multi-component protein aggregate in 
mitochondria that comprises factors in the inner as well as in the outer mitochondrial 
membrane. The scheme of the classical view of PTP complex is described in Fig.1.1. The 
pore frame was thought to be formed by the voltage-dependent anion channel (VDAC), 
known also as porin – adenine nucleotide translocase (ANT) – cyclophilin D (CyP-D) 
complex, which is located at the contact sites between IMM and OMM. It was found also that 
the peripheral benzodiazepine receptor (PBR) is a mitochondrial outer membrane protein 
associated with PTP (Szabo and Zoratti, 1993). Cytosolic hexokinase and mitochondrial 
creatine kinase also were shown to be involved in mitochondrial permeability transition 
regulation (Beutner et al., 1998).  
It was suspected for a long time that the PTP might play an important role in both 
apoptotic and necrotic cell death. Therefore, it came as no surprise when PTP was found 
under the direct control of anti-apoptotic members of the Bcl-2 family (Marzo et al., 1998a). 
Further, Bax was found to co-purify with known PTP components (Marzo et al., 1998b). 
Consequently, the Bcl-2 family members were integrated into the PTP model as regulatory 
components.  
The proposed architecture of PTP complex was based on these data. This model has 
become widely accepted and until now has been recognized by investigators in the field of 
mitochondrial research.  
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Fig. 1.1. Classical view of proposed PTP complex architecture. The pore structure is formed by the 
VDAC–ANT–CyP-D complex, which is located at the contact sites between IMM and OMM. 
Hexokinase (HK) II and mitochondrial creatine kinase (CK) are regulatory kinases. Peripheral 
benzodiazepine receptor (PBR) and Bcl-2-family members (Bcl-2, Bcl-xL, and Bax) are included as 
putative regulatory components (from (Juhaszova et al., 2008)).  
 
1.1.2 Re-evaluation of the classical model of PTP  
While not everyone in the mitochondria research community adhered to the model 
above, there did seem a consensus that as a minimum the PTP contains porin, ANT and CyP-
D. However, recent genetic evidence (based on genetic knockout of individual pore 
components) has overturned long-standing models.  
In particular, in 2004 strong evidence was provided that ANT is not essential for the 
PTP (Kokoszka et al., 2004). To investigate the role of ANTs in the PTP formation, the two 
ANT isoform genes, heart-muscle (Ant1) and the systemic (Ant2), were genetically 
inactivated in mouse liver. It was demonstrated that the PTP opening could still be induced in 
mitochondria lacking ANT. However, more Ca2+ than usual was required to activate the PTP, 
and the pore could no longer be regulated by ANT ligands, including adenine nucleotides. 
Nevertheless, the suggestion arises that a less abundant member of the carrier family than 
ANT with less sensitivity to Ca2+ or oxidative stress can replace ANT in the pore when this 
protein is absent, i.e. a compensation mechanism comes in (Halestrap, 2004).  
Three mammalian VDAC isoforms (Vdac1, Vdac2, Vdac3) have been described, and it 
has been suggested that they may each have a distinct physiological function. The generation 
of isoform-specific, Vdac-deficient mice allowed the assessment of the role of individual 
VDAC isoforms in PTP structure. Mice missing Vdac1 and Vdac3 were viable but exhibited 
distinct phenotypes; elimination of Vdac2 resulted in embryonic lethality. PTP properties in 
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mitochondria from Vdac1-null mice were indistinguishable from those of wild type mice 
(Krauskopf et al., 2006).  
In subsequent work it was found that mitochondria from Vdac 1, Vdac 3-, and Vdac 1/ 
Vdac 3-null mice exhibited Ca2+ and oxidative stress–induced opening of PTPs that were 
indistinguishable from wild type mitochondria (Baines et al., 2007). Furthermore, mouse 
embryonic fibroblasts lacking VDAC (Vdac1, Vdac2, Vdac3, various combinations of two, or 
all three VDAC isoforms), showed similar patterns of PTP induction compared to control 
cells. In addition, the existence of a VDAC-independent model of Bcl-2 family member–
mediated cell killing was confirmed. Wild type and Vdac-deficient mitochondria and cells 
responded to activation or over expression of Bax and Bid by equivalent cytochrome c 
release, caspase cleavage, and cell death. These results make a strong argument against any 
indispensable role of VDACs in both PTP-mediated and Bax–Bak-mediated cell death. The 
experiments with Vdac-deficient cells and mitochondria strongly cast doubt on the validity of 
the classical model of PTP formation, which assumes that the pore contains VDAC and is 
formed at the contact sites between mitochondrial membranes. 
While VDAC and ANT had been excluded as essential pore components, it is 
possible, that these proteins serve some regulatory function. The function of hexokinase II as 
a regulator of the pore, however, is yet unresolved. Only the role of the CyP-D has been 
clearly established. Recently, genetic studies from four independent groups on CyP-D 
knockout mice (Ppif−/− mice) confirmed the critical role of CyP-D in regulation of the PTP 
machinery and provided new insights into the role of PTP in cell death (Baines et al., 2005; 
Basso et al., 2005; Nakagawa et al., 2005; Schinzel et al., 2005). Fig. 1.2. shows the proposed 
PTP complex architecture based on re-evaluation of the classical model. 
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Fig. 1.2 Current view of proposed PTP complex architecture, based on reappraisal of the 
classical model. The elements comprising the pore itself (denoted “PTP” for permeability transition 
pore) are presently unidentified, but are probably regulated by the adjacent elements as indicated. Note 
that VDAC, portrayed as a “shadow,” is no longer seen as an essential pore component based on 
recent genetic evidence. Question mark symbols signify, where open questions remain (from 
(Juhaszova et al., 2008)). 
 
Even now, despite major efforts, the molecular nature of the PTP remains enigmatic 
(Juhaszova et al., 2008). Very recently, it was suggested that the protein fulfilling the role of 
the transmembrane pore component is the mitochondrial phosphate carrier (PiC) (Leung and 
Halestrap, 2008). Moreover, these studies implicate the PiC in PTP formation and are 
consistent with a calcium-triggered conformational change of the PiC, facilitated by CyP-D, 
inducing pore opening (Leung et al., 2008). It was proposed that this is enhanced by an 
association of the PiC with the "c" conformation of the ANT, as agents that modulate pore 
opening may act on either or both of the two proteins, PiC and ANT (Halestrap, 2009).  
1.1.3 Role of PTP in cell death 
It has been known, and accepted by most investigators for the last 10 years, that cells 
can undergo a sudden increase in mitochondrial inner membrane permeability to ions and 
solutes. This disequilibrium causes a dissipation of the membrane potential, loss of ion 
homeostasis, and impairment of ATP synthesis, which results in passive swelling of the 
organelle, release of cytochrome c and cellular apoptosis, or necrotic cell death. 
Recent genetic experiments provided critical new insights into fundamental 
mechanisms of cell death (Baines et al., 2005; Basso et al., 2005; Nakagawa et al., 2005; 
Schinzel et al., 2005). In particular, CyP-D-deficient cells also responded to various apoptotic 
stimuli in a similar manner as the wild type cells but showed considerable resistance to 
necrotic cell death, suggesting that CyP-D is not a central component of the apoptotic death 
pathway. These conclusions lead to a revision of the current dogma and support the idea that 
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the PTP is not a major participant in apoptotic cell death, but rather plays an important role in 
necrotic cell death. This seems to be the case at least in cardiac myocytes, neurons, and 
fibroblasts. These ideas represent a significant contribution to the understanding of the role, 
which mitochondria play in cell death. 
Recently, a model for the activation of the PTP for cell death was proposed (Grimm 
and Brdiczka, 2007). It was suggested that the PTP alters its composition during apoptosis, 
that anti-apoptotic factors are released and pro-apoptotic subunits recruited for apoptosis 
induction (Grimm and Brdiczka, 2007). The best evidence for this is that hexokinase inhibits 
cytochrome c (Cyt c) release. The structural change of VDAC achieved by interaction with 
ANT is recognized at the mitochondrial surface and leads to higher affinity of hexokinase. 
Recent observations suggest that this contact site structure is the preferred target of Bax 
molecules. It was found that hexokinase and Bax compete for the same binding site of VDAC 
(Pastorino et al., 2002). Moreover, VDAC and ANT were immuno-precipitated with Bax 
from extracts of cardiomyocytes (Capano and Crompton, 2002). The binding of hexokinase to 
the contact sites is induced by protein kinase B (Akt) (Gottlob et al., 2001). Activated protein 
kinase B can suppress apoptosis. The activity of mitochondrial bound hexokinase was found 
to be important for protein kinase B-linked suppression of Cyt c release and apoptosis 
(Majewski et al., 2004).  
Hexokinase was furthermore used as a tool to isolate the contact site forming complex of 
outer membrane VDAC and inner membrane ANT. Cyt c remained attached to the 
hexokinase VDAC-ANT complexes that were reconstituted in phospholipid vesicles. The 
vesicles were loaded with malate and treated with Bax in increasing concentrations. Bax 
liberated the endogenous Cyt c but did not release the internal malate. The Bax dependent 
liberation of endogenous Cyt c was abolished when the VDAC-ANT complex was dissociated 
by bongkrekate or by stabilizing the hexokinase binding through addition of glucose. The 
internal malate could be released through opening the PTP by addition of Ca2+. This 
suggested that Bax did not form unspecific pores for malate but released the Cyt c 
dependently on the actual structure of the VDAC-ANT complex (Vyssokikh et al., 2002; 
Vyssokikh et al., 2004). Thus, the permeability transition in cell death is brought about by 
dynamic protein complexes that have the physiological function to regulate energy 
metabolism. These protein complexes change according to the needs of the cell and respond 
to different external and internal stimuli. During cell death the associations are altered in a 
way that causes the permeability transition in mitochondria (Grimm and Brdiczka, 2007).  
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It was also shown that conventionally defined “pro-apoptotic” and “anti-apoptotic” 
members of the Bcl-2 family are critical mediators of protection signalling downstream of 
GSK-3β, where they regulate the susceptibility of the PTP to oxidant stress. Moreover, in the 
context of limiting PTP induction, the actions of the Bcl-2 family are effecting changes in cell 
survival and death via necrosis rather than apoptosis-related pathways (Juhaszova et al., 
2008).  
1.2 p42IP4 /centaurin-α1/ADAP1 
1.2.1 p42IP4 /centaurin-α1 domain structure  
p42IP4 is a brain-specific protein that is also called centaurin-α1 and 
phosphatidylinositoltrisphosphate binding protein, PIP3 BP (Hammonds-Odie et al., 1996; 
Stricker et al., 1997). This protein specifically recognizes two second messengers, the 
membrane lipid phosphatidylinositol(3,4,5)trisphosphate (PIP3) and the soluble 
inositol(1,3,4,5)tetrakisphosphate (IP4) (Hanck et al., 1999).  
Previously, a receptor protein with high affinity for IP4 was solubilized from pig 
cerebellar membranes and purified (Donie and Reiser, 1991). The protein was identified in 
SDS-PAGE after photoaffinity labelling as a 42 kDa protein band, p42IP4 (Reiser et al., 1991). 
Later, cloning of pig p42IP4 (Stricker et al., 1997) had revealed that this protein is 
homologous to centaurin-α, the PIP3 binding protein cloned from a rat brain (Hammonds-Odie 
et al., 1996). The protein PIP3 BP, virtually identical to pig p42IP4, was cloned from bovine 
brain and characterized as a PIP3 binding protein (Tanaka et al., 1997). In addition, the 
existence of rat p42IP4 was established (Aggensteiner et al., 1998).  
p42IP4 contains an ADP ribosylation factor (Arf) GTPase activating protein (GAP) 
homology domain, including N-terminal zinc finger motif, followed by two pleckstrin 
homology (PH) domains (Fig.1).  
 
Arf GAP PH PH
Fig.1. Domain organization of p42IP4. Arf GAP homology and PH domains are depicted. 
 
PH domains contain approximately 120 amino acids and are found in many proteins, 
such as protein kinase B, Bruton´s tyrosine kinase, phosphoinositide-dependent kinase-1 and 
phospholipase C-γ1 (Shepherd et al., 1998; Vanhaesebroeck et al., 2001). They occur in 
members of the cytohesin family [cytohesin-1, Arf nucleotide-binding-site opener (cytohesin-
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2), general receptor for phosphoinositides-1 (cytohesin-3)] (Jackson et al., 2000), RasGTPase 
activating proteins (GAP1m and GAP1IP4BP) (Cozier et al., 2000) and members of the 
centaurin-α family (p42IP4/centaurin-α1; PIP3BP, and centaurin-α2) (Tanaka et al., 1997; 
Stricker et al., 1999; Venkateswarlu et al., 1999; Hanck et al., 2004). For these proteins 
specific in vitro binding to PIP3 and IP4 has been reported (Jackson et al., 2000; Lemmon and 
Ferguson, 2000). Most of the PH domain-containing proteins have a single PH domain, which 
is required for ligand binding. In contrast, the centaurin family proteins contain two PH 
domains in tandem orientation. Both PH domains of p42IP4 within the protein are required for 
full in vitro PIP3 binding activity (Tanaka et al., 1997). PH domains are also required for 
phosphoinositide 3-kinase-dependent translocation to the plasma membrane (Hammonds-
Odie et al., 1996; Tanaka et al., 1997; Tanaka et al., 1999; Venkateswarlu et al., 1999; 
Sedehizade et al., 2002).  
The ARF GAP domain was originally identified in members of a distinct family of 
ARF1 GAPs (Cukierman et al., 1995; Poon et al., 1996). It contains a characteristic C4 - type 
zinc finger motif and a conserved arginine that is required for activity, within a particular 
spacing (CX2CX16CX2CX4R) (Kahn et al., 2008). It was demonstrated that p42IP4 is 
functionally homologous to Gcs1, a yeast ARF GAP, but it was not possible to detect any 
ARF GAP activity for p42IP4 in this time period (Venkateswarlu et al., 1999; Jackson et al., 
2000). Only recently the in vivo Arf GAP activity of p42IP4 towards Arf6 has been described 
(Venkateswarlu et al., 2004). Therefore, p42IP4 was renamed systematically ADAP1 (A Dual 
PH domain ARF GAP) to stress the relationships within the ARF GAP superfamily (Kahn et 
al., 2008).  
1.2.2 Localization of p42IP4 in brain 
p42IP4 is rather exclusively expressed in brain (Stricker et al., 2003). The respective 
cDNA has been cloned from pig (Stricker et al., 1997), rat (Hammonds-Odie et al., 1996); 
(Aggensteiner et al., 1998), bovine (Tanaka et al., 1997) and human brain (Venkateswarlu et 
al., 1999; Sedehizade et al., 2002). Expression of p42IP4 was described to be neurone-specific 
(Kreutz et al., 1997; Tanaka et al., 1999; Sedehizade et al., 2002). p42IP4 protein is localized in 
a majority of neuronal cells of human brain sections. In the hypothalamus a subpopulation of 
paraventricular and infundibular nucleus neurons were strongly immunoreactive for p42IP4. In 
cortical areas, the protein was predominantly found in large pyramidal cells. Some 
immunoreactivity for p42IP4 was also observed in the pyramidal cells of the hippocampal 
formation. Thus, p42IP4 is expressed mainly in the neurons of hippocampus, cortex, 
cerebellum and hypothalamus (Sedehizade et al., 2002). 
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1.2.3 Interaction partners of p42IP4
In an attempt to delineate the functions of this protein, several protein interaction 
partners of p42IP4 have been determined. The first protein partner identified for p42IP4 was 
casein kinases I (CKI) α (Dubois et al., 2001). Mammalian CKI belong to a family of 
serine/threonine protein kinases involved in diverse cellular processes including cell cycle 
progression, membrane trafficking, circadian rhythms, and wingless int (Wnt) signalling. It 
was shown that CKI α co-purifies with p42IP4 in brain and that both proteins interact in vitro 
and form a complex in cells. In addition, it was shown that p42IP4 associates in vitro with all 
mammalian CKI isoforms. However, p42IP4 is not a substrate for CKI α and has no effect on 
CKI α activity.  
Later, interaction of p42IP4 with protein kinase C (PKC) was demonstrated 
(Zemlickova et al., 2003). PKCs comprise a family of serine/threonine kinases classified into 
different groups according to activation parameters: conventional PKCs (PKCα, βI, βII, and 
γ), novel PKCs (PKCδ, ε, η, and θ), atypical PKCs (PKCζ and ι/λ), and PKD/PKCμ. Among 
many other functions, PKC isoforms are involved in nuclear functions, such as cell 
proliferation, differentiation, and apoptosis. PKC isoforms are also involved in the regulation 
of cytoskeletal organisation. Members of the PKC family are regulated by several lipid 
second messengers, such as PIP3. Binding of p42IP4 to all members of the PKC family and its 
phosphorylation by isoforms from all PKC classes was shown. The sites of phosphorylation 
by PKCα on p42IP4 were identified as S87 (peptide ARFESK) and T276 (peptide 
WFTMDDRR) (Zemlickova et al., 2003). 
Nucleolin has been identified as p42IP4 interacting protein (Dubois et al., 2003). 
Nucleolin, the major protein expressed in the nucleolus, is involved in ribosome biogenesis 
(Ginisty et al., 1999). It was shown that nucleolin and p42IP4 associated both in vitro and in 
vivo, and that the interaction is abolished by treatment with RNAse, indicating the presence of 
a complex composed of nucleolin, p42IP4, and RNA. 
It was demonstrated that in vitro, p42IP4 binds F-actin directly, with actin binding 
activity localized to the PIP3-binding PH domain (Thacker et al., 2004). It was shown that 
p42IP4 binds Arfs in vitro and colocalizes with Arf6 and Arf5 in vivo (Thacker et al., 2004). 
Arfs are a family of GTPases that function in vesicular trafficking and cytoskeletal 
organization. In addition to its characterized roles in trafficking, Arf6 has been implicated in 
neuronal differentiation. Arfs are regulated by GTP-exchange factors, which facilitate GTP 
binding, and by Arf GAPs, which stimulate GTP hydrolysis. It was reported that p42IP4 
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expression diminishes cortical actin and decreases Arf6GTP levels consistent with it 
functioning as an Arf6 GAP in vivo (Venkateswarlu et al., 2004).  
More recently, the kinesin motor protein KIF13B/ guanylate kinase-associated 
kinesin GAKIN was identified as a p42IP4 binding partner (Venkateswarlu et al., 2005). The 
KIFs are a superfamily of microtubule-associated motor proteins that mediate intracellular 
vesicle and organelle transport, and cell division. These motor proteins utilize the energy 
generated from ATP hydrolysis to transport intracellular vesicles and organelles along 
microtubules (MT). It was demonstrated that direct binding between p42IP4 and KIF13B could 
concentrate p42IP4 at the leading edges of the cell periphery and suppress the ARF6 GAP 
activity of p42IP4 in intact cells. Identification of interaction between p42IP4 and KIF13B 
suggests that KIF13B may transport ARF6 and/or PIP3 using p42IP4 as its receptor 
(Venkateswarlu, 2005). 
 The peptidase nardilysin, a member of the M16 family of zinc 
metalloendopeptidases, was found to bind specifically to p42IP4 (Stricker et al., 2006). 
Furthermore, this interaction is controlled by the cognate cellular ligands of p42IP4 (Stricker et 
al., 2006). Nardilysin is a metalloendopeptidase that was identified based on its ability to 
cleave peptides at the N-terminus of arginine and lysine residues in dibasic moieties 
(Chesneau et al., 1994). Recently it was shown that nardilysin is involved in the metabolism 
of amyloid precursor protein. Nardilysin enhances the α-secretase activity of a disintegrin and 
metalloprotease, which results in a decrease in the amount of amyloid-β peptide generated 
(Hiraoka et al., 2007).  
Our laboratory has also established that a protein that is called Ran binding protein in 
microtubule-organizing center (RanBPM) interacts with p42IP4 (Haase et al., 2008). RanBPM 
is a scaffold protein found in the nervous and immune system. IP4, a specific ligand for p42IP4, 
is a concentration-dependent and stereoselective inhibitor of this interaction. It was 
hypothesized that RanBPM could act as a modulator together with p42IP4 in synaptic 
plasticity. More recently, RanBPM was implicated also as a novel and potent regulator of 
amyloid precursor protein processing. It was found that RanBPM strongly increased β-
secretase cleavage of amyloid precursor protein and amyloid-β generation (Lakshmana et al., 
2009). 
1.2.4 Known functions of p42IP4 
Various functions have been proposed for p42IP4. This protein contributes to the 
activation of extracellular regulated kinase in growth factor signalling, linking the pathway of 
phosphoinositide 3-kinase (PI 3-K) to the pathway of extracellular regulated kinase mitogen-
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activated protein kinase. This occurs through its ability to interact with PIP3 (Hayashi et al., 
2006). There are reports, which showed the involvement of this protein in the activation 
cascade of the transcription factor activator protein-1 (Chanda et al., 2003). Thrombin-
dependent trafficking of p42IP4 between cytosol and plasma membrane was demonstrated in 
vivo in cells. All three protein domains of p42IP4 are important for the epidermal growth 
factor-mediated intracellular trafficking (Sedehizade et al., 2005).  
p42IP4, containing an ARF GAP domain, specifically inhibits in vivo GTP loading of 
ARF6 and redistribution of ARF6 from the endosomal compartment to the plasma membrane, 
which is indicative of its activation. p42IP4 also inhibits cortical actin formation in a PIP3-
dependent manner. Therefore, p42IP4 negatively regulates ARF6 activity by functioning as an 
in vivo PIP3-dependent ARF6 GAP (Venkateswarlu et al., 2004). Later, it was shown that by 
acting as an ARF6 GAP, p42IP4 is able to switch off ARF6 and so inhibit its ability to mediate 
β 2-adrenoceptor internalization (Lawrence et al., 2005). 
p42IP4 expression produces dramatic effects on the actin cytoskeleton, decreasing 
stress fibers, diminishing cortical actin, and enhancing membrane ruffles and filopodia. Thus, 
it was suggested that p42IP4 may be a component of the neuronal PI 3-K cascade that leads to 
regulation of the neuronal actin cytoskeleton (Thacker et al., 2004). Moreover, p42IP4 
regulates the actin cytoskeleton via both ARF GAP-dependent and ARF GAP-independent 
mechanisms (Thacker et al., 2004). 
It was shown that KIF13B directly interacts with p42IP4, and mediates the transport 
of PIP3-containing vesicles (Horiguchi et al., 2006). Recombinant KIF13B and p42IP4 form a 
complex on synthetic liposomes containing PIP3 and support the motility of the liposomes 
along MT in vitro. Finally it was suggest that, in neurons, the KIF13B - p42IP4 complex 
transports PIP3 to the neurite ends and regulates neuronal polarity formation (Horiguchi et al., 
2006).  
In cultured dissociated hippocampal neurons, p42IP4 localizes to dendrites, dendritic 
spines and the postsynaptic region (Moore et al., 2007). Both filopodia and lamellipodia have 
been implicated in dendritic branching and spine formation. Following synaptogenesis in 
cultured neurons, wild-type p42IP4 expression increases dendritic filopodia and spine-like 
protrusions. Moreover, p42IP4 was found to function through GAP-dependent Arf regulation 
of dendritic branching and spines. Thus, p42IP4 was demonstrated as developmentally 
expressed Arf GAP, which is required for dendritic differentiation in developing neurons. 
(Moore et al., 2007).  
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p42IP4 has already been linked to short-term regulation of behavioural responses in 
rat brain (Reiser and Bernstein, 2004). Down-regulation of the mRNA and protein levels 
within 2 h in amygdala, hypothalamus and cingulate/retrospenial cortex following acoustic 
and electric stimulation have been shown. This is the first indication that p42IP4 may play an 
important role in the signal transduction pathways regulating plasticity in neuronal cells 
(Reiser and Bernstein, 2004).  
Very interestingly, p42IP4 seems to be involved also in neuronal diseases, since p42IP4 
was found to be up-regulated in neurons in the brain of Alzheimer’s disease (AD) patients and 
is detected in AD plaques (Reiser and Bernstein, 2002, , 2004). It was hypothesized that 
p42IP4 might be a pivotal signalling protein in determining neuronal survival in the 
pathogenesis of AD, by interacting with CK I and nucleolin–RNA complexes (Reiser and 
Bernstein, 2004). 
1.2.5 The ligands of p42IP4
Phosphoinositides and inositol polyphosphates are central players in intracellular 
signal transduction (Prestwich, 2004). Receptor-regulated PI 3-K phosphorylates 
phosphatidylinositol(4,5)bisphosphate on position 3, yielding PIP3, which is involved in many 
cellular responses including membrane vesicle trafficking, protein sorting, cytoskeletal 
rearrangement, apoptosis and chemotaxis (Toker and Cantley, 1997). 
Receptor-activated phospholipase C isoforms hydrolyse 
phosphatidylinositol(4,5)bisphosphate, yielding inositol (1,4,5) trisphosphate (IP3) and 
diacylglycerol (Berridge, 1993). The signal of IP3 is terminated either by specific enzymatic 
dephosphorylation in position 5 or phosphorylation in position 3 by the IP3 3-kinase to IP4 
(Berridge, 1993; Stephens et al., 1993). IP4 has attracted particular attention as a putative 
second messenger. Its physiological role, however, is not yet understood. For instance, IP4 has 
been reported to regulate the frequency of Ca2+ oscillations (Zhu et al., 2000), and to facilitate 
store-operated calcium influx by inhibition of IP3 5-phosphatase (Hermosura et al., 2000). 
PIP3 mediates its effects by recruiting proteins to the membrane that are capable of 
binding tightly and, at least in some cases, specifically to the lipid through phosphoinositide 
binding domains, most commonly PH domains (Ferguson et al., 2000; Lemmon and 
Ferguson, 2000). Thus, an artificially plasma membrane-targeted p42IP4 bypasses the 
requirement of PIP3 for its involvement in ARF6 inactivation, suggesting that PIP3 is required 
for recruitment of p42IP4 to the plasma membrane but not for its activity (Venkateswarlu et al., 
2004).  
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However, it was shown that phosphorylation of the second messenger IP3 to inositol 
IP4 establishes another mode of PH domain regulation through a soluble ligand. At 
physiological concentrations, IP4 promoted PH domain binding to PIP3. In primary mouse 
thymocytes, this was required for full activation of a protein tyrosine kinase called Itk after T 
cell receptor engagement. Thus, IP4 acts as an important “third messenger” in vivo (Huang et 
al., 2007).  
In neutrophils, chemoattractant stimulation triggered rapid elevation in IP4 
concentration. Depletion of IP4 enhanced membrane translocation of the PIP3-specific PH 
domain. This led to enhanced sensitivity to chemoattractant stimulation, elevated superoxide 
production, and enhanced neutrophil recruitment to inflamed peritoneal cavity. On the 
contrary, increase of intracellular IP4 concentration blocked PH domain-mediated membrane 
translocation of target proteins and dramatically decreased the sensitivity of neutrophils to 
chemoattractant stimulation (Jia et al., 2007). Futhermore, IP4 was shown to play a role in 
maintaining neutrophil survival. Depletion of IP4 leads to accelerated neutrophil spontaneous 
death. Finally, it was established that IP4 is essential modulators of neutrophil function and 
innate immunity (Jia et al., 2008).  
In neurons, as a consequence of the elongation of one neurite, the axon is specified 
and the cell acquires its polarity. In developing hippocampal neurons, PIP3 was found that 
accumulates in the tip of the growing processes. Moreover, it was suggest that PIP3 is 
involved in axon specification, possibly by stimulating neurite outgrowth (Menager et al., 
2004). Later, it was proposed that the KIF13B - p42IP4 complex transports PIP3-containing 
vesicles from the cell body to the distal end of the neurites (Horiguchi et al., 2006).  
It was shown that PI 3-K activation and subsequent generation of PIP3 are 
responsible for membrane translocation of p42IP4. Moreover, by activation of the 
phospholipase C-coupled thrombin receptor and subsequent activation of PI 3-K via 
epidermal growth factor in HEK 293 cells it was demonstrated that in vivo cellular trafficking 
of the human p42IP4 is dependent on products of both PI 3-K and IP3 3-kinase, PIP3 and IP4  
(Sedehizade et al., 2005).  
Interestingly, cognate cellular ligands of p42IP4, PIP3 and IP4, control the interaction of 
p42IP4 with the peptidase nardilysin. Moreover, it was suggested that PIP3 and IP4 can 
modulate the recruitment of proteins, which are docked to p42IP4, to specific cellular 
compartments (Stricker et al., 2006). IP4 is also a concentration-dependent and stereoselective 
inhibitor for the interaction of p42IP4 with RanBPM (Haase et al., 2008). 
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1.3  2,3'-Cyclic nucleotide-3'-phosphodiesterase (CNP)  
CNP is a myelin-associated protein, an enzyme abundantly present in the central 
nervous system of mammals and some vertebrates. In vitro, CNP specifically catalyzes the 
hydrolysis of 2',3'-cyclic nucleotides to produce 2'-nucleotides, but the physiologically 
relevant in vivo substrate is still unknown. The purified protein from brain is highly basic, 
with an isolectric point close to 9.  
 
1.3.1 Two isoforms of CNP 
Oligodendrocytes, Schwann cells, and myelin from all species examined manifest 
two isoforms, designated CNP1 (~ 46 kDa) and CNP2 (~ 48 kDa). These have identical 
amino acid sequences except for a 20-residue extension at the N-terminus that is exclusive to 
CNP2 (Kurihara et al., 1990; Kurihara et al., 1992; Gravel et al., 1994). One gene (Douglas et 
al., 1992; Monoh et al., 1993) consisting of four exons and two promoters gives rise to two 
RNA transcripts, one of which can generate both proteins. Both polypeptides are synthesized 
on free ribosomes (Gillespie et al., 1990), both are enzymatically active, and both are post-
translationally modified by isoprenylation at the C-terminus (De Angelis and Braun, 1994; 
O'Neill and Braun, 2000). 
1.3.2 Motifs in primary structure and modifications of CNP 
The sequence identity or homology is relatively strong among amino acid sequences 
of CNP from different species, as deduced from cDNAs for bullfrog, chicken, mouse, rat, 
bovine, and human. All CNP species have strongly conserved consensus motifs for the 
potential binding of nucleotide phosphoryl groups in both the N-terminal and C-terminal 
domains. 
ATPase motifs, along with the adenine recognition motif (YFGKRPPG), are 
common to many nucleotide binding proteins and enzymes. Interestingly, since they fall 
outside the essential catalytic domain of CNP (Lee et al., 2001), they must serve another 
nucleotide-related function. ATPase activity has not been detected in purified preparations of 
CNP or in the recombinant protein. Although some preliminary experiments suggest that ATP 
(and other nucleoside triphosphates) may bind to CNP, definitive experiments have not yet 
been done. 
By alignments of nucleotide binding motifs with other enzymes, it was noted that 
CNP shares modest sequence similarities with polynucleotide kinase (Koonin and 
Gorbalenya, 1990; Gravel et al., 1994), and it was suggested that CNP might also possess this 
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activity. This possibility was subsequently tested with catalytically active recombinant CNP 
in a polynucleotide kinase assay, with no such activity being evident (Prinos et al., 1995).  
The C-terminal isoprenylation motifs, present in CNP of all species, have been the 
focus of some attention. Prenylated proteins are posttranslationally modified by formation of 
cysteine thioethers with the isoprenoid lipids farnesyl (C-15) or geranylgeranyl (C-20) at or 
near the carboxy terminus. Most of these proteins are members of signal-transducing 
pathways. CNP is typical of a large category of proteins bearing a cys-A1, A2-X motif in 
which A1 and A2 are aliphatic amino acids and X is any amino acid; these are removed once 
the cys has become isoprenylated. The terminal carboxyl end then may become modified by 
methylation (Sinensky, 2000). It was shown that isoprenylation mediates the binding of CNP 
to membranes, explaining the avid association with myelin in the absence of a protein 
transmembrane domain (Braun et al., 1991; De Angelis and Braun, 1994). It was determined 
that the isoprenylated cysteine in CNP undergoes the additional carboxymethylation step (Cox 
et al., 1994). The consequences of this for CNP biology were not established, but a body of 
evidence suggests that there is biological importance of this modification for some proteins, 
and that methylation greatly enhances the association of farnesylated peptides with lipid 
bilayers (Sinensky, 2000).  
More recently, the prenylation was determined to be a process necessary to 
permanently anchor CNP to the plasma membrane (Esposito et al., 2008). A 13 residue, C-
terminal CNP fragment, C13, was demonstrated to be directly responsible for CNP membrane 
anchoring. Furthermore, a general model was proposed, in which the post-translational 
lipidation is an important biomolecular trick to enlarge the hydrophobic surface and to enable 
the contact of the protein with the membrane (Esposito et al., 2008). 
Modification of CNP by fatty acylation (palmitoylation) has also been 
demonstrated, although the site for palmitoylation (a cysteine residue) has yet to be identified 
(Agrawal et al., 1990b). Further, acylation occurs independently of isoprenylation, since the 
C397S mutant CNP is just as strongly palmitoylated as the wild-type protein (De Angelis and 
Braun, 1994). The addition of these hydrophobic groups has significance for the targeting of 
proteins to specific membrane microdomains (‘‘lipid rafts’’). Lipid rafts are rich in 
glycosphingolipids and cholesterol and are believed to have important roles in the 
organization of signalling complexes (Kim and Pfeiffer, 1999).  
The 20 amino acid domain at the N-terminus of CNP2 (referred to as N2 for N-
terminal domain of CNP2) is highly conserved among all species studied. Its structure meets 
the basic requirements for a mitochondrial targeting signal in that it has a net positive charge, 
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some hydroxylated and hydrophobic residues, lacks acidic residues, and is predicted to form 
an α-helix (von Heijne et al., 1989; Neupert, 1997). The N2 domain is capable of being 
phosphorylated on serines 9 and 22 (O'Neill and Braun, 2000). In oligodendrocytes 
phosphorylation of serine 9 occurs after treatment with phorbol ester, a known activator of 
PKC, whereas serine 22 (putative protein kinase A phosphorylation site) is constitutively 
phosphorylated. CNP2 may either be phosphorylated by PKC and/or protein kinase A 
(Bradbury et al., 1984; Bradbury and Thompson, 1984; Vartanian et al., 1988; Agrawal et al., 
1990b; Vartanian et al., 1992; Agrawal et al., 1994).  
1.3.3 Mitochondrial localization of CNP 
Previously CNP had been observed associated with mitochondria in adrenal cells 
(McFerran and Burgoyne, 1997). Recently, it was demonstrated that CNP2 is translocated to 
mitochondria by virtue of a mitochondrial targeting signal at the N-terminus (Lee et al., 
2006). It was established that the N2 domain of CNP2 was sufficient for mitochondrial 
localization. This was determined by finding that a fusion protein of N2 with green 
fluorescent protein (GFP) was efficiently targeted to mitochondria. PKC-mediated 
phosphorylation of the targeting signal at Ser22, and, to a smaller extent, Ser9, inhibits CNP2 
translocation to mitochondria, thus retaining CNP in the cytoplasm. CNP2 is imported into 
mitochondria and the targeting signal cleaved, yielding a mature, truncated form similar in 
size to CNP1. CNP2 is entirely processed in adult liver and embryonic brain, indicating that it 
is localized specifically to mitochondria in non-myelinating cells. Therefore, a broader 
biological role for CNP2 in mitochondria during myelination was suggested. The biochemical 
analysis and electron microscopy of immunogold-labeled CNP demonstrate that CNP2 is 
peripherally and tightly associated with the mitochondrial inner membrane on the side facing 
the intermembrane space (Lee et al., 2006). Furthermore, in amoeboid microglial cells in 
developing rat brain, CNP was associated primarily with the plasma membrane, filopodial 
projections and mitochondria (Wu et al., 2006).  
All these data indicate that a mitochondrial role for CNP is likely to be different from 
its specific role in the cytoplasm. However, there were no data on the function of CNP in 
mitochondria so far. 
1.3.4 Enzymatic characteristics of CNP 
All 2’,3’-cyclic mono-nucleotides can be hydrolyzed by CNP to yield 2’-nucleotides 
exclusively. CNP does not act upon 3’, 5’-cyclic mononucleotides (cAMP, cGMP). This 
enzyme does not cleave other cyclophosphate rings. Although physiologically relevant 
substrates with 2’,3’-cyclic termini have not yet been reported, numerous cyclic phosphate-
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containing RNAs that are generated as intermediate products of splicing reactions are present 
in most cells. 
Although a range of kinetic parameters have been reported, the most rigorous study 
of CNP to date shows that purified recombinant CNP1 hydrolyzes cyclic NADP (in the assay 
of (Sogin, 1976)) with a Km of 0.26 mM and a kcat of 836 s-1 at 25 0C (Lee et al., 2001). The 
catalytic domain resides in the C-terminal region comprising two-thirds of the protein. 
Mapping of the catalytic domain by deletion mutant analysis, by chemical modification 
studies of specific amino acids and by site-directed mutagenesis have provided new insights. 
Contrary to earlier reports, cysteine residues have nonessential roles for enzymatic activity. 
On the other hand, two specific histidines (positions 230 and 309 in CNP1) are essential for 
catalytic activity (Lee et al., 2001); they are part of two tetrapeptide motifs, H-X-T/S-X 
(where X is often a hydrophobic residue), that are essential for the enzymatic activity of the 
other three classes of related enzymes (Hofmann et al., 2002).  
1.3.5 Three-dimensional structural features of CNP and link to RNA metabolism 
The solution structure of the catalytic core fragment of CNP (residues 163 to 378 of 
rat CNP1) has been determined by NMR (Kozlov et al., 2003). Interestingly, the folded 
structure is remarkably similar to known structures of two other proteins. The first protein is 
cyclic nucleotide phosphodiesterase from the plant Arabidopsis thaliana. This is an enzyme 
involved in the tRNA splicing pathway, known to hydrolyze ADP-ribose 1’,2’-cyclic 
phosphate (Hofmann et al., 2000). The second protein is bacterial 2’-5’ RNA ligase from 
Thermus thermophilus, which is an enzyme that ligates tRNA half-molecules containing 2’, 
3’-cyclic phosphate and 5’-hydroxy termini (Kato et al., 2003).  
Collectively, this group of enzymes appears to constitute a super-family of proteins, 
with enzymatic activities not yet well understood in a physiological context, but with an 
apparent link (inferred for CNP) to RNA metabolism. This inference for CNP is further 
strengthened by the observation that the β-sheet surface in the active site has an abundance of 
positively charged and aromatic residues, a common feature of RNA-binding proteins. 
Coupled with a large binding cavity, this suggests that RNA could be a substrate for CNP 
(Kozlov et al., 2003).  
Indeed, very recently, it was shown that CNP is an RNA-binding protein (Gravel et 
al., 2009). Furthermore, by using precipitation analyses, it was demonstrated that CNP 
associates with poly(A)(+) mRNAs in vivo and suppresses translation in vitro in a dose-
dependent manner. Isolated RNA aptamers can suppress the inhibitory effect of CNP on 
translation. It was also demonstrated that CNP1 could bridge an association between tubulin 
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and RNA. It was suggested that CNP1 may regulate the expression of mRNAs in 
oligodendrocytes of the central nervous system (Gravel et al., 2009).  
1.3.6 Interaction partners of CNP 
In earlier studies of cultured oligodendrocytes, CNP appears to co-localize with both 
actin and tubulin-based cytoskeletal networks (Dyer and Benjamins, 1988, , 1989; Dyer and 
Matthieu, 1994; Dyer et al., 1995). Later, CNP was shown to bind to the actin-based 
cytoskeleton (De Angelis and Braun, 1996).  
Initial work showed detailed confocal images of CNP and tubulin colocalized in 
primary cultures of differentiated oligodendrocytes (Dyer and Benjamins, 1989). The 
colocalization was particularly along the microtubular veins in the membraneous sheets and in 
numerous discrete large ‘‘cuff-like’’ punctate structures that dot the microtubule network.  
Further biochemical evidence for CNP-tubulin interaction was derived from 
observations that MT in cultured rat thyroid cells became dissociated from the plasma 
membrane after treatment with lovastatin, a drug that blocks isoprenylation. Since tubulin 
lacks the motif for isoprenylation, it was reasoned that an isoprenylated linker protein was 
responsible for membrane attachment of MT. A 48kDa isoprenylated protein was later 
identified to be CNP (Laezza et al., 1997).  
Subsequently, CNP was found not only to be associated with MT in cultured rat 
thyroid cells and brain tissue, but was also co-purified with MT by successive cycles of 
polymerization and depolymerization. Thus, CNP was identified as a microtubule-associated 
protein, which furthermore possesses microtubule polymerization activity in vitro (Bifulco et 
al., 2002). The domain responsible for this activity, but not for tubulin binding, was identified 
as the last 13 amino acids at the C terminus of CNP. This peptide containing C-terminal 13 
residues caused MT to polymerize in vitro. Moreover, preliminary in vitro data suggested that 
CNP phosphorylation by PKC negatively regulates microtubule polymerization. 
Submembranous colocalization of the proteins and CNP-dependent microtubule organization 
suggest that CNP is a membrane-bound microtubule-associated protein that can link tubulin to 
membranes and may regulate cytoplasmic microtubule distribution (Bifulco et al., 2002).  
Oligodendrocytes extend arborized processes that are supported by MT and 
microfilaments. CNP was shown to mediate process formation in oligodendrocytes (Lee et al., 
2005). It was reported that tubulin is a major CNP-interacting protein. In vitro, CNP binds 
preferentially to tubulin heterodimers compared with MT and induces MT assembly by 
copolymerizing with tubulin. Moreover, CNP overexpression induces dramatic morphology 
changes in both glial and non-glial cells, resulting in MT and F-actin reorganization and 
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formation of branched processes. These morphological effects are attributed to CNP-MT 
assembly activity. Accordingly, cultured oligodendrocytes from CNP-deficient mice extend 
smaller outgrowths with less arborized processes. Therefore, it was proposed that CNP is an 
important component of the cytoskeletal machinery that directs process outgrowth in 
oligodendrocytes (Lee et al., 2005).  
Recently, substantial colocalization of CNP with Juxtanodin in the myelin sheath 
was shown. Juxtanodin is an oligodendroglial protein featuring a putative C-terminal actin-
binding domain. Furthermore, expression of Juxtanodin promoted arborization of cultured 
OLN-93 cells and CNP trafficking to the process arbors of cultured primary oligodendrocyte 
precursors (Zhang et al., 2005).  
1.3.7 Functions of CNP 
Numerous studies were performed to link CNP to any inherited diseases of myelin and 
neurological mutations in mice, which can cause an assortment of demyelinating and 
dysmyelinating pathologies. In studies of encephalitogenic proteins that could function as 
self-antigens in inflammatory demyelinating diseases, CNP has been considered as a potential 
autoantigen. However, CNP was found not to be encephalitogenic in rodents, although a heat-
shock protein related peptide domain of CNP was shown to alter the course of experimental 
autoimmune encephalomyelitis (Birnbaum et al., 1996). Later it was confirmed that CNP was 
non-encephalitogenic in several mouse strains, even though several CNP epitopes could 
induce T-cell responses in these mice (Maatta et al., 1998; Morris-Downes et al., 2002). 
Several studies implicated CNP as an autoantigen in multiple sclerosis. It was reported 
that antibodies to CNP were detected in sera of 74% of patients with multiple sclerosis 
(Walsh and Murray, 1998). These antibodies were present as IgM in high titer also in 
cerebrospinal fluid. Further, CNP-containing immune complexes were found in brain tissue of 
some patients. Curiously, the antibody response was against CNP1 and not CNP2. However, 
both isoforms were reported to bind the C3 complement, fueling speculation about a role for 
CNP in the pathogenesis of multiple sclerosis (Walsh and Murray, 1998).  
CNP has been considered as a potential antigenic target for a T-cell response in the 
pathogenesis of demyelinating diseases. A recombinant human CNP was used to isolate 
several specific T-cell lines from a patient with multiple sclerosis, as well as from a healthy 
control (Rosener et al., 1997). Further, human CNP from brain as well as specific CNP 
peptides were used to screen for human T-cell responses. Primary proliferative responses 
were detected in some patients with multiple sclerosis as well in healthy controls. The T-cell 
responses were directed mainly to the CNP1 polypeptide region 343–373. Despite a detailed 
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analysis of their findings, an unambiguous involvement of CNP-specific T cells in multiple 
sclerosis could not be established (Muraro et al., 2002).  
Expression of CNP in amoeboid microglial cells in developing rat brain from 
prenatal day 18 to postnatal day 10 was demonstrated in vivo and in vitro, respectively. The 
functional role of CNP in amoeboid microglial cells remains speculative. Given its expression 
in amoeboid microglial cells transiently occurring in the perinatal brain and that it is markedly 
elevated in activated microglia, it is suggested that the enzyme may be linked to the major 
functions of the cell type such as release of chemokines and cytokines. In relation to this, 
CNP may play a key role associated with transportation of cytoplasmic materials (Wu et al., 
2006).  
Converging evidence from imaging, microarray, genetic, and other studies suggests 
that abnormalities in myelin may play a role in schizophrenia. The expression of CNP has 
been reported to be reduced in the schizophrenic brain (Peirce et al., 2006). Further 
confirmation implicating myelin abnormalities in the etiology of schizophrenia has been 
revealed. A genetic variation in the Cnp gene, rs2070106, has recently been shown to be 
associated with schizophrenia in Caucasians (Voineskos et al., 2008). However, no 
association between genetic variations in the Cnp gene and schizophrenia in the Han Chinese 
population was found (Tang et al., 2007). 
In a molecular genetic approach to CNP function, the expression of CNP in 
oligodendrocytes was increased by introduction of the human gene into mice (Gravel et al., 
1996). A transgenic line expressing a six-fold increase of CNP protein developed 
abnormalities suggestive of a gain of function due to the extra CNP. In adult mice, large 
vacuoles were observed, surrounded by myelin membranes that extended from myelin 
internodes. Further, an absence of the major dense lines from compact myelin was seen in 
about half of the myelin sheaths. Oligodendrocytes cultured from these adult animals 
manifested a more robust and aggressive regrowth of cellular processes. This was consistent 
with other studies, which connected CNP to the cytoskeleton and to process extensions. 
Further observations on these CNP overexpressing mice revealed aberrant oligodendrocyte 
and myelin membrane formation during early stages of oligodendrocytes differentiation (Yin 
et al., 1997).  
Generation of Cnp1-null mutant mice (Lappe-Siefke et al., 2003) has thus far 
provided little insight into CNP function in myelinogenesis. In these animals that lack CNP 
protein, myelination appears to follow a normal course and is morphologically normal. 
However, the adult mice manifest a severe neurodegenerative disorder, with axonal swellings 
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and Wallerian degeneration causing a large microglial response, hydrocephalus and premature 
death. Therefore, it was suggested that CNP is essential for axonal survival.  
Later it was reported that Cnp1-null mice have disrupted axoglial interactions, which 
underlie the clustering of ion channels and of cell adhesion molecules, regulate gene 
expression, and control cell survival in the central nervous system (Rasband et al., 2005). 
Nodal sodium channels and paranodal adhesion proteins are initially clustered normally, but 
become progressively disorganized with age. This disorganization is prominent in older 
Cnp1-null mice and occurs before axonal degeneration and microglial invasion. Disrupted 
axoglial signalling underlies progressive axonal degeneration, observed later in the central 
nervous system of Cnp1-null mice. Thus, it was suggested that CNP is a glial protein required 
for maintaining the integrity of paranodes (Rasband et al., 2005).  
Changes in brain white matter are prominent features of the aging brain. These 
include glial cell activation, disruption of myelin membranes with resultant reorganization of 
the molecular components of the node of Ranvier, and loss of myelinated fibers associated 
with inflammation and oxidative stress. Overexpression of CNP was already implicated in 
age-related changes in myelin and axons (Gravel et al., 1996; Yin et al., 1997; Lappe-Siefke 
et al., 2003). 
Very recently it was shown that with age, excess CNP which is found in myelin and 
throughout brain white matter accompanied by proteolytic fragments of CNP (Hinman et al., 
2008). It was suggested that incomplete degradation of CNP due to failure of the proteasomal 
system and aberrant degradation by calpain-1 leads to age-related CNP accumulation and 
proteolysis. Moreover, it was proposed that these phenomena result in age-related dysfunction 
of CNP in the lipid raft, which may lead to myelin and axonal pathology (Hinman et al., 
2008).  
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 1.4 Aims of this study 
1.4.1 Motivation 
Previously, expression of the p42IP4 protein in chinese hamster ovary (CHO) cells 
stably transfected with pcDNA-p42IP4 was shown in cytosol, membranes and nucleus 
(Sedehizade et al., 2002). The membrane fraction in that study also contained mitochondria. 
Moreover, the yeast protein Gcs1p, which is structurally and functionally related to p42IP4, is 
localized in mitochondria and is involved in maintenance of mitochondrial morphology 
(Huang et al., 2002). Finally, a high probability for mitochondrial localization of p42IP4 had 
been predicted by the program PSORT II (http://psort.nibb.ac.jp/; Nakai and Kanehisa, 1992). 
Therefore, we hypothesized localization of p42IP4 in mitochondria.  
Previously, CNP was found in mitochondria of adrenal medullary chromaffin cell 
cultures (McFerran and Burgoyne, 1997), amoeboid microglial cells (Wu et al., 2006) and 
oligodendrocyte cell line (OLN93 cells) (Lee et al., 2006), but the role of CNP in 
mitochondria is still obscure. We found localization of both, p42IP4 and CNP, in the inner 
membrane fraction of mitochondria. This indicates some unknown functions for these 
proteins in mitochondrial physiology.  
1.4.2 Main aims and goals of study 
The main aim of this investigation was to study as possible mitochondrial function the 
participation of p42IP4 and CNP in Ca2+-induced PTP. Cellular Ca2+ signals are crucial in the 
control of cell death. Mitochondria dampen cytosolic Ca2+ loads and support cellular Ca2+ 
homeostasis. However, mitochondria take up a limited amount of calcium up to a certain 
threshold. Accumulation of Ca2+ above this threshold leads to increased permeability of the 
inner mitochondrial membrane due to formation of an unselective pore, which is called the 
PTP. 
Since Ca2+-induced PTP opening is important in mitochondrial events leading to 
programmed cell death, we investigated whether p42IP4 and CNP are involved in Ca2+-
induced PTP functioning in mitochondria and therefore control pore-dependent apoptosis. The 
results of our investigation might be helpful for understanding the death response of 
mitochondria leading to neurodegeneration, based on the action of the PTP complex. 
To improve the understanding of p42IP4 and CNP functions in mitochondria, we 
planned in the current study to establish the possible p42IP4 /CNP interaction and to identify 
further interacting proteins.  
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 1.4.3 Strategy  
To establish exact mitochondrial localization of p42IP4 , CHO cells and N2a (mouse 
neuroblastoma) cells stably transfected with pcDNA-p42IP4 were analysed by subcellular 
fractionation, confocal microscopy and submitochondrial fractionation.  
To find out protein partners of p42IP4 and CNP in RBM, GST pull-down binding assay 
and immunoprecipitation were used. 
To perform functional studies of mitochondri, we established the method of isolation 
of functionally active mitochondria from cultured cells. The effect of the Ca2+-induced PTP 
opening on functional state of isolated mitochondria from different types of cells and tissues 
in different conditions was examined.  
The influence of overexpression of p42IP4 in N2a cells and the influence of CNP 
knock-down in OLN-93 cells on mitochondrial functions during Ca2+-induced PTP opening 
were investigated. 
 
 
 29
 2. Materials and Methods 
2.1 Materials 
2.1.1 Chemicals and Reagents 
Chemicals Manufacturer 
IP4 (D-myo-inositol 1,3,4,5-tetrakisphosphate, 
tetrapotassium salt) 
Alexis, Gruenberg, Germany 
Bacto Agar 
Bacto Tryptone 
Bacto Yeast extract 
G418 Sulphate 
BD Bioscience (Clontech), Heidelberg, 
Germany 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) 
HAM’S F12  
Fetal calf serum (FCS) 
Penicillin and Streptomycin 
Ampicillin 
Biochrom, Berlin, Germany 
Rotenone Biomol 
Bio-Rad protein assay dye reagent 
concentrate 
Bio-Rad Laboratories, München, Germany 
ImmersolTM 518N (Immersion oil for 
microscopy) 
Boehringer, Mannheim, Germany 
PIP3 (phosphatidylinositol 3,4,5-
Trisphosphate diC8)  
Echelon Biosciences Incorporated, Salt Lake 
City, UT, USA 
Ammonium peroxodisulfate 
Sodium azide 
Paraformaldehyde (PFA) 
Fluka 
Protein A Sepharose CL-4B 
Glutathione-Sepharose 4B  
GE Healthcare, Munich, Germany 
Magnet assisted transfection  IBA GmbH 
TEMED 
FuGENE 6  
Roche, Mannheim, Germany 
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protease inhibitor cocktail tablets 
trypsin 
ponceau S solution (0.2% in 3% acetic acid) 
 
Acrylamide 
N, N’-Methylenbisacrylamide 
SERVA, Heidelberg, Germany 
Protein G agarose  
Dimethyl sulfoxide (DMSO) 
TEMED 
β-mercaptoethanol 
Igepal CA630 
Bromphenol blue 
PAP pen for immunostaining 
poly-L-lysine 
Isopropyl b-D-thiogalactoside 
2’,3’cyclic AMP 
2’,3’cyclic GMP 
2’,3’cyclic NADP 
Sigma, Taufkirchen, Germany 
All other chemical reagents from Carl Roth 
2.1.2 Antibodies 
 
2.1.2.1 Primary antibodies  
Antibody Manufacturer 
Rabbit anti-CNP (antibody 27695) 
Rabbit anti-SOD 2 (Mn-superoxide dismutase 
2, antibody 13533)  
Abcam, Cambridge, UK 
 
Mouse monoclonal anti-Nucleoporin p62  
Mouse monoclonal anti-Cyt c (cytochrome c, 
clone 6H2.B4) 
BD Biosciences, Heidelberg, Germany 
 
 
Mouse monoclonal anti-plasma membrane 
calcium ATPase (clone 5F10) 
Mouse monoclonal anti- Cyt c (cytochrome c, 
clone 7H8.2C12)  
Biozol, Eching, Germany 
 
Rabbit anti-VDAC (voltage-dependent anion Calbiochem, Schwalbach, Germany 
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channel, Ab-5)  
Mouse monoclonal anti-GAPDH 
(glyceraldehyde 3-phosphate dehydrogenase, 
clone 6C5) 
Chemicon, Martinsried/Munich, Germany
Mouse monoclonal against Myc Invitrogen, Karlsruhe, Germany  
 
Mouse monoclonal against ANT (adenine 
nucleotide translocator) 
MitoSciences, Eugene, Oregon, USA 
 
Mouse monoclonal against COXIV 
(Cytochrome oxidase subunit IV, clone 
20E8C12) 
Mouse monoclonal against β-tubulin I  
Mouse monoclonal against α- tubulin  
 
Sigma, Taufkirchen, Germany 
 
Mouse monoclonal anti-Synaptotagmin I 
(clone 41.1)  
Synaptic Systems, Gottingen, Germany 
mouse monoclonal against CNP  Published 
Mouse monoclonal against p42IP4 (Mab117-2) Published 
rabbit polyclonal against p42IP4 (AS1516g) Published 
Normal mouse IgG Santa Cruz 
Normal rabbit IgG  Santa Cruz 
                                           
 
2.1.2.2 Secondary antibodies  
Antibody Manufacturer 
peroxidase-conjugated goat anti-mouse IgG 
peroxidase-conjugated goat anti-rabbit IgG  
Dianova, Hamburg, Germany 
Alexa Fluor® 555 goat anti–mouse IgG 
Alexa Fluor® 488 goat anti-rabbit 
Molecular Probes, MoBiTec, Göttingen, 
Germany 
 
2.1.3 Cells, medium and related reagents  
2.1.3.1 Mammalian cells 
Cell lines 
a) CHO631 (Hamster ovary cells) 
b) N2a (Mouse neuroblastoma) 
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c) OLN93 (Rat oligodendrocytes) 
d) HEK293 (Human embryonic kidney) 
Cell culture medium and solvents  
CHO631 cells - HAM’S F-12: 1.17 g/L NaHCO
3
, 1.802 g/L D-glucose, 0.146 g/L L-
glutamine, 100U/ml Penicillin, 100 µg/ml Streptomycin 
N2a cells - DMEM: 3.7 g/L NaHCO3, 4.5 g/L D-glucose, 1.028 g/L N-Acetyl L-alanyl-L-
glutamine, 10% FCS, 100U/ml Penicillin, 100 µg/ml Streptomycin 
OLN93 cells - DMEM: 3.7 g/L NaHCO3, 4.5 g/L D-glucose, 1.028 g/L N-Acetyl L-alanyl-L-
glutamine, 10% FCS, 100U/ml Penicillin, 100 µg/ml Streptomycin 
HEK-293 cells- DMEM/HAM’S F12 (1:1) with 2mM Glutamine, 10% FCS, 100U/ml 
Penicillin, 100 µg/ml Streptomycin  
HBSS (Hanck’s balanced salt solution) without Ca2+ and Mg2+ from PAA. 
G418 sulphate was from Calbiochem. stock: 500 mg/ml, working concentration: 500 µg/ ml 
 
2.1.3.2.Bacterial cells: 
Bacteria strains: DH5a , XL1-Blue, BL21 
LB medium  
10 g/l Bacto-tryptone (BD Bioscience), 5 g/l Bacto-yeast extract (BD Bioscience),  
10 g/l NaCl, pH 7.0  
LB agar plates  
LB medium, 18 g/l Bacto-agar (BD Bioscience), appropriate antibiotic (100 μg/ml ampicillin)  
 
2.1.4 Animals 
Male Sprague Dawley rats from Harlan-Winkelmann GmbH, Borchen, Germany 
 
2.1.5 Plasmid vectors: 
pcDNA3.1+ from Invitrogen  
pcDNA3.1/Myc-His (B) from Invitrogen 
pGEX 5X-2 from GE Healthcare 
pEGFP-C2 from BD Bioscience (Clontech) 
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2.1.6 Small interfering RNAs (siRNAs)  
ON-TARGETplus SMARTpool of 4 siRNAs targeting rat CNP1 from Dharmacon, Chicago, 
IL, USA 
 
siRNA name  siRNA sequence 
Sense Sequence 
GCACAAGCUUUGCCCGAAAUU 
siGENOME ON-TARGETplus SMARTpool 
duplex (9), J-080116-09, CNP1 
Antisense Sequence 
5’-PUUUCGGGCAAAGCUUGUGCUU 
Sense Sequence 
CCGAGGAGUACAAGCGUCUUU 
siGENOME ON-TARGETplus SMARTpool 
duplex (10), J-080116-10, CNP1 
Antisense Sequence 
5’-PAGACGCUUGUACUCCUCGGUU 
Sense Sequence 
GUGAGGAGAUCUUACGGCAUU 
siGENOME ON-TARGETplus SMARTpool 
duplex (11), J-080116-11, CNP1 
Antisense Sequence 
5’-PUGCCGUAAGAUCUCCUCACUU 
Sense Sequence 
GUUCCGAGACCCUCCGAAAUU 
siGENOME ON-TARGETplus SMARTpool 
duplex (12), J-080116-12, CNP1 
Antiense Sequence 
5’-PUUUCGGAGGGUCUCGGAACUU 
 
Non-silencing siRNA from Qiagen. 
 
2.1.7 Enzymes  
Enzymes and buffer Manufacturer 
T4 DNA Ligase Gibco BRL (Life Technologies), Karlsruhe, Germany 
Eco RI 
NotI 
Tango+ (yellow) (10X) buffer 
MBI Fermentas, St. Leon-Rot, Germany 
 
2.1.8. Molecular weight markers
Nucleic acid standard markers 
GeneRuler
™ 
1 kb and 100 bp DNA ladders from MBI Fermentas.  
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Protein standard marker 
Precision Plus Protein All Blue Standard (250-10 kDa) from Bio-Rad  
 
2.1.9 Kits 
Type of kit             Usage Manufacturer 
BigDye Terminator Cycle 
Sequencing                              
Ready Reaction kit  
DNA sequencing Applied Biosystems, 
Warrington, UK 
ECL+Plus  detection of western blot  Amersham Pharmacia 
Biotech, Buckinghamshire, 
UK 
ApoAlert Caspase-3 
Colorimetric assay Kit 
Detection of apoptosis BD Bioscience (Clontech), 
Heidelberg; Germany 
Concert Rapid PCR 
Purification system 
Cleaning of PCR, restriction 
digestion product 
Concert Rapid Gel Extraction 
system 
Cleaning of PCR product 
from gel 
Gibco BRL (Life 
Technologies), Karlsruhe, 
Germany 
Invisorb Spin Plasmid Mini 
kit 
Plasmid isolation Invitek, Berlin, Germany 
HiSpeed Plasmid Midi kit Plasmid isolation 
Hotstar Taq Master Mix kit  PCR 
Omniscript Reverse 
Transcription kit 
Making of cDNA   
Flexi Gene DNA kit Isolation of Genomic DNA 
from cell culture 
RNase-Free DNase Set Removal of genomic DNA 
during RNA isolation 
RNeasy Maxi, Midi and Mini 
kit (Isolation of RNA) 
Isolation of RNA 
Qiagen, Hilden, Germany 
Supersignal West Pico kit Detection of western blot Pierce, Rockford, IL, USA 
 
2.1.10 Laboratory instruments  
 
Instrument Manufacturer 
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ABI PRISMTM 310 Genetic Analyzer Applied Biosystems Division, Foster City, 
CA, USA 
Mighty Small II (for western blotting 
electrophoresis) 
Amersham Pharmacia Biotech, 
Buckinghamshire, UK 
Ultrasonic homogenizer  Bandelin electronic, Berlin, Germany. 
T3 Thermocycler Biometra, Göttingen, Germany 
Electrophoresis power supply 
Gel electrophoresis system 
Semi-dry Transfer Cell 
Mini PROTEAN II (Tankblot) 
GS-800 Calibrated Densitometer 
Bio-Rad Laboratories, Munich, Germany 
LSM510 laser scanning confocal microscope  Carl Zeiss, Jena, Germany 
Thermomixer comfort Eppendorf, Hamburg, Germany  
Biofuge pico and 13 R centrifuges 
Megafuge 1.0 R centrifuge  
Sorvall
® 
RC-5B Refrigerated Superspeed 
Centrifuge 
Sorvall
® 
discovery
TM 
90 ultraspeed centrifuge 
Heraeus cell culture incubator 
Heraeus refrigerator (-80
o
C) 
LaminAir
®
 (clean bench) 
Kendro, Hanau, Germany 
Millipore purification system 
Ultra-pure water system  
Millipore, Schwalbach, Germany 
Rotator  Labinco BA, Netherlands 
Microplate reader 
Microplate reader Spectramax M5 
Molecular Devices 
Innova 4230 Refrigerated incubator shaker New Brunswick Scientific, Nürtingen, 
Germany 
TPP+-selective electrode  
Ca2+-sensitive electrode  
Nico, Moscow, Russia 
UV/visible Spectrophotometer Pharmacia Biotech 
Balance (analytical and preparative)  Sartorius, Göttingen, Germany 
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Gel-blotting-papers 
Protran BA83 Cellulosenitrat (E) (0.2 µm) 
Protran BA79 nitrocellulose transfer 
membrane (0.1 µm) 
Schleicher & Schuell, Dassel, Germany 
Eagle Eye Still video system Stratagene, Heidelberg, Germany 
Vivaspin 6 filter concentrator Vivascience AG, Hannover, Germany 
pH Meter (pH526) WTW 
 
                                                                                  
2.1.11 Buffers and solvents 
All buffers were prepared with distilled water.  
2.1.11.1 Buffers and solvents 
1x HBSS : 145 mM NaCl, 5.4 mM KCl, 1mM MgCl
2
, 1.8 mM CaCl
2
, 25 mM glucose, 20 
mM HEPES, pH 7.4 adjusted with 1.67 M Tris (hydroxymethyl)-aminomethane 
1x PBS: 137 mM NaCl, 2.6 mM KCl, 8.1 mM Na2PHO4, 1.4 mM KH2PO4, pH 7.4 
E. coli-lysis buffer (PBS+ 1% Triton X- 100):137 mM NaCl, 2.6 mM KCl, 8.1 mM Na2PHO4, 
1.4 mM KH2PO4, pH 7.4, 1% Triton X- 100 
Storage buffer: 50 mM Tris/HCl pH 8,0, 100 mM NaCl, 1 mM mercaptoethanol, 20% 
glycerol 
1xTBE: 89 mM Tris, 89 mM Boric acid, 2 mM EDTA, pH 8.0 
1xTE: 10 mM Tris/HCl, pH 7.4, 1 mM EDTA, pH 8.0 
Ethidium bromide solution: 10 mg/ml 
TCM: 10 mM Tris/HCl, pH 7.5, 10 mM CaCl2, 10 mM MgCl2 
4% PFA (Paraformaldehyde) solution: 4% PFA, 120 mM sodium phosphate, pH 7.4, 4% 
Saccharose  
FTP: Blocking and Washing buffer (immunostaining): 
17% (v/v) fetal calf serum, 20 mM Na2HPO4, 450 mM NaCl, 0.3% Triton X- 100 
Lysis buffer: 50 mM Tris/HCl pH 7.4, 150 mM NaCl, 1% Igepal CA630, 0.25% Na-
deoxycholate, 1 mM EDTA and 1 mM NaF 
60% Acrylamid/Bis: 58.4% Acrylamide, 1.6% N,N’-Methylen-bisacrylamide 
Resolving buffer: 750 mM Tris/HCl, pH 8.8 
Stacking buffer: 250 mM Tris/HCl, pH 6.8 
SDS solution: 10% (w/v) SDS in H2O 
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PER solution: 10% (w/v) Ammoniumperoxodisulfat in H2O 
4x Laemmli Sample buffer: 500 mM Tris/HCl, pH6.8, 8% SDS, 40% Glycerol 
5x Laemmli Running buffer: 125 mM Tris, 960 mM Glycine, 0.5% SDS, pH 8.5 
1x Transfer buffer: 25 mM Tris, 192 mM Glycine, 20% (v/v) Methanol 
Membrane Stripping buffer: 62.5 mM Tris, pH 6.8, 100 mM β-Mercaptoethanol, 2% SDS 
PBST: 137 mM NaCl, 2.6 mM KCl, 8.1 mM Na2PHO4, 1.4 mM KH2PO4, pH 7.4 
0.1% Tween 20  
50% Protein G agarose slurry or 50% Protein A sepharose slurry: 1 ml 1x PBS and 4 µl 10% 
sodium azide 
2.1.11.2 Buffers for mitochondria studies 
All buffers for mitochondria studies were prepared with bidistilled water 
Buffer A: 0.32 M sucrose, 0.5 mM EDTA, 0.5 mM EGTA, and 10 mM Tris-HCl, pH 7.4 
Buffer for mitochondria isolation: 
0.32 M sucrose, 0.5 mM EDTA, 0.5 mM EGTA, 0.5% bovine serum albumin (BSA; fraction 
V) and 10 mM Tris-HCl, pH 7.4 
Buffer for washing of mitochondria: 
0.32 M sucrose, and 10 mM Tris-HCl, pH 7.4 
Incubation medium: 
100 mM KCl, 100 mM sucrose, 10 mM Tris-HCl, 0.4 mM K2HPO4, 5 mM potassium 
succinate, 1.5 µM oligomycin and 2 µM rotenone, pH 7.4  
2.1.12. Oligonuleotides for PCR and sequencing. 
(Synthesized by MWG, Biotech, Ebersberg, Germany) 
 
cDNA Primer name  Primer sequence  Tm 
(°C) 
application
THGAPDHFW 5’-
ATGGTGAAGGTCGGTGTGAACGGATTT
GG-3’ 
mice 
GAPDH 
THGAPDHRV 5’-
TTACTCCTTGGAGGCCATGTAGGCCAT
GAG-3’ 
58° PCR 
mice THMMP42F1 5’-TTCTCCGACTGCCAACTCCTAC-3’ 58° PCR 
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p42IP4 THMMP42R6 5’-GACAATGGTTATGCCATGAGG -3’ 
 pGEX 5’ Seq. 
Fw  
5’-GGGCTGGCAAGCCACGTTTGGTG-3’ 55° Sequencing
 pGEX 3’ Seq. 
Rev 
5’-CCGGGAGCTGCATGTGTCAGAGG-3’ 55° Sequencing
 T7 promoter 5’-GTAATACGACTCACTATAGGGC-3’ 55° Sequencing
 BGH seq 5’-CTAGAAGGCACAGTCGAGG-3’ 55° Sequencing
             
2.2 Methods  
2.2.1 RT-PCR  
Total RNA was extracted from cultured cells using RNeasy Mini kit (Qiagen). One 
microgram of RNA was reverse-transcribed using Omniscript™ Reverse Transcription kit 
(Qiagen), and the resulting cDNA was amplified in the presence of appropriate primers for 30 
cycles by PCR using HotStarTaq™ Master Mix kit (Qiagen) for 15 min at 95ºC, followed by 
repeated cycles of 30 s at 94ºC, 90 s at 58º C, 60 s at 72ºC, then a final 10 min extension at 
72ºC. The reaction products were analyzed by electrophoresis with 1% agarose gel containing 
ethidium bromide, and visualized by Bio-Rad gel document system (Bio-Rad).  
 
2.2.2 Plasmid constructs  
A NotI DNA fragment coding the full length p42IP4 was excised from pBluescript+-
p42IP4 (Sedehizade et al., 2002) and sub-cloned into pGEX-5X-2 vector (GE Healthcare, 
Munich, Germany). An EcoRI DNA fragment with the full length p42IP4 cDNA was excised 
from pBluescript+-p42IP4 and sub-cloned into the EcoRI site of pcDNA3.1Myc vector 
(Invitrogen, Karlsruhe, Germany). At first, the original pBluescript+-p42IP4 construct was 
digested with the NotI or EcoRI to obtain DNA fragments encoding for the p42IP4. Then the 
fragments obtained were ligated into the linearized pGEX-5X-2 and pcDNA3.1Myc vectors 
respectively. The ligated product was purified using the DNA purification kit from 
Gibco/BRL. The purified DNA was checked for the presence of the inset by digestion of the 
ligated DNA using NotI or EcoRI, respectively. The successfully ligated DNA constructs 
were transformed into E.coli using the heat-shock method (CaCl2 based). The E.coli were 
plated and allowed to grow for 24 hours at 37ºC on LB-agar plates containing 100 mg/ml 
ampicilin, as a selection marker. The positive clones were picked, and cultivated in 5 ml of 
LB medium containing ampicillin for 24 h. DNA was prepared from the above cultures using 
the DNA-Mini-prep kit (Qiagen). The DNA obtained from the mini prep was digested with 
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NotI or EcoRI to recheck for the presence of the inset of the DNA encoding p42IP4 in the 
appropriate construct. The DNA from the positive clones was sequenced using the DNA 
sequencing kit from ABI PRISM, using the appropriate set of primers. 
The clones that expressed the complete p42IP4 without any point mutations and frame 
shift, were retransformed in E.coli using heat-shock method (CaCl2 based), and the DNA was 
isolated using the DNA Midi-Prep kit (Qiagen). 
The construct p42IP4-pcDNA3 and CHO cells, stably transfected with pcDNA3-p42IP4 
were described before (Sedehizade et al., 2002). The sequence of all constructs used was 
verified by sequencing on automated sequencer (ABI PRISMTM 310 Genetic Analyzer) with 
the dye terminator cycle sequencing kit (ABI-Prism, Applied Biosystems) according to the 
manufacturer’s instructions in both directions prior to use.  
2.2.3 Agarose gel electrophoresis of DNA 
To check the quality of DNA (PCR product, recombinant plasmid DNA, restriction 
analysis) 1% agarose (Sigma, Taufkirchen, Germany) gel and 1.5% gel for DNA laddering 
assay in 0.5x TBE buffer were made. Gel was pre-stained in ethidium bromide (10 mg/ml) 
(Sigma). DNA samples were prepared in 6x loading buffer (containing bromophenol blue 
dye) (MBI Fermentas). Gel was run in 0.5x TBE for 60 min at 80 V for PCR samples, at 100 
V for plasmid DNA and 3 h at 30V for genomic DNA. Depending on the fragment size either 
GeneRuler 100bp DNA Ladder (1 kb) or GeneRuler DNA Ladder Mix (10 kb) (MBI 
Fermentas) used. DNA bands were visualised under UV-Transilluminator in an Eagle Eye II 
video system (Stratagene, Heidelberg, Germany). 
2.2.4 Transformation of E. coli with plasmid DNA by heat-shock method (CaCl2 based) 
To make competent cells, single colony of E.coli was grown in 5 ml LB media 
overnight at 37°C with shaking at 250 rpm. 1 ml of overnight bacterial culture was then 
transferred to 100 ml of fresh LB media and continued to grow at 37°C with shaking till the 
cells reached their logarithmic phase i.e, OD 600= 0.3-0.4. Then the bacterial suspension was 
centrifuged at 3,000 g for 5 min at 4°C. Supernatant was discarded and cell pellet was 
resuspended in 10 ml of ice-cold 100 mM CaCl2 solution. The cell suspension was then 
incubated on ice in cold room (4°C) for 1 h and centrifuged for 5 min at 3,000 g at 4 °C. 
Supernatant was discarded carefully and pellet was resuspended in 1 ml of ice-cold 100 mM 
CaCl2 containing 30% glycerine (1 ml solution= 700 µl 100 mM CaCl2+ 300µl of 100% 
glycerine). From this competent cell suspension aliquots of 200 µl were made, frozen in liquid 
nitrogen and stored at -80°C.  
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To transform bacteria, 200 µl of CaCl2 competent cells for each reaction were thawed 
on ice. To the cells we added 100 µl of cold TCM buffer and either 10-20 ng of super-coiled 
plasmid DNA or 20 µl of ligation mix. Cells were incubated on ice for 20 min and then heat –
shock given for 90 s at 42°C. Transformation reaction mix was immediately incubated on ice 
for 1 min, then 700 µl of LB media (pre-warmed at 37°C and without any antibiotic) was 
added to transformation mix and incubated for 30-60 min with shaking at 37°C. 100 µl of the 
transformation mixture in case of super-coiled DNA was plated on the LB-agar plate 
containing suitable antibiotic. For ligation transformation, reaction mix was centrifuged 
briefly, supernatant was discarded and pellet was resuspended in the residual volume and 
plated on LB-agar containing suitable antibiotic. LB-agar plates were incubated up-side down 
at 37°C to facilitate growth of tranformants under appropriate antibiotic selection pressure.  
 
2.2.5 Expression and purification of glutathione S-transferase (GST) and GST-p42IP4 
constructs from E. coli.  
For expression in E. coli, the pGEX-5X-2 constructs were transformed in BL21 (GE 
Healthcare). The expression and purification of the fusion protein was performed in the 
presence Triton-X 100 (Roth, Karlsruhe, Germany) according to a published procedure 
(Stricker et al., 2006) with modifications. In brief, E. coli transformed with the pGEX-5X-2-
p42IP4 construct were grown in LB medium containing ampicillin to absorbance at 600 nm, 
A600 = 0.6-0.8 and expression of the fusion protein was induced by the addition of 0.1 mM 
isopropyl b-D-thiogalactoside (Sigma). The cells were grown for an additional 3 h at 25 °C, 
collected by centrifugation, and stored at 80°C until use. Frozen E. coli pellets were 
solubilized in E. coli-lysis buffer (137 mM NaCl, 2.6 mM KCl, 8.1 mM Na2PHO4, 1.4 mM 
KH2PO4, pH 7.4, 1% Triton X-100) containing a cocktail of protease inhibitors (Roche, 
Mannheim, Germany) by sonication (5x10 s). After centrifugation (10,000 g for 10 min at 
4°C), glutathione-sepharose slurry was added to the supernatant and incubated on a rotator 
(60 min at 4°C). The beads were sedimented by centrifugation (500 g for 5 min at 4°C) and 
washed three times with E. coli-lysis buffer. To remove non-specifically bound proteins, the 
beads were incubated in lysis buffer supplemented with 1 M NaCl (15 min at 4°C) and after 
centrifugation the beads were resuspended in storage buffer (50 mM Tris/HCl pH 8,0, 100 
mM NaCl, 1 mM mercaptoethanol and 20% glycerol). 
The beads and lysates were analyzed by SDS-PAG electrophoresis. The purified fusion 
proteins were stored as a 50% (v/v) beads suspension and used for GST pull-down assay.  
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2.2.6 Cell culture and transfection  
CHO cells were maintained in Hams’ F12 medium supplemented with 10% fetal calf 
serum (Biochrom, Berlin, Germany) and 100 µg/ml penicillin, and 100 µg/ml streptomycin in 
a humidified 5% CO2 atmosphere at 37 °C. N2a cells were maintained under the same 
conditions with the exception that Dulbecco's Modified Eagle's Medium was used. 
OLN93 cells, an oligodendrocyte cell line (Richter-Landsberg and Heinrich, 1996), 
kindly provided by Prof. C. Richter-Landsberg (University of Oldenburg, Germany), were 
grown at 37°C in a 5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium (Biochrom 
KG) supplemented with 10% fetal calf serum (Biochrom KG, Berlin,Germany) containing 2 
mM glutamine, 100 µg/ml penicillin, and 100 µg/ml streptomycin. 
Transfections were carried out using FuGENE 6 (Roche) according to manufacturer's 
instructions. The cells were stably transfected with the respective plasmid DNA (2 μg). 
Before transfection the cells were grown in 10-cm dishes to 60% confluency. The transfected 
cells were kept for 8–10 h in serum- and antibiotic-free medium. After 24-48 h, the 
transfected cells were cultivated in selection medium containing 400 μg/ml G418 
(Calbiochem, Schwalbach, Germany). Single cell colonies were isolated after 3 weeks by 
cloning rings, verified at the transcription and translation level by RT-PCR and western blot 
and used for further experiments. 
 
2.2.7 Confocal microscopy  
For immunofluorescence, N2a cells stably transfected with p42IP4-pcDNA3.1Myc and 
CHO cells, stably transfected with pcDNA-p42IP4 were grown on poly-L-lysine-coated 
coverslips. Cells were fixed in 4% paraformaldehyde, blocked and permeabilized in blocking 
buffer (17% (v/v) fetal calf serum, 20 mM Na2HPO4, 450 mM NaCl, 0.3% Triton X- 100) and 
incubated with rabbit polyclonal anti-Myc antibody (Invitrogen, Karlsruhe, Germany; 0.8 
μg/μl) or rabbit polyclonal anti-p42IP4 antibody (AS1516g) and mouse monoclonal anti-Cyt c 
antibody (clone 6H2.B4; BD Bioscience; Heidelberg; Germany) overnight at 4°C, as 
described in the respective figure legends. After washing, the secondary antibody was applied 
(Alexa Fluor® 555 goat anti–mouse IgG antibody at 1:100; Alexa Fluor® 488 goat anti-rabbit 
at 1:200 Molecular Probes, MoBiTec, Göttingen, Germany) for 2 h at 25°C. Mounted slides 
were observed with a confocal laser scanning microscope LSM510 (Carl Zeiss, Jena, 
Germany). 
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2.2.8 Subcellular fractionation by differential centrifugation  
Subcellular fractionation and organelle isolation techniques were done by modification 
of previously reported procedures (Sharer et al., 2002; Leissring et al., 2004). All steps were 
carried out at 4°C. N2a cells were washed two times in phosphate-buffered saline, collected in 
ice-cold buffer A (0.32 M sucrose, 0.5 mM EDTA, 0.5 mM EGTA, and 10 mM Tris-HCl, pH 
7.4) containing cocktail of protease inhibitors (Roche) and gently disrupted using a Potter-
Elvehjem homogenizer. The cell homogenate was then subjected to centrifugation at 500 g for 
10 min, yielding a nuclear pellet and supernatant. The mitochondrial fraction was obtained 
from this supernatant after centrifugation at 12,000 g for 10 min. Finally, the 12,000 g 
supernatant was further fractionated at 49,000 g for 30 min, yielding the soluble cytosolic 
fraction and membrane pellet. After each centrifugation step, the resulting pellets were 
washed by resuspension in an excess of buffer A, followed by centrifugation at the 
appropriate relative centrifugal force. 
The protein concentration was determined by the Bradford method (Bio-Rad Protein 
assay, Bio-Rad, Munich, Germany) using bovine serum albumin as standard. 
2.2.9 Preparation of mitochondrial lysate and cytosolic fraction from rat brain 
Rat brains were rapidly removed and placed within 30 s in ice-cold buffer A 
containing 0.02% bovine serum albumin (fatty acid free, fraction V). All manipulations were 
carried out at 4οC. The tissue was homogenized in a Potter-Elvehjem homogenizer; the ratio 
of brain tissue to buffer used for isolation was 1:10 (w/v). The homogenate was centrifuged at 
2,000 g for 3 min. The pellet of mitochondria was obtained by centrifugation of the 2,000 g 
supernatant at 12,000 g for 10 min. RBM were suspended in ice-cold solution, containing 
0.32 M sucrose and 10 mM Tris-HCl (pH 7.4) and were additionally washed by centrifugation 
at 12,000 g for 10 min.  
For preparation of mitochondrial lysate, RBM aliquots (4 mg of protein) were 
suspended in lysis buffer (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 1% Igepal CA630, 0.25% 
Na-deoxycholate, 1 mM EDTA and 1 mM NaF) containing a cocktail of protease inhibitors 
(Roche). Then suspensions were rotated on a rotation wheel for 30 min at 4°C, solubilized by 
ultrasonic treatment and centrifuged at 14,000 g for 15 min. The 14,000 g supernatant gives 
the mitochondrial lysate. 
For preparation of brain cytosolic fraction, the brain tissue was homogenized using an 
Ultraturrax three times for 20 s at 4°C in buffer A containing a cocktail of protease inhibitors 
(Roche). The homogenates were then centrifuged at 400 g for 5 min at 4°C. The supernatant 
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obtained was centrifuged at 100,000 g for 30 min at 4°C. The 100,000 g supernatant gives the 
cytosolic fraction. 
2.2.10 Isolation of mitochondria from cultured cells  
Isolation of mitochondria from cells was carried out at 4οC according to a published 
procedure (Leissring et al., 2004) with modifications. Confluent monolayers of N2a or CHO 
cells, cultured in 15 cm dishes, or confluent monolayers of OLN93 cells, cultured in T-75 
flasks, were washed with phosphate-buffered saline, collected by scraping in buffer A, 
containing 0.02% bovine serum albumin (fatty acid free, fraction V), and pelleted at 500 g for 
5 min. Cells were re-suspended in the same ice-cold buffer and disrupted with a Potter-
Elvehjem homogenizer. The cell homogenate was centrifuged twice at 500 g for 5 min to 
remove unbroken cells and nuclei, and twice at 3,000 g for 4 min to remove trapped 
peroxisomes and other organelles. The supernatant obtained was centrifuged at 12,000 g for 
10 min. The mitochondrial pellet was suspended in ice-cold medium containing 0.32 M 
sucrose and 10 mM Tris–HCl (pH 7.4) and centrifuged at 12,000 g for 10 min. The 
mitochondria isolated were re-suspended in the same ice-cold medium. Mitochondria from 
N2a and OLN93cells were used for functional studies. 
2.2.11 Subfractionation of mitochondria 
Mitochondria isolated from CHO cells were subfractionated by using a phosphate 
swelling-shrinking method described previously (Bijur and Jope, 2003), with minor 
modifications. Briefly, mitochondria were subjected to swelling by the addition of swelling 
buffer (10 mM KH2PO4, pH 7.4) containing a cocktail of protease inhibitors, and incubated 
for 20 min at 4οC with gentle mixing. An equal volume of shrinking buffer (10 mM KH2PO4, 
pH 7.4, 32% sucrose, 30% glycerol, 10 mM MgCl2, and protease inhibitors) was added and 
samples were incubated for an additional 20 min at 4οC. The suspension was centrifuged at 
10,000 g for 10 min, yielding a supernatant containing the outer membrane and the 
intermembrane space fractions, which was saved as mixture 1, and a pellet comprised of 
mitoplasts. The mitoplasts were washed three times in the mixture of swelling and shrinking 
buffer (1 : 1), then resuspended in 500 μl of swelling buffer and sonicated 10 s x 3 with a 1-
min interval on ice by 40% of maximal power. This suspension containing the inner 
membrane and matrix fractions was saved as mixture 2. Mixtures 1 and 2 were centrifuged at 
150,000 g for 1 h. The supernatant from mixture 1 was saved as the intermembrane space 
fraction and the supernatant from mixture 2 was saved as the matrix fraction. Proteins from 
the intermembrane space fraction were concentrated using a Vivaspin 6 filter concentrator 
(Vivascience AG, Hannover, Germany). The outer membrane pellet in mixture 1 and the 
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inner membrane pellet in mixture 2 were washed once in swelling buffer and centrifuged at 
150,000 g for 1 h. The outer and inner membrane pellets were solubilized in lysis buffer 
containing protease inhibitors, as described above.  
Mitoplast and outer membranes of rat brain mitochondria were obtained according to 
previously reported procedures (Rice and Lindsay, 1997).  
2.2.12 Electrophoresis and immunoblotting 
For immunoblotting, proteins solubilized in Laemmli buffer were separated under 
denaturing conditions on sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis 
(PAGE) using 10% or 12.5% gels and transferred to nitrocellulose membranes (Protran BA83 
or BA79, Whatman, Dassel, Germany). Precision Plus Pre-stained Standards (Bio-Rad) were 
used as markers. Equal transfer was controlled by Ponceau red staining of the membrane. 
After overnight blocking, the membrane was incubated with the appropriate primary antibody. 
The monoclonal anti-CNP antibody was described before (Reiser et al., 1994). A polyclonal 
rabbit serum raised against p42IP4 (AS1516g) and monoclonal antibody, Mab117-2, were 
described before (Haase et al., 2008). Anti-Cyt c (cytochrome c, clone 7H8.2C12, Biozol, 
Eching, Germany), pan anti-plasma membrane calcium ATPase (clone 5F10, Biozol), anti-
Cytochrome oxidase subunit IV (clone 20E8C12, MitoSciences, Eugene, Oregon), anti-ANT 
(adenine nucleotide translocator, MitoSciences), anti-SOD 2 (Mn-superoxide dismutase 2, 
antibody 13533, Abcam Cambridge, UK), anti-CNP (antibody 27695, Abcam), anti-VDAC 
(voltage-dependent anion channel, Ab-5, Calbiochem), anti Synaptotagmin I (clone 41.1, 
Synaptic Systems, Gottingen, Germany), anti-Nucleoporin p62 (BD Biosciences, Heidelberg, 
Germany), anti-GAPDH (glyceraldehyde 3-phosphate dehydrogenase, clone 6C5, Chemicon, 
Martinsried/Munich, Germany), anti-β-tubulin I (Sigma) and anti-α-tubulin (Clone B-5-1-2, 
Sigma) antibodies were used for immunoblotting. Immunoreactivity was detected using the 
appropriate secondary antibody conjugated to horseradish peroxidase (Dianova; Hamburg, 
Germany). Peroxidase activity was detected with enhanced chemiluminescence reagents 
(Super-Signal West Pico; Pierce, Rockford IL). 
Quantification of the band densities from western blots was carried out using a GS800 
calibrated densitometer and QUANTITY ONE software (Bio-Rad, Munich, Germany). Films 
were scanned and the intensities of the bands were quantified.  
 
2.2.13 GST-pull-down assay 
For the GST pull-down, mitochondrial lysate was precleared by rotation 4 - 8 h with 
glutathione-Sepharose beads at 4°C. After centrifugation (500 g 5 min at 4°C) glutathione-
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Sepharose beads were discarded and precleared lysate was used for binding. To determine 
protein-protein interaction in vitro, equal amounts of GST and GST-p42IP4 fusion proteins 
immobilized on glutathione-Sepharose beads were incubated with brain cytosolic fractions or 
precleared mitochondrial lysates (4 mg of protein) overnight on a rotating wheel at 4°C. After 
centrifugation (1000 g for 5 min at 4°C) the beads were washed five times with 1 ml of lysis 
buffer described above. The proteins were eluted from the beads with 10 μl of 2× Laemmli 
buffer, separated by SDS–PAGE, transferred to nitrocellulose membranes and immunoblotted 
as described above. 
 
2.2.14 Immunoprecipitation and co-immunoprecipitation 
For immunoprecipitation, RBM lysates were precleared by protein G-agarose (Sigma) 
or A-sepharose beads (GE Healthcare), depending on the primary antibody used, for 2 h at 
4°C. Cytosolic fractions and precleared RBM lysates were incubated with primary antibody, 
i.e. monoclonal anti-CNP antibody (described before in (Reiser et al., 1994), monoclonal anti-
α-tubulin antibody (Clone B-5-1-2, Sigma), or polyclonal rabbit antiserum against p42IP4 
(AS1516g, described before in (Haase et al., 2008) for 2 h on ice. Then it was mixed with 20 
µl of suspension of protein G-agarose or A-sepharose beads, respectively, for overnight 
incubation at 4°C under rotation with a following centrifugation at 500 g for 5 min. The 
immunoprecipitated complexes were washed with lysis buffer (described above) five times. 
Samples were eluted in 10 μl of 2× Laemmli buffer and used for electrophoresis and 
immunoblotting as described above. 
2.2.15 Isolation of rat brain mitochondria for functional study 
Rat brains were rapidly removed (within 30 s) and placed in ice-cold buffer A, 
containing 0.02% bovine serum albumin (fatty acid free, fraction V). All solutions used were 
ice-cold; all manipulations were carried out at +4οC. The tissue was homogenized in a a 
Potter-Elvehjem homogenizer; the ratio of brain tissue to isolation medium was 1:10 (w/v). 
The homogenate was centrifuged at 2000 g for 3 min. The pellet of mitochondria was 
obtained by centrifugation of the 2000 g supernatant at 12,500 g for 10 min. At the next step, 
in representative experiments, mitochondria were purified on Percoll gradient (15%-23%-
40%) according to published procedures (Sims, 1990). Rat brain mitochondria were 
suspended in ice-cold solution, containing 0.32 M sucrose and 10 mM Tris-HCl (pH 7.4) and 
were additionally washed by centrifugation at 11,500 g for 10 min. The protein concentrations 
in the stock mitochondrial suspensions were 25-30 mg/ml.  
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2.2.16 Evaluation of mitochondrial functions 
Mitochondrial functions were measured, as described earlier (Azarashvili et al., 2007). 
RBM (1.0 mg protein/ml) or mitochondria from cultured cells (0.7 mg of protein/ml) were 
incubated in respiration buffer containing 100 mM KCl, 100 mM sucrose, 10 mM Tris-HCl, 
0.4 mM K2HPO4, in the presence of 2 μM rotenone and 1.5 μM oligomycin, pH 7.4 at 25°C, 
in an open chamber. Succinate (5 mM potassium succinate) was used as mitochondrial 
respiratory substrate. PTP opening was induced by threshold Ca2+ load. For Ca2+ loading, 
additions of Ca2+ per mg of protein: 70 or 200 nanomoles for mitochondria isolated from N2a, 
80-120 nanomoles for RBM and 70 nanomoles for mitochondria isolated from OLN93 cells 
were used. All experiments were performed in an open chamber. 
Extramitochondrial Ca2+ was determined with a Ca2+-sensitive electrode (Nico, 
Russia). The mitochondrial membrane potential was determined by measuring 
tetraphenylphosphonium (TPP+) in the incubation medium with a TPP+-sensitive electrode. 
Oxygen consumption rate was detected with a Clark-type O2 electrode.  
Changes in Ca2+ and TPP+ concentration, as well as in oxygen consumption were 
simultaneously monitored in the incubation medium. Parameters of Ca2+ transport, rate of 
Ca2+ influx, Ca2+ capacity (amount of Ca2+ taken up by mitochondria before PTP opening), 
lag time for Ca2+ efflux after Ca2+ addition under PTP opening were evaluated, as described 
earlier (Azarashvili et al., 2007).  
In some experiments mitochondria were pre-incubated with IP4 (D-myo-inositol 1,3,4,5-
tetrakisphosphate, tetrapotassium salt, Alexis, Gruenberg, Germany) or PIP3 
(phosphatidylinositol 3,4,5-Trisphosphate diC8, Echelon Biosciences Incorporated, Salt Lake 
City, UT, USA) for 20 min before loading with Ca2+. 
Swelling of RBM was measured as a change in scattering of the mitochondrial 
suspension absorbance at 540 nm (A540) using Microplate reader Spectramax M5 (Molecular 
Devices) at 30°C. Standard incubation medium for swelling assay contained 125 mM KCl, 10 
mM Tris, 2 mM KH2PO4, 10 mM succinate, 0.5 µM oligomycine, 0.5 µM rotenone. The 
concentration of protein in the cuvette was 0.45 mg protein/ml. The swelling was initiated by 
addition of 450 µM Ca2+.  
 
2.2.17 Detection of CNP activity in isolated mitochondria 
CNP activity was detected according to published procedure (Bradbury and 
Thompson, 1984). Aliquots of the mitochondrial suspension (rat brain mitochondria or 
OLN93 cells) containing 40 µg of protein were taken from the chamber under control 
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conditions and after PT opening and were then solubilized in Laemmli buffer. Solubilized 
mitochondria were separated by electrophoresis in a 12.5% polyacrylamide gel and were 
transferred to nitrocellulose membranes. CNP activity was detected on membrane after 
blotting. The membrane was pre-incubated for 1 h in 50 mM MES (4-morpholine-
ethanesulfonic acid) buffer, pH 6.1, containing 30 mM MgCl2, 0.1% Triton X-100, 3 M 
guanidinium chloride, 1 mM EDTA, 1 mM dithiothreitol and 5% glycerol, then for 1 h in the 
same buffer without guanidinium chloride. The pre-incubation stage is essential for recovery 
of enzyme activity after SDS- electrophoresis. The blot was then stained for activity by using 
Nitro Blue Tetrazolium [3.3’(3,3’-dimetoxy-4.4’-diphenylene)2,2’-di-p-nitrophenyl-5,5’-
diphenylditetrazolium] chloride and phenazine methosulphate to detect NADPH produced in 
enzyme-linked reaction for CNP. The coloured reaction product was immobilized with diluted 
agarose. Equal volumes of 1% agarose in water at 55°C and reaction medium (200 mM MES 
buffer pH 6.1, containing 60 mM MgCl2, 0.2 % Triton X-100, 0.1 mM 2’,3’-cyclic NADP 
and 4 mg/ml glucose-6-phosphate, 0.4 mg /ml Nitro Blue Tetrazolium, 0.04 mg/ml phenazine 
methosulphate and 0.7 units of glucose-6-phosphate dehydrogenase) were rapidly mixed and 
poured on the nitrocellulose membrane. Coloured reaction was visible within 15 min and was 
stopped with 10% acetic acid. CNP activity in the bands (intensity of coloured band) on the 
blot was evaluated by determining the optical density of the coloured product. 
2.2.18 Small interfering RNA (siRNA) 
Chemically synthesized pool of siRNAs targeting CNP was obtained from 
Dharmacon, Chicago, IL. To knockdown the endogenous CNP, OLN93 cells were transiently 
transfected with rat CNP siRNAs by using magnet assisted transfection, according to the 
manufacturer’s protocol (IBA GmbH, Germany). Briefly, one day before transfection cells 
were plated on a T-75 flasks. On the following day, the cells (50% confluent) were incubated 
for 15 min with CNP siRNAs or scrambled siRNA and magnet assisted transfection reagents 
mixture on the magnet plate. Afterwards, transfected cells were cultured for 48 h under 
normal conditions. Non-silencing siRNA served as a scrambled siRNA control (Qiagen). CNP 
knockdown was assessed by Western blot at 48 h after transfection. 
2.2.19 Apoptosis detection  
For inducing apoptosis N2a cells were exposed to 300 nM wortmannin, 10 nM and 100 
nM staurosporine or/and 100 μM LY 294002. Detection of apoptosis was checked using 
DNA- laddering and caspase-3 assays. 
For DNA laddering analysis, genomic DNA from 5 × 106 cells was isolated using Flexi 
Gene DNA kit (Qiagen) after 6 and 24 h incubation with the apoptotic-inducing drugs in 
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serum-free medium. DNA was treated with RNAse and analysed by agarose gel 
electrophoresis as described above.  
For Caspase-3 activity assay, 2 × 106 cells were harvested after 24 h incubation with the 
apoptotic-inducing drugs in serum-free or serum containing medium, and caspase-3 activity in 
cell lysate was measured using ApoAlert Colorimetric assay  kit (BD Bioscience).  
 
2.3 Statistical analysis 
For statistical analysis, relative values of mitochondrial functions and relative levels of 
protein density were expressed as mean ± SD from at least 3 independent experiments with 
samples from individual preparations of mitochondria. Statistical significance was evaluated 
using the Student’s t- test. A value of p<0.05 was accepted as significant.  
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 3. Results 
3.1. Possible role of p42IP4 in cell protection or cell death 
The protein p42IP4 was suggested to be involved in neurodegenerative processes (Reiser 
and Bernstein, 2004). However, its exact physiological role is still unknown. Earlier, it has 
been shown that the p42IP4 ligand, IP4, is able to play a key role in the induction of Ca2+ 
accumulation, which led to neuronal cell death (Tsubokawa et al., 1996). Another ligand of 
p42IP4 , PIP3 , generated from PIP2 by action of PI 3-K. PI 3-K activates serine/threonine 
protein kinase termed protein kinase B, which phosphorylates numerous regulatory proteins to 
enhance cell survival (Lawlor and Alessi, 2001). It was shown that p42IP4 binds to all 
members of the PKC family and is phosphorylated by isoforms from all PKC classes 
(Zemlickova et al., 2003). Among many other functions, PKC plays a vital role in cellular 
survival and apoptosis. It was suggested that PKC-α, PKC-ε, and the atypical PKC's, PKC-λ/ι 
and PKC-ζ, preferentially function to promote cell proliferation and survival, while the novel 
isoform, PKC-δ is an important regulator of apoptosis (Reyland, 2009). 
Recently it was shown, that PKC- and PI 3-K-mediated pathways are necessary for 
survival of mouse neuroblastoma (N2a) cell line under apoptotic conditions (Bronisz et al., 
2002). Therefore, we used staurosporine (STS) for selective inhibition of the PKC pathway 
and LY 294002 for inhibition of PI 3-K to induce apoptosis in N2a cells. We aimed to find 
out whether p42IP4 plays a role in neuroprotection or cell death. For these purposes we 
compared consequences of induced apoptosis in the control and p42IP4 overexpressing N2a 
cells.  
3.1.1 Influence of p42IP4 overexpression on apoptosis induced in N2a cells.  
To investigate the possible role of p42IP4 in neuroprotection or cell death, we first 
induced apoptosis in N2a cells, stably transfected with pEGFP-C2-p42IP4. Nontransfected and 
EGFP- C2-transfected N2a cells were used as control cells. We performed detection of 
apoptosis in N2a cells first in the early stage, using caspase-3 assay, secondly in the last step, 
using both DNA-laddering assay and flow cytometry analysis. 
It has been already shown that pro-survival pathway is totally dependent on PKC 
activity under serum-free conditions, whereas in the presence of serum it can be alternatively 
activated by undefined trophic signal(s) involving protein kinase B (Bronisz et al., 2002). 
Therefore, to induce apoptosis in N2a cells, 10 nM or 100 nM STS were applied for 24 h in 
serum-free or complete medium. STS-induced apoptosis was confirmed by oligonucleosomal 
DNA fragmentation assay (Fig. 3.1.1). DNA-laddering was observed in N2a cells stably-
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transfected with pEGFP-C2-p42IP4 and nontransfected N2a cells exposed to 10n M and 100 
nM STS (STS 10 and STS 100, respectively) for 24 h in serum-free medium. However, only 
slight differences in oligonucleosomal DNA cleavage in N2a cells stably-transfected with 
EGFP-C2-p42IP4 and control cells, which were exposed to STS, were detected. 
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Fig. 3.1.1. Oligonucleosomal fragmentation of DNA isolated from N2a cells. 
Cells were incubated in serum-free medium for 24 h with 10 nM staurosporine and 100 nM (STS 10 
and STS 100 respectively). 
 
Next, caspase-3 assay for detection of apoptosis in N2a cells in the early stage was used. 
Increase of caspase-3 activity was detected in N2a cells exposed to 100 nM STS or to 100 μM 
LY 294002, or to combination of 10 nM STS and 50 μM LY 294002 in serum-containing 
(Fig. 3.1.2) and serum-free medium (Fig. 3.1.3).  
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Fig. 3.1.3. Activity of caspase-3 
in N2a cells after induction of 
apoptosis under serum-free 
conditions. 
Caspase-3 activity of N2a cells, 
exposed to 100 nM 
staurosporine, 100 μM LY 
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nM STS and 50 μM LY 294002  
(LY and STS, respectively) for 
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presented.  
 
 
There were no significant differences between levels of caspase-3 activity in N2a cells 
stably-transfected with EGFP-C2-p42IP4 and control cells, which were exposed to either STS, 
LY 294002 or both inhibitors together (Fig. 3.1.3.). Thus, p42IP4 is not involved in caspase-3-
mediated apoptosis induced by inhibition of PKC and PI 3-K pathways in N2a cells.  
3.1.2 Influence of p42IP4 overexpression on cell cycle in N2a cells. 
Since we could not see any significant effect of p42
IP4 
overexpression on the early 
apoptotic stage, using caspase-3 assay, we decided to use flow cytometry analysis to clarify 
whether p42IP4 is involved in the last step of apoptosis. N2a cells were grown to confluence, 
hence density arrested in G0. Then cells were trypsinized and reseeded at a lower density to 
induce a synchronous entry into the cell cycle. Cells were allowed to grow 48 h before 
apoptotic treatment. Propidium iodide staining was applied to identify apoptotic cells by flow 
cytometry. Surprisingly, we observed a high level of apoptosis in EGFP-C2-transfected N2a 
cells, which were used as a control (Fig. 3.1.4). Such toxic effects of empty EGFP vector in 
N2a cells made it impossible to use further flow cytometry for counting apoptotic cells.  
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Apopt   G1    S     G2 Apopt  G1     S      G2 Apopt   G1     S     G2
Nontransfected EGFP-C2 transfected EGFP-p42IP4 transfected
Fig.3.1.4. Analysis of N2a cells by flow cytometry.  
Growth-arrested N2a cells were obtained by culture to confluence and then were released from contact 
inhibition by trypsinization. Cells were allowed to proceed 48 h, subjected to propidium iodide DNA 
staining and flow cytometry analysis. Peaks represent G1 phase cells and G2/M phase cells. Apopt - 
cells in apoptosis. For each sample 1x105 positive counts were monitored. FL2, fuorescence channel 2.  
 
However, significant changes were observed in S/G2 phase in N2a cells overexpressing 
EGFP-p42IP4 (Fig. 3.1.4). The diagram of Fig. 3.1.5. represents the quantitative analysis 
showing the mean data from several experiments to demonstrate the effect of EGFP-p42IP4 on 
cell cycle in N2a cells. Interestingly, we observed that overexpression of EGFP-p42
IP4
 leads 
to a delay in exit from S-phase and a significant decrease in G2-phase (Fig. 3.1.5). So, we 
conclude that p42IP4 seems to have an effect on cell cycle. Since there are changes in S-phase 
and G2-phase, it might be possible that p42IP4 influences the level and activity of cyclin/ 
cyclin-dependent kinases, which are specific for these phases. 
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Fig.3.1.5. Effect of p42IP4 expression on cell cycle in N2a cells 
Percentage of cells in the G1, S, and G2/M phases of the cell cycle without apoptotic treatment. The 
sum of total counted cells in G1, S and G2 phases represent 100%. Values represent the mean ± SD 
from three independent experiments. * p < 0.05, ** p < 0.01 versus nontransfected control cells. 
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3.2. Novel localization of p42IP4: mitochondrial localization 
Previously, p42IP4 was identified in brain membranes from several species (Donie and 
Reiser, 1991). Expression of p42IP4 protein in non-neuronal CHO cells stably transfected with 
pcDNA-p42IP4 was shown in cytosol, membranes and nucleus (Sedehizade et al., 2002). The 
membrane fraction in that study also contained mitochondria.  
p42IP4 associates with all PKC isoforms and is phosphorylated by PKC (Zemlickova et 
al., 2003). Additionally, protein kinase B is a target for PIP3, the ligand of p42IP4. Both, 
protein kinase B and PKC were found to be localized in mitochondria (Baines et al., 2003; 
Bijur and Jope, 2003).  
Furthermore, the yeast protein Gcs1p, which is structurally and functionally related to 
p42IP4, is localized in mitochondria and is involved in maintenance of mitochondrial 
morphology (Huang et al., 2002). Finally, a high probability for mitochondrial localization of 
p42IP4 was predicted by the program PSORT II (http://psort.nibb.ac.jp/; (Nakai and Kanehisa, 
1992). All these data indicate possible localization of p42IP4 in mitochondria. Therefore, this 
question, which has not yet been investigated, was studied here. 
3.2.1 p42IP4 is localized in mitochondria, isolated from transfected CHO cells  
We used mitochondria isolated from CHO cells, stably transfected with pcDNA-p42IP4 
to determine if the mitochondrial fraction contained p42IP4. Immunoprecipitation of p42IP4 
from the mitochondrial lysate was performed, and the precipitate was analyzed by 
immunoblotting. p42IP4 was detected using a monoclonal anti-p42IP4 antibody. Fig. 3.2.1 
demonstrates that p42IP4, which was present in the mitochondrial lysate, was highly 
concentrated in the immunoprecipitate. 
Fig. 3.2.1. Mitochondrial localization of p42IP4 in 
CHO cells. 
Lysate of mitochondria from CHO cells, 
transfected with p42IP4 (2 mg of protein) was used 
for immunoprecipitation (IP) with control rabbit 
IgG antibody or anti-p42IP4 polyclonal rabbit 
antibody AS1516g, as described in “Materials and 
Methods”. p42IP4 was visualized in the 
mitochondrial lysate (Mito) and precipitate by 
immunoblotting with monoclonal anti-p42IP4 
antibody Mab117-2. Experiments were repeated 
three times with similar results.  
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3.2.2 p42IP4 is localized in inner mitochondrial compartments of transfected CHO cells 
To investigate the compartmentalization of p42IP4 within mitochondria, mitochondria 
from CHO cells expressing p42IP4 were subfractionated into outer membrane, intermembrane 
space, inner membrane and matrix fractions. p42IP4 was found in all mitochondrial fractions 
of CHO cells (Fig. 3.2.2. A), but seems to be enriched in the intermembrane space. Separation 
of each mitochondrial compartment was verified by immunoblotting of the subfractions with 
mitochondrial compartment-specific proteins, VDAC (for outer membrane), Cyt c (for 
intermembrane space), cytochrome oxidase subunit IV (for inner membrane), and the Mn-
superoxide dismutase (SOD2) for matrix, as shown in Fig. 3.2.2. A. VDAC, an outer 
membrane protein, is enriched at contact sites between the outer and inner membranes and is, 
therefore, typically detected in both outer membrane and inner membrane fractions (Bijur and 
Jope, 2003). SOD2 was stained not only in the matrix fraction. Probably due to the fragility of 
the inner membrane of mitochondria isolated from CHO cells SOD2 was also detected in the 
intermembrane space.  
Mitochondrial compartments contain different amounts of protein. Therefore, to 
calculate the total p42IP4 content in each fraction, we had to take into account the whole 
protein amount in each subfraction of mitochondria. The relative distribution of p42IP4 was 
obtained by calculating the ratio between the total p42IP4 protein content in each 
submitochondrial fraction over the sum of p42IP4 contents of all fractions. The result shown in 
Fig. 3.2.2. B reveals that p42IP4 is localized predominantly at the inner membrane and in the 
intermembrane space of mitochondria, which is similar to the localization of Cyt c. p42IP4 is 
detectable only to a small degree in matrix and outer membrane fractions. 
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Fig. 3.2.2. Sub-mitochondrial distribution of p42IP4 in CHO cells. 
(A) Isolated mitochondria from CHO cells were sub-fractionated as described in “Materials and 
Methods”. As indicated in the figure, the isolated outer membranes (OM), intermembrane space 
(IMS), inner membrane (IM) and matrix (Mx) fractions were separated by electrophoresis in 15% 
SDS-PAGE (20 μg of protein per lane in each fraction) with following Western blot. The membrane 
was probed with anti-p42IP4 antibody Mab117-2. The same membranes were stained with antibodies 
for the compartment-specific proteins voltage-dependent anion channel (VDAC), cytochrome c (Cyt 
c), cytochrome oxidase subunit IV (COX IV), and Mn-superoxide dismutase (SOD2), respectively. 
(B) Relative distribution of p42IP4 given as the percent ratio. The ratio was calculated, as described in 
the text, taking the total p42IP4 content in each fraction over the sum of p42IP4 protein contents of all 
fractions. Data shown are the mean ± S.D. obtained from three mitochondrial preparations. **p < 0.01. 
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3.2.3 p42IP4 is localized in mitochondria, isolated from transfected N2a cells 
p42IP4 is mainly expressed in neurons. Therefore, we chose mouse neuroblastoma N2a 
cells as a model for functional studies of p42IP4 in mitochondria. N2a cells endogenously 
express p42IP4 at a very low level, which is detectable by RT-PCR (Fig. 3.2.3 A) but hardly by 
Western blotting (data not shown).  
 
1000 bp
700 bp
500 bp
1 2 3
Fig. 3.2.3. The endogenous expression of p42IP4 in 
N2a cells.  
Determination of p42IP4 mRNA by RT-PCR in N2a 
cells. Fragments were amplified by RT-PCR with 
specific primers, separated on 1% agarose gel, and 
stained with ethidium bromide. p42IP4 (691 bp, lane 1) 
mRNA is detected in N2a. GAPDH (984 bp, lane 2) 
served as an internal control. Lane 3 represents 100-bp 
DNA standard. Data are representative of three 
independent experiments. 
 
To determine mitochondrial localization of p42IP4 in the neuroblastoma cell line, we 
stably transfected N2a cells with pcDNA-p42IP4 construct and performed subcellular 
fractionation of these cells. As shown in Fig. 3.2.4, p42IP4 is localized in mitochondria as well 
as in nuclear, cytosolic, and membrane fractions. VDAC antibody (for the outer mitochondrial 
membrane) was used to verify the mitochondrial fraction. Glyceraldehyde 3-phosphate 
dehydrogenase (for cytosol fraction) was stained not only in the cytosol but also in nuclear 
fraction possibly due to a contamination of nuclei with some unbroken cells. Nevertheless, we 
were not interested in purity of all subcellular fractions. It is important that staining with 
nucleoporin antibody (for nuclear fraction), glyceraldehyde 3-phosphate dehydrogenase 
antibody and plasma membrane calcium ATPase antibody (for plasma membrane fraction) 
shows that mitochondria are not contaminated with other subcellular fractions. Therefore, 
p42IP4 is indeed localized in mitochondria. 
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Additionally, we used confocal microscopy to confirm mitochondrial localization of 
p42IP4. First, co-localization experiments were performed using N2a cells stably transfected 
with the p42IP4-Myc construct. It should be noted that due to the high level of p42IP4 in the 
cytosol, mitochondrial localization is difficult to establish by this method. However, in the 
merged picture in Figure 3.2.5 A we could detect co-localization of p42IP4 with mitochondria 
of N2a cells stably transfected with p42IP4-Myc by staining with antibodies against Myc and 
Cyt c.  
Since N2a cells have a rather small size, we also performed staining of larger cells to 
detect more clearly the mitochondrial structures. For that purpose, CHO cells stably 
transfected with pcDNA-p42IP4 were double-stained with p42IP4 and Cyt c antibodies and 
analyzed by confocal microscopy. Although the p42IP4 protein is found to a large extent in the 
nucleus and cytosol, co-localization of p42IP4 with mitochondria of CHO cells was clearly 
determined, as can be seen in Figure 3.2.5 B. Graphs of profiles of fluorescence intensity 
indicate a coincidence between red (mitochondria) and green (p42IP4) peaks (Fig. 3.2.5 B), 
confirming unequivocally the co-localization of p42IP4 with mitochondria. While p42IP4 is not 
restricted to mitochondria, there is a considerable overlap of green and red peaks in the 
profiles. Moreover, in the nuclear area a high intensity of green fluorescence (indicating 
p42IP4) and a lack of red fluorescence (representing mitochondria) were detected. Altogether, 
these results show that p42IP4 is associated with mitochondria of both CHO and neuronal N2a 
cells.  
Fig. 3.2.4. Mitochondrial localization of 
p42IP4 in N2a cells.  
Nuclear, cytosolic, mitochondrial and 
membrane fractions were obtained from N2a 
cells stably transfected with pcDNA- p42IP4. 
The fractions were separated by 
electrophoresis in 10% SDS-PAGE (20 μg of 
protein per lane in each fraction) with 
following Western blot. The membrane was 
probed with monoclonal anti-p42IP4 antibody. 
The same membranes were stained with anti-
VDAC (voltage-dependent anion channel) 
antibody (for mitochondria), anti-Nucleoporin 
antibody (for nucleus), anti-GAPDH 
(glyceraldehyde 3-phosphate dehydrogenase) 
antibody (for cytosol) and anti-PMCA (plasma 
membrane calcium ATPase) antibody (for 
plasma membrane). Experiments were 
repeated three times with similar results. 
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Fig. 3.2.5. Colocalization of p42IP4 with mitochondria.  
 (A) Confocal imaging of colocalization of p42IP4 with mitochondria in N2a cells. Stably transfected 
N2a cells expressing p42IP4 MycHis were fixed, permeabilized, double-stained with anti-myc and anti-
Cyt c (cytochrome c) antibodies, and observed by confocal microscopy. Detection of p42IP4 MycHis 
(green) by polyclonal anti-myc antibody and Alexa Fluor 488 goat anti-rabbit IgG and detection of 
mitochondria (red) by monoclonal anti-Cyt c (cytochrome c) antibody and Alexa Fluor 555 goat anti-
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mouse IgG was carried out. The merged picture in the lower right panel shows co-localization of 
p42IP4 with mitochondria (yellow). The right upper panel shows a transmission light picture. Scale bar 
indicates 20 μm. Pictures shown are representative of at least three independent experiments. (B) 
Confocal imaging of colocalization of p42IP4 with mitochondria in CHO cells. Stably transfected CHO 
cells expressing p42IP4 were fixed, permeabilized, double-stained with polyclonal rabbit serum raised 
against p42IP4 (AS1516g) and anti-Cyt c (cytochrome c) antibodies, and observed by confocal 
microscopy. Left upper panel shows detection of p42IP4 (green) by polyclonal rabbit serum and Alexa 
Fluor 488 goat anti-rabbit IgG, and the left lower panel shows detection of mitochondria (red) by 
monoclonal anti-Cyt c (cytochrome c) antibody and Alexa Fluor 555 goat anti-mouse IgG. The 
merged picture in the right upper panel shows co-localization of p42IP4 with mitochondria (yellow). 
Scale bar indicates 20 μm. The curves (right lower panel) represent the fluorescence intensity 
distribution determined for a cross-section of the cell, as indicated by the white arrow in the merged 
image. Arrow indicates the orientation of the section. Pictures shown are representative of at least 
three independent experiments. 
 
3.3 p42IP4 is involved in regulation of mitochondrial Ca2+  
The findings that p42IP4 is localized at the mitochondrial inner membrane and in the 
intermembrane space, raised the question of possible functions of this protein in 
mitochondria. To address this issue, we used a recently developed method of isolation of 
functionally active mitochondria from cultured cells and studied mitochondrial functions 
during Ca2+-induced PTP opening (Azarashvili et al., 2005; Azarashvili et al., 2007). 
We investigated whether p42IP4 might be involved in the regulation of mitochondrial 
Ca2+ transport mechanisms. The PTP forms a Ca2+ efflux pathway from mitochondria through 
a large pore (Smaili et al., 2000). To study the influence of p42IP4 on mitochondrial functions 
during Ca2+-induced PTP opening in mitochondria, we compared the functional parameters of 
mitochondria, which were isolated from N2a wild type cells, or from cells transfected with 
p42IP4, or transfected with empty vector. The effect of the over-expression of p42IP4 on Ca2+ 
transport, mitochondrial membrane potential (ΔΨm), and oxygen consumption rate were 
examined in isolated mitochondria upon Ca2+-induced PTP opening.  
3.3.1 p42IP4 accelerates Ca 2+-induced PTP opening in mitochondria from N2a cells 
We used the open recording chamber with installed electrodes selective for O2, Ca2+ 
and TPP+, as described in previous reports (Azarashvili et al., 2005; Azarashvili et al., 2007). 
The ability of mitochondria isolated from N2a wild type cells, or from cells transfected with 
p42IP4, or transfected with empty vector to accumulate Ca2+ was investigated using two 
approaches.  
First, Ca2+ was added in small bolus additions (70 nanomoles of Ca2+ per mg of 
protein per addition) to estimate the Ca2+ threshold (Ca2+ capacity) for each kind of 
mitochondria. Figure 3.3.1 A shows an experiment with mitochondria isolated from wild type 
N2a cells. After addition of the mitochondrial suspension into the chamber, the mitochondria 
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take up the membrane potential indicator TPP+ within 3 min, reflecting the amplitude of the 
mitochondrial membrane potential. Six pulses of Ca2+ were followed by rapid and complete 
accumulation of Ca2+ into the mitochondrial matrix. Each pulse was accompanied by a 
transient depolarization and restoration of ΔΨm, as shown by the TPP+ trace. The loading with 
Ca2+ was stopped, when the mitochondria were not able any more to accumulate the added 
Ca2+, as demonstrated by an increase in extramitochondrial Ca2+ in medium. 
Addition of the last (seventh) pulse of Ca2+ resulted in a decreased rate of Ca2+ influx, 
which was correlated with membrane potential decrease. After a rather short time of retaining 
of Ca2+, rapid Ca2+ efflux from the mitochondrial matrix ensued. This efflux was associated 
by complete ΔΨm dissipation. These events indicate increased permeability of the inner 
membrane and initiation of PTP opening. The precipitating Ca2+ release occurred after 
addition of threshold Ca2+ concentration. The Ca2+ threshold was above 420 nanomoles of 
Ca2+ per mg of protein for this kind of mitochondria. The same amount of Ca2+ had to be 
added to open PTP in mitochondria from N2a cells transfected with empty vector (Figure 
3.3.1 B). 
As shown in Fig. 3.3.1 C, mitochondria from N2a cells overexpressing p42IP4 were 
able to take up much less Ca2+ and thus had a lower Ca2+ threshold. In mitochondria isolated 
from N2a cells transfected with p42IP4 the Ca2+ efflux was observed already after the fourth 
addition of Ca2+. The Ca2+ threshold was above 210 nanomoles of Ca2+ per mg of protein. 
Moreover, the mitochondria accumulated TPP+ with a slower time course. This indicates that 
these mitochondria have a lower membrane potential.  
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Fig. 3.3.1. p42IP4 expression in mitochondria accelerates PTP opening induced by small bolus 
additions of Ca2+. 
Mitochondria (0.7 mg of protein per ml) isolated from N2a wild type cells (A), from N2a cells 
transfected with empty vector (B) and transfected with p42IP4 (C) were added (the first arrow, mito) to 
respiration buffer, as described in Methods. Oxygen consumption, transmembrane potential and extra-
mitochondrial Ca2+ concentration were measured with O2, TPP+ (tetraphenylphosphonium) and Ca
2+-
selective electrodes, respectively, upon Ca2+-induced PTP opening. Ca2+ arrows show additions of 70 
nanomoles of Ca2+ per mg of protein. Mitochondria isolated from N2a wild type cells (A) and from 
N2a cells transfected with empty vector (B) were able to accumulate more Ca2+ and TPP+ before PTP 
opening in comparison with mitochondria transfected with p42IP4 (C). 
 
 
Next, we used the second approach with big bolus additions (200 nanomoles of Ca2+ 
per mg of protein per addition) to determine the retention time of Ca2+, before initiation of its 
release (lag time) under PTP opening in each kind of mitochondria. There was a significant 
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decrease in the Ca2+ threshold and acceleration of PTP opening in mitochondria isolated from 
N2a cells transfected with p42IP4 in comparison with mitochondria from N2a wild type cells 
(Fig. 3.3.1). Therefore, we performed determination of lag time with the amount of Ca2+ 
which had to be added to open PTP in N2a cells transfected with p42IP4. With this amount of 
Ca2+ we expected that in mitochondria from N2a cells transfected with p42IP4 the lag time 
would be shorter than in mitochondria from N2a wild type cells.  
Figure 3.3.2 clearly shows the difference in lag time for PTP opening between 
mitochondria isolated from N2a wild type cells (A), and from N2a cells transfected with 
p42IP4 (C). The kinetics of Ca2+ uptake in these kinds of mitochondria were different, namely 
the rate of Ca2+ influx was decreased in mitochondria from N2a cells overexpressing p42IP4 in 
comparison with mitochondria from wild type. Lag time for PTP opening in mitochondria 
from N2a cells transfected with empty vector (Fig. 3.3.2 B) was the same as for mitochondria 
isolated from N2a wild type cells (Fig. 3.3.2 A). 
 
 63
 
 
Fig. 3.3.2. p42IP4 expression in mitochondria accelerates PTP opening induced by big bolus 
additions of Ca2+. 
Mitochondria (0.7 mg of protein per ml) isolated from N2a wild type cells (A), from N2a cells 
transfected with empty vector (B) and from N2a cells transfected with p42IP4 (C) were added (the first 
arrow, mito) to respiration buffer, as described in Methods. Oxygen consumption, transmembrane 
potential and extra-mitochondrial Ca2+ concentration were measured with O2, TPP+ 
(tetraphenylphosphonium) and Ca2+-selective electrodes, respectively, upon Ca2+-induced PTP 
opening. Ca2+ arrows show additions of 200 nanomoles of Ca2+ per mg of protein. The difference in 
time before Ca
2+
 release (lag time) for PTP opening is illustrated between mitochondria isolated from 
N2a wild type cells (A), and from N2a cells transfected with p42IP4 (C). Lag time for PTP opening in 
mitochondria from N2a cells transfected with empty vector (B) was the same as for mitochondria 
isolated from N2a wild type cells (A). Results shown are representative of at least three independent 
experiments. 
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To exclude possible influence of traces of endoplasmic reticulum (ER) on results of 
Ca2+ measurement, we determined mitochondrial functions in the presence of thapsigargin, a 
specific inhibitor of the Ca2+ ATPase in the intracellular Ca2+ stores of the ER. The result that 
is shown in Fig. 3.3.3 reveals that thapsigargin did not influence the mitochondrial Ca2+ 
transport parameters measured. Therefore, we can rule out contamination of the mitochondrial 
fraction with ER. 
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Fig.3.3.3. Lack of effect of thapsigargin on functions of mitochondria from N2a cells. 
(A and B) Mitochondria (0.7 mg of protein per ml) isolated from wild type cells were added to 
respiration buffer, as described in Methods. Oxygen consumption, transmembrane potential and extra-
mitochondrial Ca2+ concentration were measured with O2, TPP P+ and Ca
2+-selective electrodes, 
respectively, upon Ca2+-induced PTP opening. Arrows show addition of 200 nanomoles of Ca2+ per 
mg of protein, each.  
In the lower diagram (B) thapsigargin (a specific inhibitor of Ca2+ ATPase in the intracellular ER Ca2+ 
stores) (0.5 μM) was applied 20 s after the addition of mitochondria to the incubation medium. There 
were no differences in ability to accumulate Ca2+ and in time before Ca2+ release (lag time) under PTP-
opening between mitochondria treated with thapsigargin and nontreated mitochondria. Therefore, 
there is no relevant contamination of ER in mitochondria. 
 
 
It was discovered that PTP induction is inhibited by cyclosporin A (CsA) (Crompton 
et al., 1988; Broekemeier et al., 1989), an effect that has been attributed to a blockade of Cyp-
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D association with ANT (Halestrap and Davidson, 1990). However, some studies on respiring 
isolated brain mitochondria have reported a limitation of CsA to inhibit PTP (Brustovetsky 
and Dubinsky, 2000; Kristal et al., 2000).  
We investigated the influence of CsA on PTP induction in mitochondria isolated from 
N2a cells. As shown in Fig. 3.3.4. there were no differences in the Ca2+-induced Ca2+ release 
and the accompanying decrease of the membrane potential between mitochondria isolated 
from N2a cells treated with CsA and nontreated mitochondria. Therefore, mitochondria 
isolated from N2a cells were CsA-insensitive (Fig. 3.3.4). 
 
Fig. 3.3.4. Lack of effect of cyclosporine A (CsA) on functions of mitochondria from N2a cells. 
(A and B) Mitochondria (0.7 mg of protein per ml) isolated from wild type cells were added to 
respiration buffer, as described in Methods. Oxygen consumption, transmembrane potential and extra-
mitochondrial Ca2+ concentration were measured with O2, TPP P+ and Ca
2+-selective electrodes, 
respectively, upon Ca2+-induced PTP opening. Arrows show addition of 200 nanomoles of Ca2+ per 
mg of protein, each.  
In the lower diagram (B) 1 μM CsA, was applied 20 s after the addition of mitochondria to the 
incubation medium. There were no differences in ability to accumulate Ca2+ and in time before Ca2+ 
release (lag time) under PTP opening between control mitochondria and mitochondria treated with 
CsA.  
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Fig. 3.3.5 demonstrates an example, which shows how we evaluated the parameters of 
Ca2+ transport. To determine the lag time for Ca2+ release we first plot a tangential line at the 
point of inflection of the curve of Ca2+ influx (i), then a tangential line at the point of 
inflection of the curve of Ca2+ efflux (ii). The length of the segment of the tangential line on 
the lower peak of the Ca2+ trace, which intersects lines (i) and (ii), defines the lag time for 
Ca2+ release. The slope of tangential line (i) is the rate of Ca2+ influx.  
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Fig. 3.3.5. Evaluation of the parameters of mitochondrial Ca2+ transport.  
Isolated mitochondria were added to respiration buffer, as described in Methods. Extra-mitochondrial 
Ca2+ concentration was measured with Ca2+-selective electrode upon Ca2+-induced PTP opening. Ca2+ 
arrows show additions of 200 nanomoles of Ca2+ per mg of protein. Mitochondrial functions, rate of 
Ca2+ influx (slope of tangential line (i) ), rate of Ca2+ efflux (slope of  tangential line (ii) ), lag time 
(length of segment of tangential line at lower peak of Ca2+ trace intersected by lines (i) and (ii)) were 
evaluated, as described in the text. 
 
The amount of Ca2+ taken up by mitochondria before PTP opening is the Ca2+ capacity 
or Ca2+ threshold. The Ca2+ capacity was evaluated and is presented on the basis of small 
bolus Ca2+ additions. For the calculation, we used the sum of additions of Ca2+, taking into 
account interpolation for the last addition, and then we determined the exact amount of Ca2+ 
load, which was accumulated before release of Ca
2+
 at PTP opening. That allowed presenting 
the statistical data. 
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Figure 3.3.6 represents the analysis of the functional Ca2+ parameters of mitochondria 
isolated from N2a wild type cells, mitochondria isolated from N2a cells transfected with 
empty vector, and mitochondria from N2a cells transfected with p42IP4. Data from both 
approaches, small and big bolus Ca2+ additions, are presented. As shown in the diagram, 
overexpression of p42IP4 lead to a significant decrease in the rate of Ca2+ influx, probably 
associated with a lowered membrane potential. The lag time was shortened and the Ca2+ 
capacity (threshold Ca2+concentration) was decreased. These data indicate that p42IP4 was 
able to promote pore formation and Ca2+-induced PTP opening in mitochondria. 
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Fig.3.3.6. Influence of p42IP4on mitochondrial functional parameters at Ca2+-induced PTP opening. 
After loading with Ca2+ to induce PTP opening, the relative values of mitochondrial Ca2+ influx rate, 
lag time and Ca2+ capacity were evaluated for wild type N2a cells mitochondria, mitochondria from 
N2a cells transfected with p42IP4, and from N2a cells transfected with empty vector. The levels of 
functional parameters of mitochondria isolated from wild type N2a cells loaded with threshold Ca2+ 
were taken as 1 (dashed line). Data shown are the mean ± S.D. obtained from four mitochondrial 
preparations. *** p < 0.001 versus wild type control.  
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3.3.2 Effects of p42IP4 ligands, phosphatidylinositol(3,4,5)trisphosphate (PIP3) and 
inositol(1,3,4,5)tetrakisphosphate (IP4), on mitochondrial functions 
The effects of PIP3 and IP4 on mitochondrial functions were also studied. Table 3.3.7. 
represents their influence on the functional Ca2+ parameters of PTP opening. The Ca2+ influx 
rate, lag time and Ca2+ capacity of mitochondria were reduced in the presence of 5 µM PIP3 or 
5 µM IP4 in comparison with nontreated mitochondria from all three kinds of cells. The 
maximal decrease was observed in the lag time. Addition of IP4 significantly shortened the lag 
time in comparison with nontreated mitochondria from all three kinds of cells. This means 
that IP4 accelerates PTP opening. Also in the presence of 5 µM PIP3 the reduction of the rate 
of Ca2+ influx, lag time and Ca2+ capacity was considerable for mitochondria isolated from all 
three kinds of cells in comparison with nontreated mitochondria.  
 
Table 3.3.7. 
 Ca2+ influx rate Lag time Ca2+ capacity 
 IP4 PIP3 IP4 PIP3 IP4 PIP3
Wild type 0.82 ± 0.04 b 0.79 ± 0.01 c 0.61 ± 0.11 c 0.44 ± 0.08 c 0.65 ± 0.05a 0.44 ± 0.06 c
Empty vector 
transfected 0.90 ± 0.12 0.77 ± 0.10 a 0.55 ± 0.08 c 0.53 ± 0.12 a 0.74 ± 0.06 0.68 ± 0.14a
p42IP4 
transfected 0.86 ± 0.09 a 0.71 ± 0.08 a 0.53 ± 0.04 a 0.51 ± 0.07 0.74 ± 0.11 0.49 ± 0.09 
 
a p < 0.05, b p < 0.01, c p < 0.001 versus respective control (without addition).  
 
Table 3.3.7. The effects of IP4 and PIP3  on Ca
2+ parameters of mitochondria from N2a cells. 
Mitochondria isolated from N2a cells transfected with p42IP4, transfected with empty vector 
and from N2a wild type cells were pre-incubated with 5 µM IP4 (D-myo-inositol 1,3,4,5-
tetrakisphosphate, tetrapotassium salt) or 5 µM PIP3 (phosphatidylinositol 3,4,5-trisphosphate diC8) 
for 20 min. After that, the mitochondria were loaded with Ca2+ to induce PTP opening, as described in 
Fig. 3.3.2. Relative values of mitochondrial Ca2+ influx rate, lag time and Ca2+ capacity in the presence 
of IP4 and PIP3 versus respective control (without addition) are presented. Data shown are the mean ± 
S.D. obtained from three mitochondrial preparations. 
 
To keep out the possibility that these effects observed were probably caused by the 
high number of negative charges present in PIP3, we performed experiments with D-
inositol(1,3,5,6) tetrakisphosphate. The latter has the same net charge, but is a poor ligand for 
p42IP4 (Hanck et al., 1999).  
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There were no differences between Ca2+ traces recorded for mitochondria in the 
chamber, when they were either treated with 5 µM D-inositol(1,3,5,6) tetrakisphosphate or 
not treated (control). Effects of D-inositol(1,3,5,6) tetrakisphosphate were not distinguishable 
from control (example is presented on Fig.3.3.3.), that was observed on at least two 
mitochondrial preparations. Therefore, we ruled out an influence of D-inositol(1,3,5,6) 
tetrakisphosphate on the mitochondrial Ca2+ transport parameters measured. 
Thus, our results demonstrate that the ligands of p42IP4, PIP3 and IP4, destabilize 
mitochondria during Ca2+-induced PTP opening specifically. Since the effects of PIP3 and IP4 
on the rate of Ca2+ influx, lag time and Ca2+ capacity were considerable for mitochondria 
isolated from all three kinds of cells, we concluded that the action of the p42IP4 ligands on 
PTP opening was independent of the overexpression of p42IP4. 
3.4. Interaction of p42IP4 with CNP and α-tubulin in rat brain mitochondria 
Since p42IP4 has been identified as a brain-specific protein (Hammonds-Odie et al., 
1996; Stricker et al., 1997), it was important to examine in RBM the localization of p42IP4 and 
the possible association of p42IP4 with other mitochondrial proteins. Because we found p42IP4 
mainly in the inner membrane fraction of mitochondria, it was reasonable to look for p42IP4-
interacting proteins within inner membrane and contact sites. One such protein was CNP. 
CNP was found in mitochondria of adrenal medullary chromaffin cell cultures 
(McFerran and Burgoyne, 1997), amoeboid microglial cells (Wu et al., 2006) and 
oligodendrocyte cell line (OLN93 cells) (Lee et al., 2006). Recently, we described for the first 
time that CNP localizes in the mitochondrial membrane fractions and associates with VDAC 
of the outer membrane and ANT of the inner membrane of RBM (data shown below, in Fig. 
3.5.1; Fig. 3.5.2). Moreover, the involvement of CNP in acceleration of Ca2+ release via PTP 
functioning, using mitochondria isolated from wild type OLN93 cells and CNP knock-down 
OLN93 cells was shown by us (data shown below, in Fig. 3.6.3; Fig. 3.6.4). Localization of 
both proteins, CNP and p42IP4, in the inner membrane of mitochondria and their participation 
in Ca2+-induced PTP opening allow us to hypothesize a possible interaction between these 
proteins.  
Another protein possibly interacting with p42IP4 is α-tubulin. Microtubules (MTs) are 
a major component of cytoskeletal systems that are responsible for the regulation of the 
distribution of mitochondria in mammalian cells. Moreover, it was shown that α-tubulin is an 
inherent component of mitochondrial membranes specifically interacting with the VDAC  
(Carre et al., 2002). Kinesins are a superfamily of microtubule-associated motor proteins, and 
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some members of this family are responsible for the movement of mitochondria along 
microtubules. Recently, the kinesin-3 protein KIF13 B was found as interaction partner for 
p42IP4 (Venkateswarlu et al., 2005). Therefore, we supposed possible association between α-
tubulin and p42IP4 in mitochondria. 
3.4.1 Localization of p42IP4, CNP and α-tubulin in rat brain mitochondria 
At first, we determined whether p42IP4, CNP and α-tubulin are localized in RBM. 
Since for these proteins cytosolic localization was shown before, we performed Western blot 
analysis of two brain fractions, mitochondria and cytosol. As shown in Fig. 3.4.1, p42IP4, CNP 
and α-tubulin are detected in RBM. The mitochondrial fraction isolated from rat brain 
contained both nonsynaptic and synaptic mitochondria, as shown by staining with 
synaptotagmin I antibody (for the synaptic vesicles). VDAC and Cyt c antibodies were used 
to verify mitochondria. As shown by the lack of staining with the Cyt c antibody in the 
cytosol, mitochondria were not disrupted during the preparation. In addition, staining with 
GAPDH antibody confirmed that RBM were not contaminated with cytosolic fraction.  
 
CNP
p42IP4
Synaptotagmin I
VDAC
cytosol
RBM
α-tubulin
Cyt c
GAPDH
Fig. 3.4.1. p42IP4, CNP, and α-tubulin are 
localized in RBM. 
Mitochondria were isolated from rat brain 
without additional purification. Brain cytosolic 
fraction was used as positive control for p42IP4 
expression. Aliquots of mitochondria or 
cytosol (30 µg of protein per lane) were 
separated by 10% SDS-PAGE with following 
Western blot. The membrane was probed with 
the antibodies indicated on the right side, as 
described in Methods. RBM were positive for 
the mitochondrial markers VDAC (voltage-
dependent anion channel; for the outer 
mitochondrial membrane) and Cyt c 
(cytochrome c; for intermembrane space), and 
the synaptosomal marker Synaptotagmin I. 
GAPDH (glyceraldehyde 3-phosphate 
dehydrogenase) antibody was used as marker 
for cytosolic fraction. Experiments were 
repeated three times with similar results. 
 
3.4.2 p42IP4 interacts with CNP and α-tubulin in vitro  
To check the association between p42IP4, CNP and α-tubulin we performed pull-down 
assay using GST-p42IP4 fusion protein, expressed in bacteria. Since p42IP4, CNP and α-tubulin 
localize to both cytosol and mitochondria, we used these two subcellular fractions for 
interaction studies. Cytosolic fraction or mitochondrial lysate were incubated with 
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immobilized GST-p42IP4. Fig. 3.4.2. (I, II) demonstrates that CNP and α-tubulin from the 
mitochondrial fraction bind to GST-p42IP4, but not to GST protein alone used as control. As 
shown in Fig. 3.4.2. (III, IV), α-tubulin and CNP from the cytosolic fraction bind to GST-
p42IP4  as well. 
 
 
RBM GSTGST-
p42IP4
Cytosol GSTGST-
p42IP4
IB: α-tubulin
IB: CNP
Mitochondria Cytosol
I
II
III
IV
input pull-down control input
pull-
down control
 
Fig. 3.4.2. p42IP4 interacts with CNP and α-tubulin in vitro, shown by pull-down binding assay. 
(I, II) Rat brain mitochondria (RBM) lysate or (III, IV) cytosol (2 mg of protein) (input) were 
incubated overnight with glutathione S-transferase (GST) protein alone (control) or GST-p42IP4 fusion 
protein (pull-down) immobilized on glutathione beads followed by SDS-PAGE (sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis) and immunoblotting (IB) with the anti-CNP or anti-α-
tubulin antibody. Experiments were repeated three times with similar results. 
 
3.4.3 p42IP4 interacts with CNP and α-tubulin in vivo  
To verify the interaction between p42IP4 and CNP in vivo, immunoprecipitation of 
p42IP4 from RBM and rat brain cytosol was performed, and the precipitate was analyzed for 
the presence of CNP by Western blot. Only CNP from the mitochondrial fraction was found 
to be co-immunoprecipitated with p42IP4 (Fig. 3.4.3. A). The CNP band can be detected in the 
mitochondrial precipitate also with control rabbit IgG, although to a much lesser extent than 
in the precipitate using the p42IP4 antibody. Therefore, we made the reverse co-
immunoprecipitation with monoclonal CNP antibody. The p42IP4-immunoreactive band was 
observed in the precipitate with CNP antibody from the mitochondrial fraction (Fig. 3.4.3. B), 
but not from cytosol, indicating that these two proteins interact only in RBM in vivo.  
Next, to confirm that binding of p42IP4 to α-tubulin also occurs in vivo, we performed 
co-immunoprecipitation experiments. We found that p42IP4 could be specifically co-
immunoprecipitated together with α-tubulin from RBM (Fig. 3.4.3. C).  
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Fig. 3.4.3. In vivo interaction of p42IP4 with CNP and α-tubulin in RBM. 
(A) Mitochondrial lysate from RBM or cytosol were immunoprecipitated (IP) with control rabbit IgG 
antibody or anti-p42IP4 antibody, and CNP was visualized in the precipitates and mitochondrial or 
cytosolic fractions by SDS-PAGE and immunoblotting with anti-CNP antibody. Here and in the 
following parts of the figure, the bands marked by (*) represent IgG heavy chains. (B) Mitochondrial 
or cytosolic fractions were immunoprecipitated with isotype-specific control antibody or anti-CNP 
antibody, and p42IP4 was detected in the precipitates and mitochondrial lysate by SDS-PAGE and 
immunoblotting using anti-p42IP4 antibody. (C) RBM lysates were immunoprecipitated with anti-α-
tubulin antibody or isotype-specific control antibody and p42IP4 was visualized in the precipitates and 
mitochondrial lysate by SDS-PAGE and immunoblotting with anti-p42IP4 antibody. For all 
experiments, 2 mg of protein of mitochondrial or cytosolic fractions were used for IP. Experiments 
were repeated three times with similar results. 
 
3.4.4 CNP interacts with α-tubulin in vivo  
Since CNP is known to serve as a membrane anchor for tubulin (Bifulco et al., 2002), 
we also investigated the possible physical interaction of CNP and α-tubulin in RBM by co-
immunoprecipitation study. As shown in Fig. 3.4.4. (I), α-tubulin was found in the precipitate 
using the CNP antibody. Vice versa, CNP was observed in the α-tubulin antibody 
immunoprecipitate, but CNP was not detected in that with the control IgG (Fig. 3.4.4., II). 
Altogether, these results indicate that there is in vivo formation of a complex between p42IP4, 
CNP and α-tubulin in rat brain mitochondria.  
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Fig. 3.4.4. In vivo interaction between CNP and α-tubulin in RBM 
(I) RBM lysates (2 mg of protein) were immunoprecipitated with anti-CNP antibody (IP) or isotype-
specific control antibody (control IP). α-Tubulin was visualized in the precipitates and mitochondrial 
lysate by immunoblotting (IB) with anti-α-tubulin antibody. Here and in the part II of the figure, the 
band marked by (*) represents IgG heavy chain (II) The lysates of RBM were immunoprecipitated 
with anti-α-tubulin antibody (IP) or isotype-specific control antibody (control IP), and CNP was 
detected in the precipitates and mitochondrial lysate by SDS-PAGE and immunoblot (IB) using anti-
CNP antibody. Experiments were repeated three times with similar results. 
 
3.5. Mitochondrial localization of CNP 
3.5.1 CNP localization in sub-mitochondrial fractions of RBM 
CNP was found to be located in mitochondria (McFerran and Burgoyne, 1997; Lee et 
al., 2006; Wu et al., 2006). We have shown here that CNP is localized in RBM (Fig. 3.4.1). 
However, there are no data on the function of CNP in mitochondria. At first we examined the 
localization of CNP in membrane fractions of RBM, such as mitoplasts (the inner membrane 
with matrix) and outer membranes. As shown in Fig. 3.5.1., CNP was found in both fractions. 
The fractions tested were also stained for SOD 2 (marker for mitoplasts) and for VDAC 
(marker for outer membranes). The faint staining of mitoplasts with VDAC antibodies 
revealing the presence of small amounts of VDAC in the mitoplast fraction can be explained 
by the presence of contact sites in the mitoplast that usually contain VDAC. SOD 2 was found 
mainly in mitoplasts and only a small trace amount of SOD 2 was detected in the outer 
membranes.  
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Fig. 3.5.1. CNP localization in   
sub-mitochondrial fraction  
Isolated RBM were sub-fractionated, as 
described in Materials and Methods. Isolated 
outer membranes and mitoplasts were 
separated by electrophoresis in 12.5% SDS-
PAGE (20 μg of protein per lane) with 
following immunoblotting (IB). The 
membrane was probed with CNP antibody. 
The same membranes were stained with 
antibodies for the compartment-specific 
proteins voltage-dependent anion channel 
(VDAC) and Mn-superoxide dismutase 
(SOD2), respectively.  
 
3.5.2 CNP interaction with ANT and VDAC 
The discovery of CNP in the inner and outer membranes forced us to look for CNP-
interacting proteins within contact sites. ANT and VDAC are considered to be main 
regulators of the PTP complex, which comprises components in the inner as well as in the 
outer mitochondrial membrane. Therefore, we proposed interaction between these proteins 
and CNP. Thus, we performed immunoprecipitation of CNP, and the precipitate was analyzed 
by Western blot using ANT antibodies and VDAC antibodies. As shown in Fig. 3.5.2., the 
CNP antibodies immunoprecipitate contained immuno-reactive bands for ANT and VDAC 
antibodies. The immuno-reactive bands were not observed in the immunoprecipitate obtained 
with isotype-specific control antibodies. Co-immunoprecipitation of CNP specifically with 
ANT and VDAC was confirmed by immunostaining with SOD2 antibody. The results 
obtained indicate the interaction of CNP with regulatory components of PTP. 
 
Fig. 3.5.2. CNP interaction with regulators of 
the PTP complex, ANT and VDAC.  
Co-immunoprecipitation of CNP with ANT and 
VDAC. Experimental procedures are described 
in Materials and Methods. The lysates of RBM 
(2% of RBM lysate used for the IP experiments) 
and RBM immunoprecipitates with monoclonal 
CNP Ab (IP CNP), and with isotype-specific 
control antibody (control IP) were visualized by 
immunoblotting (IB) with ANT antibody, or with 
VDAC antibody. The same membranes were 
stained with SOD2 Ab and with polyclonal CNP 
Ab to show the specificity of co-
immunoprecipitation and immunoprecipitation, 
respectively. Experiments were repeated three 
times with similar results. 
IB: VDAC
IB: ANT
RBM IP
CNP
Control
IP
IB: SOD2
IB: CNP
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3.6. CNP is involved in regulation of mitochondrial Ca2+
3.6.1 Influence of Ca 2+-induced PTP on CNP activity in RBM 
CNP activity was revealed in rat liver mitochondria, specifically in the outer and inner 
mitochondrial membranes (Dreiling et al., 1981). To investigate whether CNP activity might 
be changed during Ca2+-induced PTP opening, we used CNP enzyme activity assay published 
before (Bradbury and Thompson, 1984). Determination of the enzymatic CNP activity in 
isolated RBM after SDS-PAGE and Western blot on nitrocellulose membrane was performed. 
A suspension of purified RBM was added to the incubation medium in the chamber with 
installed electrodes to measure PTP development induced by threshold Ca2+ load. The 
samples were taken for CNP enzyme activity assay from the chamber before and after Ca 2+-
induced PTP. The enzymatic activity was decreased in the presence of threshold Ca2+ load as 
shown in Fig. 3.6.1., A and B. However, equal levels of CNP in RBM were found both in 
control condition and after Ca2+ threshold loading (Fig. 3.6.1., C and D).  
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Fig. 3.6.1. Decrease of CNP activity in RBM under Ca2+-induced PTP 
Detection of CNP activity (see Methods) in RBM is shown under control conditions and in the 
presence of threshold Ca2+ in the medium. (A) Detection of CNP activity on membrane, (B) Relative 
level of CNP activity under control conditions and in RBM loaded with threshold Ca2+. OD in control 
was taken as 100%. (C) Detection of CNP protein level by immunoblotting (IB) with monoclonal 
CNP Ab on the same membrane in control (in the absence of Ca2+ in the medium) or in the presence of 
threshold Ca2+ concentration. (D) Relative levels of CNP protein under control conditions and in Ca2+ 
overloaded RBM. Values represent the mean ± SD from three independent experiments. *p < 0.05. 
 
 
3.6.2 Effect of CNP knock-down on Ca2+-induced PTP 
To obtain direct evidence supporting the involvement of CNP in Ca2+-induced PTP 
functioning in mitochondria, RNA interference studies were carried out. We studied the 
question of whether the CNP content was related to the induction of PTP. At first, we tested 
the expression of CNP in different types of cultured cells, such as human embryonic kidney 
HEK293, mouse neuroblastoma N2A and the rat oligodendrocyte line OLN93. As shown in 
Fig. 3.6.2. A, endogenous expression of CNP detected with the CNP Ab was highest in the 
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OLN93 cells. Thus, OLN93 cells were chosen for transfection with siRNA targeting CNP. 
Non-targeting scrambled siRNA served as a control. 48 h after transfection, the level of CNP 
expression was assayed by Western blot.  
Transfection with CNP-targeting siRNA significantly reduced the CNP protein 
expression, as measured in total OLN93 cell lysate (Fig. 3.6.2. B). Next, mitochondria were 
isolated from OLN93 wild type cells as well as from CNP knock-down OLN93 cells. 
Scrambled siRNA did not affect CNP expression. In mitochondria isolated from CNP knock-
down OLN93 cells the level of CNP was reduced to about 20% of control level (Fig. 3.6.2. 
C). Reduction of CNP expression in mitochondria correlated with decreased enzymatic CNP 
activity (Fig. 3.6.2. D). However, there was no effect on mitochondria isolated from OLN93 
cells transfected with scrambled siRNA  
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Fig. 3.6.2. CNP protein level in different types of cultured cells. CNP protein level and enzymatic 
activity in OLN93 mitochondria and OLN93 cells downregulated by siRNA. 
(A) Endogeneous expression of CNP protein in HEK 293, N2a and OLN 93 was evaluated by Western 
blotting, as described in Materials and methods. Experiments were repeated three times with similar 
results. Twenty-five µg of total cell lysates were loaded. (B) OLN93 cells were transfected with either 
50 nM scrambled siRNA (control siRNA) or CNP siRNAs. At 48 h after transfection, CNP protein 
level in total cell lysates was determined by Western blot analysis. Representative data from three 
independent experiments are given, and β-tubulin I served as control for specificity of knock-down. 
(C) OLN93 cells were transfected with either CNP siRNAs (50 nM) or scrambled siRNA (50 nM), 
after 48 h mitochondria were isolated. The reduction of CNP expression in mitochondria was 
evaluated by Western blotting. CNP and SOD2 protein bands were quantified by densitometry. The 
histogram shows relative units as ratio of CNP to SOD2. Mitochondria isolated from non-transfected 
OLN93 cells were used as reference and assigned the value of 100% . Values represent the mean ± SD 
from three independent experiments. *** p < 0.001 (D) CNP activity in mitochondria isolated from 
OLN93 cells, transfected with siRNA or non-transfected, was detected, as described in Materials and 
methods. The activity of CNP in mitochondria isolated from non-transfected OLN93 cells was taken 
as 100%. Values represent the mean ± SD from three independent experiments. * p<0.05. 
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To investigate whether the reduction in CNP level in mitochondria could influence the 
Ca2+-induced PTP opening, we measured the parameters of mitochondria isolated from wild 
type OLN93 cells, scrambled siRNA-treated OLN93 cells as well as cells, transfected with 
siRNA targeting CNP, as described above. 
Fig. 3.6.3. A shows that threshold Ca2+ concentration in mitochondria isolated from 
wild type OLN93 cells was achieved after four additions of Ca2+ (70 nanomoles of Ca2+ per 
mg of protein each), giving a threshold Ca2+ for OLN93 mitochondria of 280 nanomoles per 
mg of protein in the given experiment. A similar threshold was found in mitochondria isolated 
from scrambled siRNA-treated OLN93 cells (Fig.3.6.3. B). Mitochondria isolated from CNP 
knock-down OLN93 cells released Ca2+ after the third addition (also 70 nanomoles of Ca2+ 
per mg of protein each), yielding a lower threshold calcium concentration which was equal to 
210 nanomoles Ca2+ per mg of protein (Fig. 3.6.3. C). 
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Fig.3.6.3. Reduction of CNP expression facilitates Ca2+-induced PTP opening in mitochondria from 
OLN93 cells 
Mitochondria isolated from wild type OLN93 cells (A) from scrambled siRNA-transfected OLN93 
cells (B) and from CNP siRNA-transfected OLN93 cells (C) were incubated in the open chamber, as 
described in Materials and Methods. Changes of Ca2+ concentration in the incubation medium and of 
mitochondrial membrane potential are shown. The time scale represents the time after OLN93 
mitochondria were added to the chamber. Ca2+ arrows show additions of 70 nanomoles of Ca2+ per mg 
of protein  
 
The average data on Ca2+-induced PTP opening in mitochondria isolated from wild 
type and CNP knock-down cells are shown in Fig. 3.6.4. No noticeable changes in Ca2+ influx 
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rate were observed in all kinds of isolated mitochondria. However, a reduced Ca2+ capacity 
and lag time were found for CNP knock-down mitochondria. These results demonstrate that 
reduction of CNP expression facilitates Ca2+-induced PTP opening in mitochondria. 
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Fig.3.6.4. Influence of CNP knock-down on mitochondrial functional parameters at Ca2+-induced 
PTP opening 
After loading with Ca2+ to induce PTP opening, the relative values of mitochondrial Ca2+ influx rate, 
lag time and Ca2+ capacity were evaluated as described above in Fig 3.3.5. Values represent the mean 
± SD from three independent experiments. The levels of functional parameters of mitochondria 
isolated from wild type OLN93 cells loaded with threshold Ca2+ were taken as 1.0 (control).* p < 0.05, 
**p < 0.01, versus control.  
 
3.6.3 Effects of CNP substrates, 2’,3’-cAMP, 2’,3’-cNADP, on mitochondrial functions 
It is known that 2’,3’-cAMP as well as 2’,3’-cNADP are CNP substrates (Vogel and 
Thompson, 1988; Sprinkle, 1989). Therefore, we also studied the effect of the substrates of 
CNP on mitochondrial functions. At first, we assayed the influence of 2’,3’-cAMP on RBM 
functions in the open recording chamber with installed electrodes, as described above. Fig. 
3.6.5. demonstrates typical results on Ca2+-induced PTP in RBM in the absence and in the 
presence of 5 μM 2’,3’-cAMP. In control RBM (Fig. 3.6.5. A), Ca2+ efflux was activated by 
two Ca2+ additions (80 nanomoles of Ca2+ per mg of protein). After the second, threshold Ca2+ 
addition the oxygen consumption rate returned to the resting state and added Ca2+ was almost 
fully accumulated. Subsequent Ca 2+ efflux and activation of oxygen consumption indicated 
initiation of PTP opening that was observed after a lag time of about 3 min. Ca2+ efflux from 
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the mitochondrial matrix and membrane potential dissipation were fully developed after 6 
min. In RBM treated with 5 μM 2’,3’-cAMP (Fig. 3.6.5. B), PTP opening was accelerated. 
After the second Ca 2+ addition the oxygen consumption rate did not return fully to the resting 
state and Ca2+-induced Ca2+ efflux occurred faster with a very short lag time.  
The diagram of Fig. 3.6.5. C represents the quantitative analysis showing the mean 
data from several experiments to demonstrate the action of 2’,3’-cAMP on mitochondrial 
functions during Ca2+-induced PTP opening. The lag time of PTP opening was decreased 2-
fold, and the Ca2+ efflux rate was increased by 30%. These data demonstrate that 2’,3’-cAMP 
was able to promote PTP opening.  
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Fig. 3.6.5. Effect of 2’,3’-сAMP on mitochondrial functions in RBM. 
Isolated RBM (1.0 mg of protein per ml) were incubated in the electrode chamber in conditions 
described in Materials and Methods. Oxygen consumption rate, Ca2+ concentration in the incubation 
medium and changes in mitochondrial membrane potential are shown for control RBM (A), and RBM 
treated with 2’,3’-сAMP (B). The time scale represents the time after RBM were added to the 
chamber. 2’,3’-сAMP (5 μM) was applied 20 s after addition of RBM to the incubation medium. Two 
additions of Ca2+ (80 nanomoles of Ca2+ per mg of protein, each) shown by arrows, were applied to 
induce PTP opening. (C) Summary of effects of 2’,3’-сAMP on RBM functions. The following 
parameters of Ca2+-induced PTP opening were calculated from curves: Ca2+ influx rate, Ca2+ efflux 
rate and lag time for Ca2+ efflux. A detailed description of the parameter analysis is given in Fig 3.3.5. 
Values are given relative to the control value of 1.0 and represent the mean ± SD from three 
independent experiments, *p < 0.05.  
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 We also evaluated the effect of combined application of 2’,3’-cAMP and CsA, as well 
as of 2’,3’-cNADP and CsA. As shown in Fig. 3.6.6. A, with addition of CsA, inhibitor of 
PTP, no Ca2+-induced Ca2+ efflux was seen in the presence of 2’,3’-cAMP. This inhibition of 
Ca2+ efflux by CsA supports the conclusion of participation of PTP.  
Next, we checked whether 2’,3’-cNADP, as well as 2’,3’-cGMP were able to promote 
PTP opening. Figure 3.6.6. B demonstrates the effects of 2’,3’-cNADP and 2’,3’-cGMP used 
at the same concentration as 2’,3’-cAMP (5 μM). In Fig. 3.6.6. B, trace 1 demonstrates Ca2+ 
fluxes in control RBM at threshold Ca2+ load. In the presence of 2’,3’-cNADP, after the 
threshold Ca2+ load, a decreased rate of Ca2+ influx and a shortened lag time of Ca2+ efflux 
were seen (trace 2). The lag time in 2’,3’-cNADP-treated RBM was about 2-times shorter 
than in control RBM (compare traces 1 and 2). No acceleration of Ca2+ efflux was observed in 
the presence of 2’,3’-cGMP (trace 3). CsA was found to prevent the 2’,3’-cNADP-induced 
stimulation of PTP opening (trace 4).  
Fig. 3.6.6. C represents the average data obtained with 5 µM 2’,3’-cNADP, 2’,3’-
cAMP and 2’,3’-cGMP on the parameters of PTP opening, lag time and Ca2+ efflux. The 
effect of 2’,3’-cCMP on PTP opening was not significant (data not shown), like that of 2’,3’-
cGMP. Thus, the efficiency of acceleration of Ca2+-induced PTP opening was decreasing in 
the following series: 2’,3’-cAMP > 2’,3’-cNADP >> 2’,3’-cGMP, 2’,3’-cCMP. 
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Fig. 3.6.6. Effect of 2’, 3’-сAMP, 2’,3’-сNADP and 2’,3’-сGMP on Ca2+-induced PTP opening in 
RBM.  
(A) Effects of 2’, 3’-сAMP and CsA on Ca2+-induced PTP opening. Recordings represent Ca2+ fluxes 
in the presence of 2’, 3’-сAMP (5 μM) and the combined application of 2’, 3’-сAMP and CsA (1 μM). 
(B) Traces of the effect of 2’,3’-сNADP (5 μM), in the absence and in the presence of CsA (1 µM), 
and 2’,3’-сGMP (5 μM) on Ca2+ fluxes in RBM: trace 1 -control RBM, trace 2- RBM treated with 
2’,3’-сNADP, trace 3- RBM treated with 2’,3’-сGMP, trace 4- RBM treated with CsA and 2’,3’-
сNADP. Experimental conditions as in Fig. 3.6.5. 2’, 3’-сAMP, CsA, 2’,3’-сNADP and 2’,3’-сGMP 
were applied 20 s after the addition of RBM to the incubation medium. Arrows show the times at 
which Ca2+ (80 nanomoles of Ca2+ per mg of protein, each) was applied in the experiments. (C) 
Summary of effects of 5 μM 2’,3’-сNADP, 5 μM 2’,3’-сAMP, and 5 μM 2’,3’-сGMP on Ca2+- 
induced Ca2+ efflux and lag time in RBM. For analysis, of the parameters see Fig 3.3.5. Lag time 
before Ca2+ efflux was significantly decreased and Ca2+ efflux rate was significantly increased by 
2’,3’-сNADP and for 2’,3’-сAMP, but not by 2’,3’-сGMP. Values are given relative to the control 
value of 100 and represent the mean ± SD from three independent experiments, *p < 0.05. 
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Induction of mitochondrial swelling is a prominent feature of PTP. Therefore, we 
examined the influence of 2’,3’-cAMP and 2’,3’-cNADP on Ca2+-induced swelling of isolated 
RBM to corroborate our hypothesis that the CNP substrates are involved in PTP regulation. 
Swelling was initiated by addition of Ca2+ to mitochondria incubated in standard medium (see 
Materials and Methods). Typical curves in Fig. 3.6.7. A demonstrate the decrease of light 
scattering at 540 nm, which indicates swelling. RBM swelling was accelerated in the presence 
of 5 μM 2’,3’-cAMP or 5 μM 2’,3’-cNADP.  
We used the half time for reaching the maximum of the RBM swelling as characteristic 
parameter for quantification. The data in Fig. 3.6.7. B show that the swelling of RBM is 
significantly enhanced by 2’,3’-cAMP and 2’,3’-cNADP.  
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Fig. 3.6.7. Effect of 2’,3’-сNADP, 2’,3’-сAMP on RBM swelling  
(A) Effect of 2’,3’-сNADP, 2’,3’-сAMP on RBM swelling. Swelling was initiated by addition of 100 
µM Ca2+ to RBM incubated in standard medium (see Materials and Methods). Light scattering at 540 
nm in RBM was measured. Trace 1- control- Ca2+-induced swelling of RBM, trace 2 - effect of 5 μM 
2’,3’-сNADP, trace 3 - effect of 2’,3’-сAMP. (B) Average results of half time for reaching the 
maximal swelling of RBM in the presence of 2’,3’-сNADP and 2’,3’-сAMP. Values are given relative 
to the control value of 100 and represent the mean ± SD from three independent experiments, * p < 
0.05, versus control 
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 4. Discussion 
 
4.1 The mechanism of mitochondrial Ca2+-induced PTP opening remains 
unknown 
Mitochondria are important regulators of cellular Ca2+ homeostasis, producers of ATP 
via oxidative phosphorylation, and regulators of cell death pathways (Sullivan et al., 2005). 
Mitochondria assist in maintaining Ca2+ homeostasis by sequestering and releasing Ca2+. 
Isolated mitochondria in the presence of phosphate take up Ca2+ to a fixed capacity, in a 
membrane potential (∆Ψm)-dependent fashion (Chalmers and Nicholls, 2003). When the 
mitochondria become overloaded with Ca2+, they undergo the cataclysmic mitochondrial 
permeability transition. Mitochondrial permeability transition is manifested as a sudden 
opening of a non-selective megachannel, PTP, in the inner mitochondrial membrane. The PTP 
opening increases the permeability to solutes with molecular mass up to 1500 Da in response 
to mitochondrial Ca2+ overload and/or oxidative stress (Bernardi, 1999; Halestrap, 2006). The 
Ca2+-induced PTP opening is a complex process with many known inducers, modulators, and 
inhibitors. The PTP is a multi-protein complex formed in the contact sites between outer and 
inner membranes of mitochondria to increase the permeability of the inner membrane. Main 
events of PTP opening are collapse of the membrane potential, Ca2+-induced Ca2+ efflux, 
induction of mitochondrial swelling and release of apoptotic factors (Bernardi, 1999; 
Halestrap et al., 2002; Zoratti et al., 2005). The quest for the pore identity has been ongoing 
for several decades. However, the PTP structure remains unknown (Juhaszova et al., 2008). 
Evidence has been accumulating that numerous signalling molecules and drugs affect the 
Ca2+-induced PTP opening. Thus, it is important to explore fully the mechanism of 
mitochondrial Ca2+-induced PTP opening and to search for new proteins involved in control 
of this complex process. 
4.2 Known functions of p42IP4  
Different functions have been already proposed for p42IP4. There were reports which 
showed the involvement of this protein in the activation of the mitogen-activated protein 
kinase cascade of the extracellular regulated kinase (Hayashi et al., 2006), in the ARF6 
signalling pathway (Lawrence et al., 2005) or in the transcription factor activator protein-1 
activation cascade (Chanda et al., 2003). p42IP4 was found to be involved in dendritic 
differentiation/synaptic plasticity and/or transport of PIP3-containing vesicles along axons to 
regulate neuronal cell polarity (Horiguchi et al., 2006; Moore et al., 2007). In neuronal cells, 
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p42IP4 regulates the actin cytoskeleton via ARF GAP-dependent and ARF GAP-independent 
mechanisms (Thacker et al., 2004; Venkateswarlu et al., 2004). p42IP4 has already been linked 
to short-term regulation of behavioural responses in rat brain (Reiser et al., 2004). Very 
interestingly, p42IP4 seems to be involved in neuronal diseases, since we found that p42IP4 is 
up-regulated in neurons in the brain of AD patients and is detected in AD plaques (Reiser and 
Bernstein, 2002, 2004). Although various functions of p42IP4 have been proposed, there were 
no data concerning a role of this protein related to mitochondria. 
 
4.3 Novel localization and function of p42IP4. Involvement of p42IP4 and its 
ligands in regulation of mitochondrial Ca2+-induced PTP opening 
 
Previously, analysis of subcellular localization of the p42IP4 protein in non-neuronal 
CHO cells stably transfected with pcDNA-p42IP4 was performed. p42IP4 was found in 
membranes, cytosol, and nucleus (Sedehizade et al., 2002). In this study, we detected that 
p42IP4 is localized both in RBM and in mitochondria of the transfected cell lines CHO and 
N2a. Moreover, in mitochondria of CHO cells, p42IP4 was found predominantly at the inner 
membrane and in the intermembrane space of mitochondria, and to a lesser degree in the 
matrix and outer membrane. Such mitochondrial localization of the p42IP4 allowed us to 
suppose that p42IP4 might be involved in the regulation of mitochondrial Ca2+ transport 
mechanisms.  
We used the mouse neuroblastoma N2a cells as an expression system as we have 
demonstrated that the N2a cells do endogenously express the p42IP4. The neuronal nature of 
N2a cells and the endogenous expression of the p42IP4 make these cells an ideal system for 
studying the mitochondrial functions. Two approaches, where Ca2+ was added either in small 
or big bolus additions, were used to compare the ability of mitochondria to accumulate and 
retain Ca2+ before PTP opening. Study of the functional parameters of mitochondria isolated 
from N2a cells transfected with p42IP4 revealed that overexpression of p42IP4 accelerates Ca2+-
induced PTP opening in mitochondria from these cells. In comparison with the mitochondria 
isolated from N2a cells transfected with p42IP4, mitochondria from N2a wild type cells can 
accumulate significantly more Ca2+ before they undergo Ca2+-induced PTP. Thus, an 
important function of mitochondrial p42IP4 in neurons seems to be regulation of mitochondrial 
Ca2+ through PTP opening.  
 90
Moreover, in comparison with mitochondria from N2a wild type cells, mitochondria 
isolated from N2a cells transfected with p42IP4 have a lower membrane potential. This could 
cause p42IP4-containing mitochondria to take up less Ca2+ and thus lead to destabilization. 
It was found that CsA did not prevent PTP opening in mitochondria isolated from N2a 
cells. Tissue-specific differences in the nature of PTP induction are already well known. In 
liver mitochondria, CsA nearly completely inhibits PTP induction, whereas in 
nonsynaptosomal brain mitochondria CsA has very modest effects (Kristal et al., 2000). It 
was also reported that only in the presence of a low concentration of exogenous ADP, CsA 
fully inhibits PTP in brain mitochondria exposed to Ca2+ (Hansson et al., 2004). Thus, the 
inhibition of the PTP by CsA depends on the model, which is used. 
Mitochondria isolated from brain represent a heterogeneous mixture from different cell 
types (Bambrick et al., 2006). Therefore, they have differing sensitivities to Ca2+ as inducer of 
PTP and to CsA as inhibitor of the PTP. It was shown that CsA increased the calcium uptake 
capacity of mitochondria isolated from astrocytes, while it had no effect on PTP in neuronal 
mitochondria. It was also observed that the astrocytes had a maximal mitochondrial calcium 
uptake capacity, which was twice as high as that of the neurons (Bambrick et al., 2006). 
Moreover, a difference in Ca2+ accumulation between synaptic and nonsynaptic mitochondria 
was shown (Brown et al., 2006). The reduced Ca2+ buffering capacity of synaptic 
mitochondria and their increased susceptibility to undergo PTP was proposed to contribute to 
synapse and neurite degeneration (Brown et al., 2006). Thus, the acceleration of Ca2+-induced 
PTP opening by overexpression of p42IP4, which we describe here, may have pathological 
implications for neurons in the brain. 
The function of “higher order” inositol phosphates, such as the ligand of p42IP4, IP4, in 
biological processes, has remained greatly a mystery (Miller et al., 2008). Early studies 
addressing the function of IP4 examined Ca2+ responses, as it was initially thought that IP3 3-
kinase functioned to regulate strictly the intracellular concentration of IP3 by simply 
converting it to IP4. Studies examining the function of IP4 in endothelial and neuroblastoma 
cells demonstrated that IP4 could directly activate Ca2+ channels in the plasma membrane 
(Luckhoff and Clapham, 1992; Tsubokawa et al., 1996; Szinyei et al., 1999). It was also 
described that IP4 inhibited IP3-activated Ca2+ permeable ion channels, which were purified 
from liver plasma membrane (Mayrleitner et al., 1995).  
Other functions for IP4 include the direct competitive inhibition of inositol phosphate 
5-phosphatase in a mast cell line, thus preventing the conversion of IP3 to IP2 and facilitating 
store-operated Ca2+ entry (Hermosura et al., 2000). However, it was demonstrated in the same 
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report that at high levels, IP4 inhibits IP3 receptors. The net effect was an inhibition of the 
Ca2+ signal. The discrepancies between some of these reports may be explained by the 
differences in the role for IP4 in specific cell types as well as the strength of IP3 receptor 
stimulation (Miller et al., 2008).  
Very recently a new function of IP4 as a negative regulator of Ca2+ was described in 
immune B cells (Miller et al., 2008). While IP3 was known to regulate positively ER-mediated 
Ca2+ release upon binding to the IP3 receptor on the ER membrane, IP4 possessed inhibitory 
functions. IP4 inhibited store-operated calcium channels. IP4 also negatively regulated the 
localization of signalling molecules in immune cells. Interestingly, it was proposed that IP4 
mediated its inhibitory function by competing with PIP3 for PH domain-containing proteins, 
and p42IP4 is one of these proteins (Miller et al., 2008).  
Moreover, the mechanism of feedback inhibition for regulating Ca2+ uptake was 
suggested to be a general for lymphocytes, as IP4 was also capable of inhibiting store-operated 
Ca2+ channels in thymocytes, and peripheral T cells (Miller et al., 2007). 
In this study, we have demonstrated the influence of p42IP4 ligands, IP4 and PIP3, on 
functions of mitochondria isolated from N2a cells under Ca2+-induced PTP opening. To check 
the possible influence of binding of the ligands to p42IP4 on mitochondrial functions, we 
compared the functional parameters of mitochondria, which were isolated from N2a wild type 
cells, or from cells transfected with p42IP4, or transfected with empty vector. The Ca2+ influx 
rate, lag time, and Ca2+ capacity of mitochondria were reduced in the presence of PIP3 or IP4 
in comparison with nontreated mitochondria from all three kinds of cells. The maximal 
decrease was observed in the lag time. Addition of IP4 significantly shortened the lag time in 
comparison with nontreated mitochondria from all three kinds of cells. Also in the presence of 
PIP3, the reduction of the rate of Ca
2+ influx, lag time and Ca2+ capacity was considerable for 
mitochondria isolated from all three kinds of cells in comparison with nontreated 
mitochondria 
Therefore, for the first time we have shown that IP4 as well as PIP3 destabilize 
mitochondria during Ca2+-induced PTP opening. However, the action of the p42IP4 ligands on 
PTP opening was found to be independent of the overexpression of p42IP4. 
4.4 Known functions of CNP  
The majority of studies investigating the role of CNP were focused exclusively on the 
expression of CNP in oligodendrocytes and Schwann cells and the involvement of CNP in 
myelinogenesis. However, there is increasing evidence showing that this enzyme has possible 
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functions in mitochondria. Thus, CNP activity was revealed in rat liver mitochondria, 
specifically in the outer and inner mitochondrial membranes (Dreiling et al., 1981). CNP was 
found to be localized in mitochondria of adrenal medullary chromaffin cell cultures and in 
mitochondria of amoeboid microglial cells (McFerran and Burgoyne, 1997; Wu et al., 2006). 
The in vivo biological roles of CNP are still largely unknown, and the possible 
function of CNP in mitochondria is even more enigmatic. Two CNP isoforms, CNP1 (46 
kDa) and CNP2 (48 kDa), were found which are encoded by a single gene (Kurihara et al., 
1992; Gravel et al., 1994). The two isoforms are due to the presence of two alternative 
translation start sites (O'Neill et al., 1997). Several posttranslational modifications of CNP, 
such as phosphorylation, isoprenylation and acylation, with unclear functional consequences 
are known (Vogel and Thompson, 1988; Sprinkle, 1989; Agrawal et al., 1990a, 1990b; De 
Angelis and Braun, 1994; Stricker et al., 1994). A recent study of transfected oligodendrocyte 
cells (OLN93), overexpressing CNP1 and CNP2 showed that CNP2 can be translocated to 
mitochondria due to the presence of a mitochondrial targeting signal at the N-terminus which 
is cleaved upon import into mitochondria (Lee et al., 2006). The translocation of CNP2 is 
regulated via phosphorylation of the targeting signal by PKC (Lee et al., 2006). Nevertheless, 
the definite functions of CNP in mitochondria were not understood. 
 
4.5 Novel function of CNP. Involvement of CNP and its substrates in 
regulation of mitochondrial Ca2+-induced PTP opening 
 
We have found that CNP localized in the inner and outer membranes of rat brain 
mitochondria. Such CNP localization in mitochondria indicates its possible concentration in 
contact sites, where the PTP complex is located. The PTP was previously considered as a 
complex formed by the association of ANT of the inner membrane and CyP-D of the matrix, 
the VDAC and PBR localized in the outer membrane and additional proteins such, as proteins 
of the Bcl-2 family, creatine kinase and hexokinase.  
The two Ant genes in mice were knocked out in hepatocytes (Kokoszka et al., 2004). 
This led to a number of secondary responses such as the upregulation of Cyt c, the down-
regulation of the uncoupling protein 2, the stimulation of the respiratory rate and an increased 
mitochondrial membrane potential. Experiments on the PTP revealed that its sensitivity for 
Ca2+ was reduced. Also, ANT ligands such as atractyloside and ADP had no modifying effect 
on the PTP anymore. Since PTP could still be induced, the authors of this study suggested that 
ANT is not essential for the PTP (Kokoszka et al., 2004). Nevertheless, the fact that the 
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deletion of the two mouse ANT forms led to only a minor effect on the PTP was surprising 
and caused several different interpretations. The first is a doubt that Ant-1/2-deficient tissues 
are indeed devoid of ANT activity. This possibility is supported by the recent discovery of 
ANT4 (Rodic et al., 2005). An alternative explanation is that other carriers of this gene family 
might substitute for ANT (Halestrap, 2004). Although recent experiments with mitochondria 
from Ant- and Vdac-deficient mice demonstrated that both proteins are not indispensable 
structural elements of the unselective pore, ANT and VDAC could still be considered as 
regulators or modulators of PTP (Baines et al., 2007; Juhaszova et al., 2008). We have shown 
the interaction of CNP with ANT and VDAC, which was the first indication of the 
involvement of CNP in regulation of mitochondrial PTP.  
Furthermore, we revealed that the enzymatic activity of CNP in RBM was reduced 
under PTP opening, whereas the levels of CNP protein detected before and after PTP opening 
were unchanged. Earlier, CNP activity was discovered in rat liver mitochondria (Dreiling et 
al., 1981) and later, in mitochondria in cultured adrenal cells (McFerran and Burgoyne, 1997). 
The finding that CNP activity in RBM decreased under Ca2+-induced PTP opening provided 
us additional evidence for CNP functioning in mitochondria.  
The functional importance of CNP in mitochondria was unequivocally confirmed by 
RNA interference experiments using OLN93 cells. These cells contain a high endogenous 
level of CNP. OLN93 cells were transfected with siRNA targeting CNP. As a result, the 
endogenous CNP protein expression level was reduced. Mitochondria isolated from CNP 
knock-down OLN93 cells possessed reduced level of CNP and decreased enzymatic CNP 
activity in comparison with mitochondria isolated from wild type OLN93 cells. Mitochondria 
isolated from scrambled non-targeting siRNA OLN93 cells served as a control. The most 
important finding in this context is that lowered level of CNP and reduced CNP activity 
correlated with facilitation of Ca2+-induced PTP opening. These results allow us to suppose 
that the CNP level and activity in mitochondria are important for the regulation of PTP 
development.  
CNP hydrolyzes 2’,3’-cyclic nucleotides and oligonucleotides containing a 2’,3’-
cyclic terminus to produce 2’-nucleotides. The influence of the CNP substrates, 2’,3’-cyclic 
nucleotides, on the mitochondrial function has not yet been investigated. In our experiments, 
we for the first time studied the effect of the CNP substrates on mitochondrial functions. We 
found that 2’,3’-cAMP and 2’,3’-cNADP did not affect Ca2+ transport and other functions in 
mitochondria having the PTP closed. However, 2’,3’-cAMP and 2’,3’-cNADP enhanced PTP 
opening after Ca2+ loading. This effect was seen on Ca2+ transport, membrane potential 
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dissipation and swelling of rat brain mitochondria. Both CNP substrates were able to shorten 
the lag time and to increase the rate of Ca2+ efflux from rat brain mitochondria during Ca2+-
induced PTP opening. 2’,3’-cGMP and 2’,3’-cCMP were not effective in induction of Ca2+-
induced PTP opening. The potency sequence of 2’,3’-cyclic nucleotides to stimulate Ca2+-
induced PTP opening in RBM was determined as: 2’,3’-cAMP >2’,3’-cNADP>> 2’,3’-
cGMP, 2’,3’-cCMP. Interestingly, the weak capacity of 2’,3’-cCMP to activate Ca2+-induced 
PTP opening is in parallel with the earlier reported lower capacity of CNP to hydrolyze 2’,3’-
cCMP compared to the cAMP analog (Drummond et al., 1962).  
The enzymatic CNP activity was decreased under Ca2+-induced PTP opening. Hence, 
hydrolysis of 2’,3’-cyclic nucleotides was prevented. Consequently, this increases the 
efficiency of the action of 2’,3’-cAMP and 2’,3’-cNADP on stimulation of the Ca2+-induced 
PTP opening in a feedback cycle. Therefore, we propose that in living cells inhibition of CNP 
activity under Ca2+-induced PTP opening in mitochondria contributes to elevating the 2’,3’-
cyclic nucleotides level. An important question is still, what are the sources of the 2’,3’- 
cyclic nucleotides in mitochondria. Oligonucleotides containing a 2’,3’-cyclic terminus could 
be generated as 2’,3’-cyclic intermediate in the enzymatic degradation of RNA as well as in 
processing and splicing reactions for mammalian RNA. On the other hand, we can suppose 
that at the conditions of our experiments, under threshold Ca2+ load the mitochondrial soluble 
adenylyl cyclase was activated by Ca2+ and 3’,5’-cAMP was produced. 2’,3’-cAMP could be 
created by transformation of the 3’,5’-cyclic terminus to the 2’,3’-cyclic one. This can occur 
in alkaline conditions, which are prevalent in mitochondria under threshold Ca2+ load. 
Thus, CNP substrates, 2’,3’-cAMP and 2’,3’-cNADP, in turn seem to work as second 
messengers by promoting the mitochondrial PTP opening.  
4.6 Hypothesis for functional importance of interaction between p42IP4, 
CNP and α-tubulin in mitochondria.  
 
Several protein interaction partners of p42IP4 were determined. Among these are 
protein kinases, such as casein kinase I (Dubois et al., 2001), and PKC (Zemlickova et al., 
2003), several ARFs (Thacker et al., 2004; Venkateswarlu et al., 2004), F-actin (Thacker et 
al., 2004) and nucleolin (Dubois et al., 2003). More recently, further interesting protein 
interactions were reported for p42IP4. Among these proteins were (i) the kinesin motor protein 
KIF13B/ GAKIN (Venkateswarlu et al., 2005; Horiguchi et al., 2006), (ii) the peptidase 
nardilysin, a N-arginine dibasic convertase (Stricker et al., 2006), and (iii) the Ran binding 
protein in microtubule-organizing centre, RanBPM (Haase et al., 2008). While a variety of 
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protein interaction partners of p42IP4 in different cellular compartments were determined, no 
proteins interacting with p42IP4 in mitochondria have been found so far. 
In the present study, we demonstrated that p42IP4 is specifically associated with CNP 
and α-tubulin in mitochondrial and cytosolic fractions of rat brain by pull-down assay. 
Interestingly, the co-immunoprecipitation of p42IP4 and CNP was observed only in 
mitochondria but not in the cytosol. The co-immunoprecipitation can be taken as evidence for 
in vivo interaction between the respective proteins. Since technically it was not possible to 
show interaction all three proteins at the same time, therefore we demonstrated co-
immunoprecipitation of p42IP4 with CNP, p42IP4 with α-tubulin, and CNP with α-tubulin in 
mitochondrial fraction. These co-immunoprecipitations led us to suggestion that in vivo 
complex formed between p42IP4, CNP and α-tubulin in rat brain mitochondria. 
CNP is one of the major proteins of myelin. Myelin-producing oligodendrocytes play 
an essential role in supporting normal neuronal functions of the mammalian central nervous 
system. Cnp1-null mice appeared to myelinate normally but suffered severe 
neurodegeneration from axonal loss with increasing age (Lappe-Siefke et al., 2003). Further 
analysis revealed that CNP deficiency caused major abnormalities to the structure of the 
paranodal loops of the optic nerves of mice as early as 3 months of age, which is before any 
visible onset of axonal degeneration (Rasband et al., 2005). Paranodal loops contact the 
axolemma for axon–glial signalling, which is critical for axonal integrity and organization 
(Salzer, 2003). Therefore, it was suggested that the loss of CNP from myelin disrupts axon– 
glial interactions which in turn causes many axons to degenerate (Rasband et al., 2005). Thus, 
in myelinating glia the function of CNP is crucial in maintaining axonal integrity. Moreover, 
expression of CNP in developing neuronal cells was revealed (Cho et al., 2003). These 
findings suggest significant contribution of CNP to the functioning of neurons.  
Another protein that binds to p42IP4 is α-tubulin, protein belonging to MT. We 
hypothesize that an association between p42
IP4
, CNP and α-tubulin in mitochondria can be 
implicated in the regulation of Ca2+ signalling by different cellular organelles. Fig. 4.1 shows 
our hypothesis based on present findings and data from the current literature. 
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Fig. 4.1. Hypothesis for in vivo complex formation 
between p42IP4, α-tubulin and CNP in mitochondria and 
its possible involvement in intracellular regulation of Ca2+ 
signalling. 
Mitochondria and ER take up cytoplasmic Ca2+ and can 
correspondingly release Ca2+ into the cytoplasm. MT, the 
self-assembly of α- and β-tubulin heterodimers, are 
additionally needed to keep ER and mitochondria together. 
For simplification of the figure, the second component of 
microtubules (MT), β-tubulin, is not shown. CNP interacts 
with regulatory components of PTP, VDAC and ANT, 
which are not shown here. α-Tubulin associates with CNP 
and VDAC. CNP interacts with α-tubulin and p42IP4 in 
mitochondria. p42IP4 binds to CNP and to α-tubulin in 
mitochondria. CNP and p42IP4 regulate the Ca2+-induced 
opening of PTP. Complex formed between p42IP4, α-tubulin 
and CNP connects MT and mitochondria and possibly is 
involved in Ca2+ signalling between mitochondria and 
ER/cytosol through regulation of PTP. (Modified from 
(Mironov et al., 2005)). 
Mitochondria and ER take up cytoplasmic Ca2+ and can correspondingly release Ca2+ 
into the cytoplasm. Indeed, a major functional interaction between mitochondria and the ER is 
the control of Ca2+ signalling. This is because Ca2+ exchange between the ER and 
mitochondria not only has a crucial role in regulating the physical interactions between the 
two organelles, but it also regulates a variety of physiological processes, including apoptosis  
and necrosis (Pizzo and Pozzan, 2007). Recently, a functional link between ER, Ca2+ and 
proapoptotic mitochondrial alterations was revealed. It was shown that ER stress results in the 
IP3 receptor-mediated release of Ca2+, which in turn causes mitochondrial membrane 
permeabilization. Thus, PTP opening was revealed to be required for ER stress-induced 
apoptosis (Deniaud et al., 2008). 
MT, the self-assembly of α- and β-tubulin heterodimers, are additionally needed to 
keep ER and mitochondria together (Mironov et al., 2005). Close interactions of MT with 
mitochondria in living neurons and with isolated mitochondria were revealed. Moreover, the 
MT network was shown to play an important role in the maintenance of mitochondrial 
functions by regulating PTP opening and positioning of mitochondria close to the ER 
(Mironov et al., 2005). Coordination of basal cytoplasmic Ca2+ signalling between 
mitochondria and ER by MT can control neuronal functions. Among these functions, there 
were the temporal integration of cytoplasmic Ca2+ dynamics and long-term changes in Ca2+ 
that underlie synaptic plasticity (Levy et al., 2003; Loewenstein and Sompolinsky, 2003). 
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α-Tubulin was shown to be a component of mitochondrial membranes specifically 
interacting with the VDAC (Carre et al., 2002). VDAC mediates the complex interactions 
between mitochondria and other parts of the cell by transporting anions, cations, ATP, Ca2+ 
and metabolites. Thus, VDAC plays an important role in coordinating the communication 
between mitochondria and cytosol (Grimm and Brdiczka, 2007). Moreover, there were some 
indications that VDAC may be part of mitochondrial microdomains linking Ca2+ efflux from 
the ER to mitochondrial matrix Ca2+ influx, in itself a potent trigger of PTP (Szabadkai et al., 
2006).  
CNP interacts with regulatory components of PTP, VDAC and ANT. Thus, CNP and 
α-tubulin binding to each other also associate with PTP. p42IP4 binds to CNP and to α-tubulin 
in RBM. Therefore, the complex, which is formed by p42IP4, CNP and α-tubulin, connects 
MT and mitochondria. Moreover, p42
IP4
and CNP are involved in control of Ca2+-induced PTP 
opening. Therefore, one of the important functions of this connection between MT and 
mitochondria could be the regulation of Ca2+ signalling between cellular organelles through 
regulation of PTP. 
Thus, we hypothesize that in the brain p42IP4 possibly acts together with CNP and α–
tubulin in order to regulate mitochondrial Ca2+ transport mechanisms. The reduction of 
mitochondrial Ca2+ buffering capacity induced by p42IP4 may increase the vulnerability of 
neurons to PTP and thereby contribute to processes leading to neurodegeneration.  
This hypothesis could also be applied to AD development. Indeed, it was described 
that in neocortical areas of AD patients the neuronal expression of the protein p42IP4 is 
markedly increased, and the protein is associated with neuritic plaques (Reiser and Bernstein, 
2002). Moreover, p42IP4 interacts with the protein kinase CK Iα (Dubois et al., 2001), which 
hyperphosphorylates β-amyloid precursor protein in the brains of AD patients (Walter et al., 
2000). Specific interaction of p42IP4 with nucleolin, another player in AD pathology, has also 
been revealed (Dubois et al., 2003). However, the significance of the increase in p42IP4 protein 
expression in terms of AD pathology is still unknown (Reiser and Bernstein, 2004). Our 
recent finding that nardilysin is an interacting partner for p42IP4 (Stricker et al., 2006) might 
also be of interest regarding the possible involvement of p42IP4 in AD pathology. Nardilysin 
enhances the cleavage of amyloid precursor protein by α-secretase through the activation of a 
disintegrin and metalloprotease proteases, which results in a decreased amount of amyloid-β 
peptide, the principal component of senile plaques in the brains of patients with AD (Hiraoka 
et al., 2007). 
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Involvement of CNP in AD was claimed in several studies. However, its role is still 
completely unclear. In AD patients, the activity of CNP was shown to be decreased in the 
hippocampus and putamen (Reinikainen et al., 1989). Another study showed a significant 
decrease in CNP protein in AD brain (Vlkolinsky et al., 2001), in contrast to a recent report, 
which demonstrated that the protein level of CNP in AD hippocampus was increased (Sultana 
et al., 2007).  
Neurodegeneration in AD has been linked to dysregulation of intracellular Ca2+  
(Giacomello et al., 2007). In an adult triple transgenic mouse model of AD that exhibits 
intraneuronal accumulation of amyloid-β proteins, the resting free Ca2+ concentration was 
shown to be greatly elevated in cortical neurons (Lopez et al., 2008). This Ca2+ deregulation in 
the AD brain may be associated with defective mitochondrial functions. Moreover, in neurons 
from AD brain, morphological alterations of mitochondria were revealed (Baloyannis, 2006). 
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4.7 Conclusions. Novel regulators of Ca2+-induced PTP opening. 
In summary, the results obtained here suggest that p42IP4 and CNP in mitochondria 
play a role in regulation of mitochondrial Ca2+ transport mechanisms in the brain. The 
influence of p42IP4 and CNP as well as their substrates/ligands on Ca2+-induced PTP opening 
is summarized in Figure 4.2.  
Fig. 4.2. The influence of the p42IP4 
and its ligands on Ca2+-induced 
PTP opening. The influence of 
CNP and its substrates on Ca2+-
induced PTP opening. 
Overexpression of p42IP4 accelerate 
Ca2+-induced PTP opening. Ligands 
of p42IP4 (here only IP4 is shown) 
stimulate PTP opening. CNP-
knockdown stimulates PTP opening, 
thus we suppose that CNP 
suppresses PTP development. 
Inhibition of CNP activity under 
Ca2+-induced PTP leads to elevation 
of 2’,3’cyclic nucleotides levels 
(here only 2’,3’-cAMP is shown), 
promoting PTP development. In 
addition, p42IP4 interacts with CNP 
in vitro and in vivo in mitochondria. 
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Importantly, here we have shown that p42IP4 stimulates Ca2+-induced PTP opening. 
The destabilization of mitochondria during Ca2+-induced PTP opening by overexpression of 
p42IP4 may have dramatic consequences for neuronal survival. Additionally, p42IP4 ligands, 
IP4 and PIP3, significantly accelerate Ca2+-induced PTP opening.  
Furthermore, a regulatory role of CNP in PTP opening was established. This is derived 
from our findings that CNP knockdown facilitates Ca2+-induced PTP opening. Interestingly, 
CNP activity was reduced under Ca2+-induced PTP opening. Therefore, the intra-
mitochondrial 2’,3’-cyclic nucleotides level might be elevated due to inhibition of CNP 
activity under Ca2+-induced PTP opening. In addition, CNP substrates, 2’,3’-cAMP and 2’,3’-
cNADP, enhanced PTP development. Thus, 2’,3’-cAMP and 2’,3’-cNADP might probably 
act as a second messengers.  
Taken together, our results support the suggestion that p42IP4 and CNP are involved in 
regulation of Ca2+-induced PTP opening, important stage of initiation of cell death and, 
consequently, of the processes leading to neurodegenerative diseases. 
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5. Abstract 
The neuronal protein p42IP4 was suggested to be involved in neurodegenerative 
processes. To find out a role of p42IP4 in cell death, we detected apoptosis in control and 
p42IP4 overexpressing mouse neuroblastoma (N2a) cells by caspase-3 assay, DNA-laddering 
assay and flow cytometry analysis. We have shown that p42IP4 is not involved in apoptosis. 
However, we observed that p42IP4 had an effect on cell cycle. 
Cellular Ca2+ signals are crucial in the control of most physiological processes, cell 
injury and cell death. Mitochondria play a central role in cellular Ca2+ signalling. During 
cellular Ca2+ overload, mitochondria take up cytosolic Ca2+, which, in turn, can lead to 
opening of the permeability transition pore (PTP). Although Ca2+-dependent PTP has been 
implicated in a broad range of cell death pathways, the exact mechanism of the PTP opening 
remains elusive.  
Previously, p42IP4 was identified in brain membrane fraction, which also contained 
mitochondria. Some other data indicate possible localization of p42IP4 in mitochondria. 
Therefore, this important question was studied here.  
We determined for the first time mitochondrial localization of p42IP4. Moreover, in rat 
brain mitochondria (RBM), we found interaction of p42IP4 with 2',3'-cyclic nucleotide 3'-
phosphodiesterase (CNP) and α-tubulin by pull-down binding assay and by 
immunoprecipitation.  
Localization of p42IP4 and CNP in the inner membrane fraction of mitochondria 
prompted us to study whether p42IP4 and CNP are involved in regulation of mitochondrial 
Ca2+-induced PTP. Simultaneous measurements of the respiratory rate, trans-membrane 
potential, and Ca2+ transport in the mitochondrial suspension were performed. We determined 
the rate of Ca2+ influx, Ca2+ capacity and lag time for PTP opening in mitochondria isolated 
from p42IP4-transfected and from control N2a cells. Overexpression of p42IP4 led to promotion 
of Ca2+-induced PTP opening. Furthermore, p42IP4 ligands, 
phosphatidylinositol(3,4,5)trisphosphate and inositol(1,3,4,5)tetrakisphosphate, accelerated 
PTP opening in mitochondria isolated from N2a cells. 
We found the interaction of CNP with modulators of PTP, adenine nucleotide 
transporter and voltage-dependent anion channel. The enzymatic activity of CNP was reduced 
under PTP opening. Involvement of CNP in PTP operation was confirmed in experiments 
using mitochondria isolated from CNP-knock-down oligodendrocyte cell line (OLN93). In 
mitochondria isolated from OLN93 cells transfected with CNP-targeting small interfering 
RNA, CNP reduction was correlated with facilitation of Ca2+-induced PTP opening. The CNP 
substrates, 2’,3’- cyclic AMP and 2’,3’- cyclic NADP, enhanced PTP development in RBM.  
In summary, our results suggest that p42IP4 and CNP in mitochondria play a role in 
regulation of mitochondrial Ca2+ transport mechanisms in the brain. While Ca2+-induced PTP 
opening is important stage of initiation of cell death, consequently we hypothesize that in the 
brain p42IP4 and CNP contribute to processes leading to neurodegenerative diseases. 
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6. Zusammenfassung 
 
Verschiedene in der Literatur beschriebene Befunde deuten auf die Bedeutung des 
gehirnspezifischen Proteins p42IP4 bei neurodegenerativen/neuroprotektiven Prozessen hin. 
p42IP4 wird auch als Centaurin α-1, und nach einem neueren Vorschlag als ADAP1 
bezeichnet. Ein Ziel der vorliegenden Arbeit war aufzuklären, ob p42IP4 eine Rolle bei 
Neuroprotektion oder Zelltod spielt.  
In einem ersten Ansatz wurden die Auswirkungen der Überexpression von p42IP4 auf 
die induzierte Apoptose untersucht. Dazu wurde die Mäuse-Neuroblastoma-Zelllinie N2a 
eingesetzt. Der Nachweis der Apoptose in den N2a-Zellen erfolgte mittels Caspase-3-Assay, 
DNA-Fragmentierung und Durchflusszytometrie. Hierbei ergaben sich keine Hinweise auf 
eine direkte Beteiligung von p42IP4 an der Apoptose. Wir konnten aber feststellen, dass die 
Überexpression von p42IP4 einen Effekt auf die Verteilung der Zellen im Zellzyklus hat. In 
den p42IP4 überexprimierenden Zellen kam es zu einer Verschiebung des Anteils der Zellen 
von der G2-Phase zur S-Phase. 
Mitochondrien spielen eine zentrale Rolle in der zellulären Ca2+-Homöostase und 
beim Ca2+-Signalling. Bei der Überladung von Zellen mit Ca2+ können Mitochondrien große 
Menge an Ca2+ aufnehmen, was in der Folge zur Öffnung der Permeabilitätstransitionspore 
(PTP) führen kann. Die Beteiligung einer Ca2+-abhängigen PTP an vielen zu Zelltod und 
Gewebsschädigungen führenden Vorgängen konnte gezeigt werden. Aber der genaue 
Mechanismus der PTP ist noch weitgehend unbekannt. Daher ist die Suche nach neuen 
Proteinen und Molekülen, die an der Kontrolle der Ca2+-induzierten PTP beteiligt sind äußerst 
wichtig. 
p42IP4 wurde ursprünglich in Membranfraktionen aus Gehirn identifiziert, die auch 
Mitochondrien enthielten. Das Hefeprotein Gsc1p, das strukturell und funktionell mit p42IP4 
eng verwandt ist, ist an der Aufrechterhaltung der mitochondrialen Morphologie beteiligt. 
p42IP4 interagiert mit Proteinkinase C Isoformen, für die ebenfalls eine mitochondriale 
Lokalisation beschrieben wurde. Eine hohe Wahrscheinlichkeit für eine mitochondriale 
Lokalisation von p42IP4 wurde durch das Programm PSORTII vorhergesagt. Diese Befunde 
deuteten auf eine mögliche mitochondriale Lokalisation und Funktion von p42IP4 hin. Daher 
wurde diese wichtige Fragestellung in der vorliegenden Arbeit untersucht. 
Wir konnten mit verschiedenen Methoden erstmals eine mitochondriale Lokalisation 
von p42IP4 in Mitochondrien aus Rattenhirn, sowie aus N2A- und CHO-Zellen zeigen. 
Darüberhinaus fanden wir mittels Glutathion-S-Transferase Pull-Down-Versuchen und 
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Koimmunopräzipitation eine Interaktion von p42IP4 mit den Proteinen 2',3'-cyklische 
Nukleotid 3'-Phosphodiesterase (CNP) und α-Tubulin.  
Wir untersuchten die Verteilung von p42IP4 und CNP in den mitochondrialen 
Kompartimenten durch Subfraktionierung von Mitochondrien. Die Lokalisation von p42IP4 
und CNP in der inneren Membranfraktion und in Kontaktstellen zwischen innerer und äußerer 
Membran deuteten auf eine funktionelle Rolle beider Proteine in Mitochondrien hin. Daher 
wurden im Folgenden Studien zur möglichen Beteiligung von p42IP4 und CNP an der 
mitochondrialen Ca2+- induzierten PTP durchgeführt. Wir etablierten eine Methode zur 
Isolierung von funktionell aktiven Mitochondrien aus Zellkulturen und untersuchten 
mitochondriale Funktionen während der Ca2+- induzierten PTP. Eine simultane Messung der 
Atmungsrate, des Ca2+-Transports und des mitochondrialen Membranpotenzials in 
Mitochondriensuspensionen erfolgte in einer offenen Messkammer. Dabei wurden selektive 
Elektroden für O2, Ca2+ und Tetraphenylphosphonium (TPP+) eingesetzt. Letztere diente zur 
Membranpotentialmessung. Damit wurden die Geschwindigkeit des Ca2+-Einstroms, die Ca2+-
Kapazität und die Verzögerungszeit für die Ca2+-induzierte PTP bestimmt. Es wurden 
Messungen für Mitochondrien aus p42IP4-transfizierten und nichttransfizierten N2a-Zellen 
durchgeführt. Die Überexpression von p42IP4 führte zu einer signifikanten Forcierung der 
Ca2+-induzierten Öffnung der PTP. Phosphatidylinositol(3,4,5)trisphosphat und 
Inositol(1,3,4,5)tetraphosphat, beides spezifische Liganden für p42IP4, beschleunigten die 
Öffnung der PTP in Mitochondrien aus N2a-Zellen. Erstaunlicherweise war dieser Einfluss 
der p42IP4-Liganden auf die PTP-Öffnung unabhängig von der Überexpression von p42IP4.  
In Rattenhirnmitochondrien fanden wir mittels Koimmunopräzipitation eine 
Proteinwechselwirkung von CNP mit Modulatoren der PTP, dem Adeninnukleotid-
Transporter (ANT) und dem spannungsabhängigen Anionen-Kanal (VDAC). Darüberhinaus 
konnten wir zeigen, dass die Enzymaktivität von CNP bei der PTP-Öffnung reduziert war, 
während der CNP-Proteingehalt gleich blieb. Eine Beteiligung von CNP an der PTP-
Regulation wurde in weiteren Experimenten bestätigt, bei denen Mitochondrien aus OLN93-
Zellen, einer Oligodendrozyten-Zelllinie, verwendet wurden, bei denen CNP durch 
Transfektion mit siRNA herunterreguliert wurde. In den Mitochondrien aus diesen Zellen 
korrelierte die Reduktion der CNP-Expression mit einer  Erniedrigung der Schwelle für eine 
Ca2+-induzierte PTP Bildung. Des Weiteren erhöhten 2',3'-cAMP und 2',3'-cyklisches NADP, 
beides Substrate der CNP, die PTP Bildung in Mitochondrien aus Rattenhirn. 
Zusammenfassend zeigen die hier beschriebenen Ergebnisse, dass p42IP4 und CNP in 
Mitochondrien eine wichtige Funktion bei der Regulation mitochondrialer Ca2+-
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Transportvorgänge im Gehirn ausüben. Da die Ca2+-induzierte PTP-Bildung einen wichtigen 
Schritt bei der Einleitung des Zelltods darstellt, könnten p42IP4 und CNP an Prozessen 
beteiligt sein, die zu neurodegenerativen Krankheiten führen.  
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8. Abbreviations  
 
2’,3’-cAMP, 2’,3’cyclic AMP; 
2’,3’-cGMP, 2’,3’cyclic GMP; 
2’,3’-cNADP, 2’,3’cyclic NADP; 
Ab, antibody; 
AD, Alzheimer’s disease; 
ADAP, a Dual PH domain ARF GAP; 
ANT, adenine nucleotide transporter;  
ARF GAP, ARF GTPase activating protein; 
ARF, ADP ribosylation factor;  
ATP, adenosine 5-triphosphate; 
BSA, bovine serum albumin; 
CHO, Chinese hamster ovary cells; 
CK I, casein kinase I; 
CNP, 2', 3'-cyclic nucleotide 3'-phosphodiesterase; 
COXIV, cytochrome oxidase subunit IV; 
CsA, cyclosporin A; 
CyP-D, cyclophilin D;  
Cyt c, cytochrome c; 
DMEM, Dulbecco’s Modified Eagle’s Medium; 
DNA, deoxyribonucleic acid; 
EDTA, ethylene diamaine tetraacetic acid; 
EGF, epidermal growth factor; 
EGTA, ethylene glycol tetraacetic acid; 
ER, endoplasmic reticulum; 
FCS, fetal calf serum; 
G418, Geneticin sulphate; 
GST, glutathione S-transferase; 
HEK293, human embryonic kidney cell line; 
IM/IMM, inner mitochondrial membrane; 
IMS, intermembrane space; 
IP3, inositol (1,4,5) trisphosphate;  
IP4, inositol(1,3,4,5)tetrakisphosphate; 
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KIF, kinesin; 
MT, microtubules; 
Mx, matrix; 
N2a, mouse neuroblastoma cells; 
OLN-93, oligodendrocyte cell line; 
OM/OMM outer mitochondrial membrane; 
PAGE, polyacrylamide gel electrophoresis; 
PBR, peripheral benzodiazepine receptor; 
PBS, phosphate-buffered saline; 
PCR, polymerase chain reaction; 
pEGFP-C2, enhanced green fluorescencent protein expression vector; 
PH, pleckstrin homology; 
PI 3-K, phoshoinositide 3-kinase or phosphatidylinositol 3-kinase;  
PiC, mitochondrial phosphate carrier; 
PIP2, phosphatidylinositol(4,5)bisphosphate; 
PIP3 BP, phosphatidylinositoltrisphosphate binding protein;  
PIP3, phosphatidylinositol(3,4,5)trisphosphate; 
PKC, protein kinase C; 
PTP, permeability transition pore; 
RanBPM, Ran binding protein in microtubule-organizing centre; 
RBM, rat brain mitochondria; 
ROS, reactive oxygen species; 
SDS, sodium dodecyl sulphate; 
siRNA, small interfering RNA; 
SOD2, Mn-superoxide dismutase; 
STS, staurosporin; 
TPP+, tetraphenylphosphonium;  
VDAC, voltage-dependent anion channel; 
Δψm, mitochondrial membrane potential. 
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